,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
1421,GO:0030258,0.00228809722021069,0.999573025948921,13,20,lipid modification,BP,HACL1;ACAT1;ACADVL;ACAA2;ABCG1;ACAT2;ECI1;ETFDH;DECR1;FGF18;CPT1C;ZFYVE21;ETFB
518,GO:0006635,0.00273585968848033,0.999679363449686,9,12,fatty acid beta-oxidation,BP,ACAT1;ACADVL;ACAA2;ACAT2;ECI1;ETFDH;DECR1;CPT1C;ETFB
789,GO:0009062,0.00281812561202955,0.999602912174915,10,14,fatty acid catabolic process,BP,HACL1;ACAT1;ACADVL;ACAA2;ACAT2;ECI1;ETFDH;DECR1;CPT1C;ETFB
3046,GO:0072329,0.00609745018409845,0.998924765793181,10,15,monocarboxylic acid catabolic process,BP,HACL1;ACAT1;ACADVL;ACAA2;ACAT2;ECI1;ETFDH;DECR1;CPT1C;ETFB
1282,GO:0019395,0.0112326045788902,0.99764088227818,10,16,fatty acid oxidation,BP,HACL1;ACAT1;ACADVL;ACAA2;ACAT2;ECI1;ETFDH;DECR1;CPT1C;ETFB
1773,GO:0034440,0.0112326045788902,0.99764088227818,10,16,lipid oxidation,BP,HACL1;ACAT1;ACADVL;ACAA2;ACAT2;ECI1;ETFDH;DECR1;CPT1C;ETFB
879,GO:0009887,0.0206832396533305,1,4,4,animal organ morphogenesis,BP,RBP4;TH;PSMB10;FGF18
2372,GO:0046488,0.0236056493756221,1,4,4,phosphatidylinositol metabolic process,BP,PLA2G16;FGF18;ZFYVE21;DPM3
880,GO:0009888,0.0265811715955913,0.995470014682306,7,10,tissue development,BP,ACAT1;RBP4;ACADVL;KRT10;PSMB10;PLA2G16;FGF18
352,GO:0005515,0.0300162648832422,0.988496457870467,31,74,protein binding,MF,HACL1;ACAT1;PXMP2;PXK;RBP4;CNIH4;ARL6IP4;ACAA2;TH;NUDT7;TSFM;ABCG1;ACAT2;BOLA1;DEPTOR;FADD;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;LINGO1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;PEPD;IFI30
382,GO:0005759,0.0328407791618848,0.990760620209146,10,18,mitochondrial matrix,CC,ACAT1;MRPL14;ACADVL;ACAA2;PUS1;TSFM;ECI1;ETFDH;DECR1;ETFB
1102,GO:0016054,0.0382525776749158,0.988885252392983,10,18,organic acid catabolic process,BP,HACL1;ACAT1;ACADVL;ACAA2;ACAT2;ECI1;ETFDH;DECR1;CPT1C;ETFB
2350,GO:0046395,0.0382525776749158,0.988885252392983,10,18,carboxylic acid catabolic process,BP,HACL1;ACAT1;ACADVL;ACAA2;ACAT2;ECI1;ETFDH;DECR1;CPT1C;ETFB
1713,GO:0033539,0.0396175711496874,1,3,3,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,ACADVL;ETFDH;ETFB
243,GO:0003988,0.0404754691015196,1,3,3,acetyl-CoA C-acyltransferase activity,MF,ACAT1;ACAA2;ACAT2
2156,GO:0044255,0.0412566895796885,0.983616307299093,18,39,cellular lipid metabolic process,BP,HACL1;ACAT1;RBP4;ACADVL;ACAA2;TH;NUDT7;ABCG1;ACAT2;ECI1;ETFDH;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB
2865,GO:0061448,0.0470271565118414,1,3,3,connective tissue development,BP,ACAT1;PLA2G16;FGF18
1559,GO:0031974,0.0503162614980558,0.978757536335877,20,45,membrane-enclosed lumen,CC,HACL1;MSRA;ACAT1;MRPL14;ACADVL;ARL6IP4;ACAA2;PUS1;NUDT7;TSFM;ACAT2;ECI1;ETFDH;PSMB10;LAGE3;TBC1D14;DECR1;FGF18;ETFB;IFI30
2072,GO:0043233,0.0503162614980558,0.978757536335877,20,45,organelle lumen,CC,HACL1;MSRA;ACAT1;MRPL14;ACADVL;ARL6IP4;ACAA2;PUS1;NUDT7;TSFM;ACAT2;ECI1;ETFDH;PSMB10;LAGE3;TBC1D14;DECR1;FGF18;ETFB;IFI30
2877,GO:0070013,0.0503162614980558,0.978757536335877,20,45,intracellular organelle lumen,CC,HACL1;MSRA;ACAT1;MRPL14;ACADVL;ARL6IP4;ACAA2;PUS1;NUDT7;TSFM;ACAT2;ECI1;ETFDH;PSMB10;LAGE3;TBC1D14;DECR1;FGF18;ETFB;IFI30
2197,GO:0044446,0.055553498765224,0.976302176625782,30,76,intracellular organelle part,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;ACADVL;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;ECI1;KRT10;ETFDH;PSMB10;LAGE3;TBC1D14;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
2073,GO:0043234,0.0599344493614245,0.985861609666335,7,11,protein complex,CC,PXMP2;PXK;RBP4;ETFDH;FADD;PSMB10;HNF1A
1117,GO:0016197,0.0613356421684703,1,2,2,endosomal transport,BP,TBC1D14;ZFYVE21
1142,GO:0016482,0.0613356421684703,1,2,2,cytosolic transport,BP,TBC1D14;ZFYVE21
1918,GO:0042147,0.0613356421684703,1,2,2,retrograde transport, endosome to Golgi,BP,TBC1D14;ZFYVE21
1096,GO:0016042,0.0616813399654005,0.978594876631214,11,21,lipid catabolic process,BP,HACL1;ACAT1;ACADVL;ACAA2;ACAT2;ECI1;ETFDH;PLA2G16;DECR1;CPT1C;ETFB
2168,GO:0044282,0.0622307917713751,0.979347560371486,10,19,small molecule catabolic process,BP,HACL1;ACAT1;ACADVL;ACAA2;ACAT2;ECI1;ETFDH;DECR1;CPT1C;ETFB
1181,GO:0016746,0.0656637489523916,0.987564395947585,5,8,transferase activity, transferring acyl groups,MF,ACAT1;ACAA2;ACAT2;PLA2G16;CPT1C
2182,GO:0044422,0.069215135819339,0.969389059727548,30,77,organelle part,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;ACADVL;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;ECI1;KRT10;ETFDH;PSMB10;LAGE3;TBC1D14;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
2152,GO:0044242,0.0702472856989871,0.976029346015175,10,19,cellular lipid catabolic process,BP,HACL1;ACAT1;ACADVL;ACAA2;ACAT2;ECI1;ETFDH;DECR1;CPT1C;ETFB
2459,GO:0048193,0.0777584899742242,1,2,2,Golgi vesicle transport,BP,CNIH4;TBC1D14
2065,GO:0043226,0.0791733921397439,0.981874371795022,41,112,organelle,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;TMEM160;CNIH4;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;BOLA1;ECI1;KRT10;ETFDH;CCDC51;FADD;PSMB10;LYPLAL1;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;PEPD;IFI30
1097,GO:0016043,0.0796577539822825,0.967913503556787,13,27,cellular component organization,BP,HACL1;ACAT1;MRPL14;ACAA2;PUS1;ABCG1;DEPTOR;FADD;TBC1D14;HNF1A;PLA2G16;LINGO1;DECR1
2066,GO:0043227,0.0801570667534965,0.977284148604412,40,108,membrane-bounded organelle,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;RBP4;ACADVL;TMEM160;CNIH4;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;BOLA1;ECI1;KRT10;ETFDH;CCDC51;FADD;PSMB10;LYPLAL1;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;PEPD;IFI30
1561,GO:0031981,0.0864563539903388,0.969897992208569,9,18,nuclear lumen,CC,MSRA;ACADVL;ARL6IP4;ACAT2;PSMB10;LAGE3;TBC1D14;DECR1;FGF18
368,GO:0005622,0.0876813442052831,0.97959224031869,41,113,intracellular,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;TMEM160;CNIH4;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;BOLA1;ECI1;KRT10;ETFDH;CCDC51;DEPTOR;FADD;PSMB10;LYPLAL1;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
2183,GO:0044424,0.0876813442052831,0.97959224031869,41,113,intracellular part,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;TMEM160;CNIH4;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;BOLA1;ECI1;KRT10;ETFDH;CCDC51;DEPTOR;FADD;PSMB10;LYPLAL1;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
5,GO:0000045,0.0883747752870584,1,1,1,autophagosome assembly,BP,TBC1D14
318,GO:0005096,0.0883747752870584,1,1,1,GTPase activator activity,MF,TBC1D14
601,GO:0006906,0.0883747752870584,1,1,1,vesicle fusion,BP,TBC1D14
920,GO:0010507,0.0883747752870584,1,1,1,negative regulation of autophagy,BP,TBC1D14
1098,GO:0016050,0.0883747752870584,1,1,1,vesicle organization,BP,TBC1D14
1121,GO:0016236,0.0883747752870584,1,1,1,macroautophagy,BP,TBC1D14
1122,GO:0016241,0.0883747752870584,1,1,1,regulation of macroautophagy,BP,TBC1D14
1455,GO:0030695,0.0883747752870584,1,1,1,GTPase regulator activity,MF,TBC1D14
1517,GO:0031338,0.0883747752870584,1,1,1,regulation of vesicle fusion,BP,TBC1D14
2143,GO:0044088,0.0883747752870584,1,1,1,regulation of vacuole organization,BP,TBC1D14
2228,GO:0044801,0.0883747752870584,1,1,1,single-organism membrane fusion,BP,TBC1D14
2464,GO:0048284,0.0883747752870584,1,1,1,organelle fusion,BP,TBC1D14
2840,GO:0060589,0.0883747752870584,1,1,1,nucleoside-triphosphatase regulator activity,MF,TBC1D14
2851,GO:0061025,0.0883747752870584,1,1,1,membrane fusion,BP,TBC1D14
2946,GO:0070925,0.0883747752870584,1,1,1,organelle assembly,BP,TBC1D14
3032,GO:0071955,0.0883747752870584,1,1,1,recycling endosome to Golgi transport,BP,TBC1D14
3090,GO:0090174,0.0883747752870584,1,1,1,organelle membrane fusion,BP,TBC1D14
3117,GO:0090630,0.0883747752870584,1,1,1,activation of GTPase activity,BP,TBC1D14
3302,GO:1902115,0.0883747752870584,1,1,1,regulation of organelle assembly,BP,TBC1D14
3434,GO:1905037,0.0883747752870584,1,1,1,autophagosome organization,BP,TBC1D14
3496,GO:2000785,0.0883747752870584,1,1,1,regulation of autophagosome assembly,BP,TBC1D14
374,GO:0005654,0.088487487459008,0.976436514664776,6,11,nucleoplasm,CC,MSRA;ARL6IP4;PSMB10;LAGE3;TBC1D14;DECR1
3158,GO:0098552,0.0919962113440593,1,2,2,side of membrane,CC,TH;ABCG1
3018,GO:0071840,0.0945574649420057,0.96013013248383,13,28,cellular component organization or biogenesis,BP,HACL1;ACAT1;MRPL14;ACAA2;PUS1;ABCG1;DEPTOR;FADD;TBC1D14;HNF1A;PLA2G16;LINGO1;DECR1
1434,GO:0030425,0.0968866316386407,1,2,2,dendrite,CC,TH;CPT1C
345,GO:0005488,0.100925575256395,0.958604130187646,36,96,binding,MF,HACL1;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;CNIH4;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ABCG1;ACAT2;BOLA1;ETFDH;DEPTOR;FADD;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;LINGO1;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;PEPD;IFI30
2831,GO:0060429,0.101850489198494,0.98274344029947,4,6,epithelium development,BP,ACAT1;ACADVL;KRT10;PSMB10
1136,GO:0016408,0.112257877428353,0.988054921894441,3,4,C-acyltransferase activity,MF,ACAT1;ACAA2;ACAT2
2070,GO:0043231,0.117923126652228,0.949817683777937,36,95,intracellular membrane-bounded organelle,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;ACADVL;TMEM160;CNIH4;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;BOLA1;ECI1;KRT10;ETFDH;CCDC51;FADD;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;DPM3;ETFB;IFI30
2159,GO:0044260,0.120118995478234,0.941950726106778,17,40,cellular macromolecule metabolic process,BP,MSRA;MRPL14;ARL6IP4;PUS1;TSFM;ALG5;ABCG1;KRT10;DEPTOR;FADD;PSMB10;LYPLAL1;LAGE3;HNF1A;FGF18;DPM3;ETFB
377,GO:0005739,0.120182522508444,0.940388848135917,20,47,mitochondrion,CC,MSRA;ACAT1;MRPL14;ACADVL;TMEM160;ACAA2;TH;PUS1;TSFM;ABCG1;ACAT2;BOLA1;ECI1;ETFDH;CCDC51;NUDT6;PTS;DECR1;CPT1C;ETFB
241,GO:0003985,0.121263831162417,1,2,2,acetyl-CoA C-acetyltransferase activity,MF,ACAT1;ACAT2
1135,GO:0016407,0.121263831162417,1,2,2,acetyltransferase activity,MF,ACAT1;ACAT2
1139,GO:0016453,0.121263831162417,1,2,2,C-acetyltransferase activity,MF,ACAT1;ACAT2
1245,GO:0018193,0.121726021786756,0.986496823006065,3,4,peptidyl-amino acid modification,BP,ALG5;FGF18;DPM3
1816,GO:0035295,0.126146107170743,0.985744409404441,3,4,tube development,BP,ACAT1;RBP4;FGF18
1182,GO:0016747,0.126516254120751,0.972634011018715,4,7,transferase activity, transferring acyl groups other than amino-acyl groups,MF,ACAT1;ACAA2;ACAT2;CPT1C
1360,GO:0022900,0.127107594069953,1,2,2,electron transport chain,BP,ETFDH;ETFB
1361,GO:0022904,0.127107594069953,1,2,2,respiratory electron transport chain,BP,ETFDH;ETFB
2841,GO:0060612,0.129167792001327,1,2,2,adipose tissue development,BP,ACAT1;PLA2G16
2538,GO:0050662,0.129882625475995,0.959096003565335,6,12,coenzyme binding,MF,HACL1;ACAT1;ACADVL;TH;ETFDH;DECR1
2096,GO:0043412,0.132367385513833,0.945382524343183,10,21,macromolecule modification,BP,MSRA;PUS1;ALG5;KRT10;DEPTOR;PSMB10;LYPLAL1;FGF18;DPM3;ETFB
803,GO:0009109,0.135135397146744,1,2,2,coenzyme catabolic process,BP,ACAT1;NUDT7
1088,GO:0015936,0.135135397146744,1,2,2,coenzyme A metabolic process,BP,ACAT1;NUDT7
1722,GO:0033865,0.135135397146744,1,2,2,nucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
1725,GO:0033875,0.135135397146744,1,2,2,ribonucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
1729,GO:0034032,0.135135397146744,1,2,2,purine nucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
2344,GO:0046356,0.135135397146744,1,2,2,acetyl-CoA catabolic process,BP,ACAT1;NUDT7
2651,GO:0051187,0.135135397146744,1,2,2,cofactor catabolic process,BP,ACAT1;NUDT7
291,GO:0004620,0.135562897294459,1,2,2,phospholipase activity,MF,LYPLAL1;PLA2G16
1125,GO:0016298,0.135562897294459,1,2,2,lipase activity,MF,LYPLAL1;PLA2G16
1395,GO:0030145,0.141489067753872,1,2,2,manganese ion binding,MF,NUDT7;PEPD
1192,GO:0016790,0.141593749774274,1,2,2,thiolester hydrolase activity,MF,NUDT7;LYPLAL1
2403,GO:0046834,0.141698527845614,1,2,2,lipid phosphorylation,BP,FGF18;ZFYVE21
2406,GO:0046854,0.141698527845614,1,2,2,phosphatidylinositol phosphorylation,BP,FGF18;ZFYVE21
70,GO:0001654,0.143349602976937,1,2,2,eye development,BP,RBP4;TH
213,GO:0003007,0.143349602976937,1,2,2,heart morphogenesis,BP,RBP4;TH
670,GO:0007423,0.143349602976937,1,2,2,sensory organ development,BP,RBP4;TH
671,GO:0007507,0.143349602976937,1,2,2,heart development,BP,RBP4;TH
682,GO:0007601,0.143349602976937,1,2,2,visual perception,BP,RBP4;TH
873,GO:0009790,0.143349602976937,1,2,2,embryo development,BP,RBP4;TH
2027,GO:0043010,0.143349602976937,1,2,2,camera-type eye development,BP,RBP4;TH
2485,GO:0048562,0.143349602976937,1,2,2,embryonic organ morphogenesis,BP,RBP4;TH
2486,GO:0048568,0.143349602976937,1,2,2,embryonic organ development,BP,RBP4;TH
2491,GO:0048592,0.143349602976937,1,2,2,eye morphogenesis,BP,RBP4;TH
2492,GO:0048593,0.143349602976937,1,2,2,camera-type eye morphogenesis,BP,RBP4;TH
2494,GO:0048598,0.143349602976937,1,2,2,embryonic morphogenesis,BP,RBP4;TH
2609,GO:0050953,0.143349602976937,1,2,2,sensory perception of light stimulus,BP,RBP4;TH
3116,GO:0090596,0.143349602976937,1,2,2,sensory organ morphogenesis,BP,RBP4;TH
187,GO:0002699,0.144820637895064,1,2,2,positive regulation of immune effector process,BP,RBP4;FADD
481,GO:0006464,0.146523447220781,0.940334248990975,9,19,cellular protein modification process,BP,MSRA;ALG5;KRT10;DEPTOR;PSMB10;LYPLAL1;FGF18;DPM3;ETFB
1872,GO:0036211,0.146523447220781,0.940334248990975,9,19,protein modification process,BP,MSRA;ALG5;KRT10;DEPTOR;PSMB10;LYPLAL1;FGF18;DPM3;ETFB
2764,GO:0055037,0.147298867699672,0.986399938751292,2,3,recycling endosome,CC,ABCG1;TBC1D14
704,GO:0008083,0.148908301012555,1,2,2,growth factor activity,MF,NUDT6;FGF18
784,GO:0009056,0.151123647901896,0.924189120214932,16,38,catabolic process,BP,HACL1;ACAT1;ACADVL;ACAA2;NUDT7;ACAT2;ECI1;ETFDH;PSMB10;LYPLAL1;TBC1D14;PLA2G16;DECR1;CPT1C;ETFB;PEPD
1166,GO:0016667,0.151743280393249,1,2,2,oxidoreductase activity, acting on a sulfur group of donors,MF,MSRA;IFI30
1919,GO:0042157,0.152291898617842,0.980971972998055,3,4,lipoprotein metabolic process,BP,ABCG1;LYPLAL1;DPM3
651,GO:0007267,0.152319924603011,0.954643491447274,5,10,cell-cell signaling,BP,PXK;RBP4;TH;PSMB10;FGF18
369,GO:0005623,0.153826854019344,0.972750934011725,42,119,cell,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;TMEM160;CNIH4;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;BOLA1;ECI1;KRT10;ETFDH;CCDC51;DEPTOR;FADD;PSMB10;LYPLAL1;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;LINGO1;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
2205,GO:0044464,0.153826854019344,0.972750934011725,42,119,cell part,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;TMEM160;CNIH4;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;BOLA1;ECI1;KRT10;ETFDH;CCDC51;DEPTOR;FADD;PSMB10;LYPLAL1;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;LINGO1;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
223,GO:0003676,0.154547329973151,0.942572133550994,7,15,nucleic acid binding,MF,MRPL14;ARL6IP4;ACAA2;PUS1;NUDT7;TSFM;HNF1A
2068,GO:0043229,0.155282251522655,0.937161210232968,38,104,intracellular organelle,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;ACADVL;TMEM160;CNIH4;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;BOLA1;ECI1;KRT10;ETFDH;CCDC51;FADD;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
495,GO:0006520,0.157887698328885,0.946895696318695,6,12,cellular amino acid metabolic process,BP,MSRA;ACAT1;TH;PSMB10;PTS;PEPD
380,GO:0005743,0.15812123455566,0.946790058890791,6,12,mitochondrial inner membrane,CC,ACAT1;MRPL14;ACADVL;ACAA2;ECI1;ETFDH
631,GO:0007049,0.159544997678211,1,2,2,cell cycle,BP,PSMB10;PLA2G16
2297,GO:0045786,0.159544997678211,1,2,2,negative regulation of cell cycle,BP,PSMB10;PLA2G16
2737,GO:0051726,0.159544997678211,1,2,2,regulation of cell cycle,BP,PSMB10;PLA2G16
2186,GO:0044429,0.162128864359957,0.925643852440369,11,25,mitochondrial part,CC,ACAT1;MRPL14;ACADVL;ACAA2;PUS1;TSFM;ECI1;ETFDH;DECR1;CPT1C;ETFB
1691,GO:0032991,0.163714145444688,0.928556666553761,10,21,macromolecular complex,CC,MRPL14;PXMP2;PXK;RBP4;ETFDH;FADD;PSMB10;HNF1A;CPT1C;DPM3
516,GO:0006631,0.16499515850409,0.923362709939814,11,26,fatty acid metabolic process,BP,HACL1;ACAT1;ACADVL;ACAA2;TH;ACAT2;ECI1;ETFDH;DECR1;CPT1C;ETFB
157,GO:0002474,0.165149502024137,1,2,2,antigen processing and presentation of peptide antigen via MHC class I,BP,PSMB10;IFI30
158,GO:0002478,0.165149502024137,1,2,2,antigen processing and presentation of exogenous peptide antigen,BP,PSMB10;IFI30
1313,GO:0019884,0.165149502024137,1,2,2,antigen processing and presentation of exogenous antigen,BP,PSMB10;IFI30
1989,GO:0042590,0.165149502024137,1,2,2,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,PSMB10;IFI30
1378,GO:0030054,0.166000769667656,0.96982836690612,3,5,cell junction,CC,CPT1C;ZFYVE21;IFI30
530,GO:0006661,0.166674034588152,1,2,2,phosphatidylinositol biosynthetic process,BP,FGF18;DPM3
487,GO:0006487,0.175992147743361,1,2,2,protein N-linked glycosylation,BP,ALG5;DPM3
1246,GO:0018196,0.175992147743361,1,2,2,peptidyl-asparagine modification,BP,ALG5;DPM3
1249,GO:0018279,0.175992147743361,1,2,2,protein N-linked glycosylation via asparagine,BP,ALG5;DPM3
526,GO:0006650,0.184524483472034,0.959312295047607,4,6,glycerophospholipid metabolic process,BP,PLA2G16;FGF18;ZFYVE21;DPM3
2728,GO:0051649,0.184658574307209,0.940794799052517,5,10,establishment of localization in cell,BP,CNIH4;TH;ABCG1;TBC1D14;ZFYVE21
2150,GO:0044237,0.187405646215169,0.906700280659794,34,93,cellular metabolic process,BP,HACL1;MSRA;ACAT1;MRPL14;RBP4;ACADVL;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;ECI1;KRT10;ETFDH;DEPTOR;FADD;PSMB10;LYPLAL1;LAGE3;TBC1D14;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;PEPD
2043,GO:0043087,0.189003606765491,0.979311067434465,2,3,regulation of GTPase activity,BP,TBC1D14;FGF18
2116,GO:0043547,0.189003606765491,0.979311067434465,2,3,positive regulation of GTPase activity,BP,TBC1D14;FGF18
1179,GO:0016740,0.189221264283992,0.914967090942649,9,21,transferase activity,MF,ACAT1;ACAA2;ALG5;ACAT2;PLA2G16;FGF18;CPT1C;ZFYVE21;DPM3
2229,GO:0044802,0.192969885419625,0.978566538114075,2,3,single-organism membrane organization,BP,ACAA2;TBC1D14
2850,GO:0061024,0.192969885419625,0.978566538114075,2,3,membrane organization,BP,ACAA2;TBC1D14
1155,GO:0016604,0.195371497276932,0.978109736792387,2,3,nuclear body,CC,ARL6IP4;LAGE3
2199,GO:0044451,0.195371497276932,0.978109736792387,2,3,nucleoplasm part,CC,ARL6IP4;LAGE3
3257,GO:1901575,0.195491823861952,0.899022875296479,14,33,organic substance catabolic process,BP,HACL1;ACAT1;ACADVL;ACAA2;NUDT7;ACAT2;ECI1;ETFDH;PSMB10;LYPLAL1;PLA2G16;DECR1;CPT1C;ETFB
1484,GO:0031090,0.200789495953366,0.898487072571144,12,30,organelle membrane,CC,ACAT1;MRPL14;PXMP2;ACADVL;ACAA2;TH;ABCG1;ECI1;ETFDH;PLA2G16;CPT1C;ZFYVE21
3092,GO:0090181,0.202870047952335,0.976654338108694,2,3,regulation of cholesterol metabolic process,BP,ACADVL;ABCG1
370,GO:0005634,0.204692669313286,0.88935020355562,16,40,nucleus,CC,MSRA;ACADVL;ARL6IP4;TH;PUS1;TSFM;ACAT2;KRT10;FADD;PSMB10;LAGE3;TBC1D14;NUDT6;HNF1A;DECR1;FGF18
2057,GO:0043170,0.208725067439428,0.884378578598429,18,46,macromolecule metabolic process,BP,MSRA;MRPL14;ARL6IP4;PUS1;TSFM;ALG5;ABCG1;KRT10;DEPTOR;FADD;PSMB10;LYPLAL1;LAGE3;HNF1A;FGF18;DPM3;ETFB;PEPD
541,GO:0006695,0.208929508126323,0.956996270488297,3,5,cholesterol biosynthetic process,BP,ACAA2;ABCG1;ACAT2
1109,GO:0016126,0.208929508126323,0.956996270488297,3,5,sterol biosynthetic process,BP,ACAA2;ABCG1;ACAT2
2333,GO:0046165,0.208929508126323,0.956996270488297,3,5,alcohol biosynthetic process,BP,ACAA2;ABCG1;ACAT2
3328,GO:1902653,0.208929508126323,0.956996270488297,3,5,secondary alcohol biosynthetic process,BP,ACAA2;ABCG1;ACAT2
387,GO:0005768,0.209830334975827,0.950350670954512,3,6,endosome,CC,ABCG1;TBC1D14;ZFYVE21
2218,GO:0044712,0.219577966621204,0.885007015338832,13,31,single-organism catabolic process,BP,HACL1;ACAT1;ACADVL;ACAA2;NUDT7;ACAT2;ECI1;ETFDH;PLA2G16;DECR1;CPT1C;ETFB;PEPD
1473,GO:0030855,0.221722993014192,0.972798880780683,2,3,epithelial cell differentiation,BP,ACADVL;KRT10
437,GO:0006091,0.230291555043766,0.949923369441407,3,5,generation of precursor metabolites and energy,BP,ACADVL;ETFDH;ETFB
1091,GO:0015980,0.230291555043766,0.949923369441407,3,5,energy derivation by oxidation of organic compounds,BP,ACADVL;ETFDH;ETFB
3457,GO:2000026,0.23224765424835,0.910166640708115,6,12,regulation of multicellular organismal development,BP,RBP4;FADD;PSMB10;PLA2G16;LINGO1;FGF18
2225,GO:0044767,0.23531032783763,0.871220270543646,14,36,single-organism developmental process,BP,ACAT1;RBP4;ACADVL;TH;NUDT7;ALG5;ABCG1;KRT10;FADD;PSMB10;PTS;PLA2G16;LINGO1;FGF18
2528,GO:0048871,0.23615160675208,0.969656344146056,2,3,multicellular organismal homeostasis,BP,RBP4;ACADVL
859,GO:0009628,0.237671932064387,0.915557735623523,5,10,response to abiotic stimulus,BP,ACADVL;ACAA2;TH;FADD;PSMB10
433,GO:0006084,0.237723109802075,0.969303917897685,2,3,acetyl-CoA metabolic process,BP,ACAT1;NUDT7
38,GO:0000975,0.241577415303288,1,1,1,regulatory region DNA binding,MF,HNF1A
39,GO:0000976,0.241577415303288,1,1,1,transcription regulatory region sequence-specific DNA binding,MF,HNF1A
40,GO:0000977,0.241577415303288,1,1,1,RNA polymerase II regulatory region sequence-specific DNA binding,MF,HNF1A
41,GO:0000981,0.241577415303288,1,1,1,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,HNF1A
42,GO:0000982,0.241577415303288,1,1,1,transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,HNF1A
45,GO:0001012,0.241577415303288,1,1,1,RNA polymerase II regulatory region DNA binding,MF,HNF1A
46,GO:0001067,0.241577415303288,1,1,1,regulatory region nucleic acid binding,MF,HNF1A
47,GO:0001071,0.241577415303288,1,1,1,nucleic acid binding transcription factor activity,MF,HNF1A
48,GO:0001077,0.241577415303288,1,1,1,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,HNF1A
52,GO:0001228,0.241577415303288,1,1,1,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,HNF1A
217,GO:0003014,0.241577415303288,1,1,1,renal system process,BP,HNF1A
225,GO:0003690,0.241577415303288,1,1,1,double-stranded DNA binding,MF,HNF1A
226,GO:0003700,0.241577415303288,1,1,1,transcription factor activity, sequence-specific DNA binding,MF,HNF1A
464,GO:0006352,0.241577415303288,1,1,1,DNA-templated transcription, initiation,BP,HNF1A
470,GO:0006367,0.241577415303288,1,1,1,transcription initiation from RNA polymerase II promoter,BP,HNF1A
1840,GO:0035623,0.241577415303288,1,1,1,renal glucose absorption,BP,HNF1A
2118,GO:0043565,0.241577415303288,1,1,1,sequence-specific DNA binding,MF,HNF1A
2148,GO:0044212,0.241577415303288,1,1,1,transcription regulatory region DNA binding,MF,HNF1A
2807,GO:0060260,0.241577415303288,1,1,1,regulation of transcription initiation from RNA polymerase II promoter,BP,HNF1A
2808,GO:0060261,0.241577415303288,1,1,1,positive regulation of transcription initiation from RNA polymerase II promoter,BP,HNF1A
2901,GO:0070293,0.241577415303288,1,1,1,renal absorption,BP,HNF1A
3454,GO:1990837,0.241577415303288,1,1,1,sequence-specific double-stranded DNA binding,MF,HNF1A
3468,GO:2000142,0.241577415303288,1,1,1,regulation of DNA-templated transcription, initiation,BP,HNF1A
3469,GO:2000144,0.241577415303288,1,1,1,positive regulation of DNA-templated transcription, initiation,BP,HNF1A
1310,GO:0019866,0.24170541131707,0.902270136471671,6,13,organelle inner membrane,CC,ACAT1;MRPL14;ACADVL;ACAA2;ECI1;ETFDH
669,GO:0007420,0.24217306806123,0.968295071321386,2,3,brain development,BP,ACAT1;TH
2811,GO:0060322,0.24217306806123,0.968295071321386,2,3,head development,BP,ACAT1;TH
668,GO:0007417,0.242922631317099,0.94552564079932,3,5,central nervous system development,BP,ACAT1;TH;PTS
2575,GO:0050793,0.244305537478908,0.892341352718523,7,16,regulation of developmental process,BP,RBP4;ABCG1;FADD;PSMB10;PLA2G16;LINGO1;FGF18
2059,GO:0043178,0.246500478869734,0.967298504834284,2,3,alcohol binding,MF,RBP4;ABCG1
1433,GO:0030424,0.247476350411,0.967071650048604,2,3,axon,CC,TH;CPT1C
3235,GO:1901137,0.247481281926694,0.94389893414087,3,5,carbohydrate derivative biosynthetic process,BP,ACAT1;ALG5;DPM3
229,GO:0003723,0.250630214982002,0.897248656931106,6,13,RNA binding,MF,MRPL14;ARL6IP4;ACAA2;PUS1;NUDT7;TSFM
393,GO:0005777,0.251735010752527,0.919499688617288,4,8,peroxisome,CC,HACL1;PXMP2;NUDT7;PLA2G16
1987,GO:0042579,0.251735010752527,0.919499688617288,4,8,microbody,CC,HACL1;PXMP2;NUDT7;PLA2G16
2192,GO:0044438,0.251735010752527,0.919499688617288,4,8,microbody part,CC,HACL1;PXMP2;NUDT7;PLA2G16
2193,GO:0044439,0.251735010752527,0.919499688617288,4,8,peroxisomal part,CC,HACL1;PXMP2;NUDT7;PLA2G16
2083,GO:0043279,0.251754979882359,0.966067782489836,2,3,response to alkaloid,BP,TH;FADD
863,GO:0009653,0.253023172978838,0.907675542688834,5,10,anatomical structure morphogenesis,BP,RBP4;TH;PSMB10;LINGO1;FGF18
1712,GO:0033500,0.254568820569812,0.932980738045383,3,6,carbohydrate homeostasis,BP,RBP4;TH;HNF1A
1991,GO:0042593,0.254568820569812,0.932980738045383,3,6,glucose homeostasis,BP,RBP4;TH;HNF1A
2448,GO:0048037,0.260128452374273,0.889396125760012,6,14,cofactor binding,MF,HACL1;ACAT1;ACADVL;TH;ETFDH;DECR1
3053,GO:0072359,0.261364543913109,0.938815017308629,3,5,circulatory system development,BP,RBP4;TH;FGF18
10,GO:0000139,0.26286249575278,1,1,1,Golgi membrane,CC,ABCG1
361,GO:0005548,0.26286249575278,1,1,1,phospholipid transporter activity,MF,ABCG1
765,GO:0008565,0.26286249575278,1,1,1,protein transporter activity,MF,ABCG1
852,GO:0009593,0.26286249575278,1,1,1,detection of chemical stimulus,BP,ABCG1
867,GO:0009720,0.26286249575278,1,1,1,detection of hormone stimulus,BP,ABCG1
869,GO:0009726,0.26286249575278,1,1,1,detection of endogenous stimulus,BP,ABCG1
889,GO:0009897,0.26286249575278,1,1,1,external side of plasma membrane,CC,ABCG1
961,GO:0010742,0.26286249575278,1,1,1,macrophage derived foam cell differentiation,BP,ABCG1
962,GO:0010743,0.26286249575278,1,1,1,regulation of macrophage derived foam cell differentiation,BP,ABCG1
963,GO:0010745,0.26286249575278,1,1,1,negative regulation of macrophage derived foam cell differentiation,BP,ABCG1
980,GO:0010874,0.26286249575278,1,1,1,regulation of cholesterol efflux,BP,ABCG1
981,GO:0010875,0.26286249575278,1,1,1,positive regulation of cholesterol efflux,BP,ABCG1
983,GO:0010878,0.26286249575278,1,1,1,cholesterol storage,BP,ABCG1
984,GO:0010883,0.26286249575278,1,1,1,regulation of lipid storage,BP,ABCG1
985,GO:0010885,0.26286249575278,1,1,1,regulation of cholesterol storage,BP,ABCG1
986,GO:0010887,0.26286249575278,1,1,1,negative regulation of cholesterol storage,BP,ABCG1
987,GO:0010888,0.26286249575278,1,1,1,negative regulation of lipid storage,BP,ABCG1
1046,GO:0015197,0.26286249575278,1,1,1,peptide transporter activity,MF,ABCG1
1056,GO:0015399,0.26286249575278,1,1,1,primary active transmembrane transporter activity,MF,ABCG1
1057,GO:0015405,0.26286249575278,1,1,1,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ABCG1
1140,GO:0016462,0.26286249575278,1,1,1,pyrophosphatase activity,MF,ABCG1
1198,GO:0016817,0.26286249575278,1,1,1,hydrolase activity, acting on acid anhydrides,MF,ABCG1
1199,GO:0016818,0.26286249575278,1,1,1,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,ABCG1
1200,GO:0016820,0.26286249575278,1,1,1,hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,MF,ABCG1
1217,GO:0016887,0.26286249575278,1,1,1,ATPase activity,MF,ABCG1
1231,GO:0017111,0.26286249575278,1,1,1,nucleoside-triphosphatase activity,MF,ABCG1
1290,GO:0019534,0.26286249575278,1,1,1,toxin transporter activity,MF,ABCG1
1593,GO:0032370,0.26286249575278,1,1,1,positive regulation of lipid transport,BP,ABCG1
1596,GO:0032373,0.26286249575278,1,1,1,positive regulation of sterol transport,BP,ABCG1
1599,GO:0032376,0.26286249575278,1,1,1,positive regulation of cholesterol transport,BP,ABCG1
1732,GO:0034040,0.26286249575278,1,1,1,lipid-transporting ATPase activity,MF,ABCG1
1733,GO:0034041,0.26286249575278,1,1,1,sterol-transporting ATPase activity,MF,ABCG1
1758,GO:0034374,0.26286249575278,1,1,1,low-density lipoprotein particle remodeling,BP,ABCG1
1771,GO:0034436,0.26286249575278,1,1,1,glycoprotein transport,BP,ABCG1
1772,GO:0034437,0.26286249575278,1,1,1,glycoprotein transporter activity,MF,ABCG1
1993,GO:0042623,0.26286249575278,1,1,1,ATPase activity, coupled,MF,ABCG1
1994,GO:0042626,0.26286249575278,1,1,1,ATPase activity, coupled to transmembrane movement of substances,MF,ABCG1
2020,GO:0042982,0.26286249575278,1,1,1,amyloid precursor protein metabolic process,BP,ABCG1
2021,GO:0042987,0.26286249575278,1,1,1,amyloid precursor protein catabolic process,BP,ABCG1
2107,GO:0043492,0.26286249575278,1,1,1,ATPase activity, coupled to movement of substances,MF,ABCG1
2113,GO:0043531,0.26286249575278,1,1,1,ADP binding,MF,ABCG1
2134,GO:0043691,0.26286249575278,1,1,1,reverse cholesterol transport,BP,ABCG1
2188,GO:0044431,0.26286249575278,1,1,1,Golgi apparatus part,CC,ABCG1
2274,GO:0045542,0.26286249575278,1,1,1,positive regulation of cholesterol biosynthetic process,BP,ABCG1
2725,GO:0051606,0.26286249575278,1,1,1,detection of stimulus,BP,ABCG1
2779,GO:0055094,0.26286249575278,1,1,1,response to lipoprotein particle,BP,ABCG1
2780,GO:0055099,0.26286249575278,1,1,1,response to high density lipoprotein particle,BP,ABCG1
3085,GO:0090077,0.26286249575278,1,1,1,foam cell differentiation,BP,ABCG1
3099,GO:0090205,0.26286249575278,1,1,1,positive regulation of cholesterol metabolic process,BP,ABCG1
3240,GO:1901264,0.26286249575278,1,1,1,carbohydrate derivative transport,BP,ABCG1
3251,GO:1901505,0.26286249575278,1,1,1,carbohydrate derivative transporter activity,MF,ABCG1
3264,GO:1901618,0.26286249575278,1,1,1,organic hydroxy compound transmembrane transporter activity,MF,ABCG1
3291,GO:1901998,0.26286249575278,1,1,1,toxin transport,BP,ABCG1
3347,GO:1902932,0.26286249575278,1,1,1,positive regulation of alcohol biosynthetic process,BP,ABCG1
3445,GO:1905954,0.26286249575278,1,1,1,positive regulation of lipid localization,BP,ABCG1
2938,GO:0070848,0.262909498014985,0.963379458406124,2,3,response to growth factor,BP,TH;FGF18
2980,GO:0071363,0.262909498014985,0.963379458406124,2,3,cellular response to growth factor stimulus,BP,TH;FGF18
3263,GO:1901617,0.26616351204724,0.912545774510702,4,8,organic hydroxy compound biosynthetic process,BP,ACAA2;TH;ABCG1;ACAT2
326,GO:0005154,0.267489317302249,1,1,1,epidermal growth factor receptor binding,MF,LINGO1
960,GO:0010721,0.267489317302249,1,1,1,negative regulation of cell development,BP,LINGO1
965,GO:0010769,0.267489317302249,1,1,1,regulation of cell morphogenesis involved in differentiation,BP,LINGO1
966,GO:0010771,0.267489317302249,1,1,1,negative regulation of cell morphogenesis involved in differentiation,BP,LINGO1
1008,GO:0010975,0.267489317302249,1,1,1,regulation of neuron projection development,BP,LINGO1
1009,GO:0010977,0.267489317302249,1,1,1,negative regulation of neuron projection development,BP,LINGO1
1521,GO:0031345,0.267489317302249,1,1,1,negative regulation of cell projection organization,BP,LINGO1
2286,GO:0045664,0.267489317302249,1,1,1,regulation of neuron differentiation,BP,LINGO1
2287,GO:0045665,0.267489317302249,1,1,1,negative regulation of neuron differentiation,BP,LINGO1
2564,GO:0050768,0.267489317302249,1,1,1,negative regulation of neurogenesis,BP,LINGO1
2566,GO:0050770,0.267489317302249,1,1,1,regulation of axonogenesis,BP,LINGO1
2567,GO:0050771,0.267489317302249,1,1,1,negative regulation of axonogenesis,BP,LINGO1
2746,GO:0051961,0.267489317302249,1,1,1,negative regulation of nervous system development,BP,LINGO1
2517,GO:0048732,0.268687088171856,0.961946204170381,2,3,gland development,BP,ACAT1;FADD
404,GO:0005829,0.269737815049411,0.84219615546618,17,44,cytosol,CC,MSRA;PXK;RBP4;ACADVL;TH;ACAT2;KRT10;FADD;PSMB10;LYPLAL1;TBC1D14;PTS;PLA2G16;DECR1;ZFYVE21;ETFB;IFI30
378,GO:0005740,0.270158734674663,0.876619810039614,7,16,mitochondrial envelope,CC,ACAT1;MRPL14;ACADVL;ACAA2;ECI1;ETFDH;CPT1C
1555,GO:0031966,0.270158734674663,0.876619810039614,7,16,mitochondrial membrane,CC,ACAT1;MRPL14;ACADVL;ACAA2;ECI1;ETFDH;CPT1C
376,GO:0005737,0.270903335194782,0.87346921821377,38,107,cytoplasm,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;TMEM160;CNIH4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;BOLA1;ECI1;KRT10;ETFDH;CCDC51;DEPTOR;FADD;PSMB10;LYPLAL1;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;DECR1;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
2162,GO:0044267,0.271407444131704,0.851988897138117,12,29,cellular protein metabolic process,BP,MSRA;MRPL14;TSFM;ALG5;KRT10;DEPTOR;FADD;PSMB10;LYPLAL1;FGF18;DPM3;ETFB
2430,GO:0046982,0.271811526211144,0.961159420808432,2,3,protein heterodimerization activity,MF,RBP4;ABCG1
2524,GO:0048856,0.276778050470654,0.847461988018333,12,30,anatomical structure development,BP,ACAT1;RBP4;ACADVL;TH;ALG5;KRT10;FADD;PSMB10;PTS;PLA2G16;LINGO1;FGF18
486,GO:0006486,0.278075035620619,0.959557272166154,2,3,protein glycosylation,BP,ALG5;DPM3
801,GO:0009101,0.278075035620619,0.959557272166154,2,3,glycoprotein biosynthetic process,BP,ALG5;DPM3
2097,GO:0043413,0.278075035620619,0.959557272166154,2,3,macromolecule glycosylation,BP,ALG5;DPM3
2881,GO:0070085,0.278075035620619,0.959557272166154,2,3,glycosylation,BP,ALG5;DPM3
508,GO:0006577,0.279674722494094,1,1,1,amino-acid betaine metabolic process,BP,CPT1C
847,GO:0009437,0.279674722494094,1,1,1,carnitine metabolic process,BP,CPT1C
2727,GO:0051641,0.281149896376012,0.888598369388309,5,11,cellular localization,BP,CNIH4;TH;ABCG1;TBC1D14;ZFYVE21
197,GO:0002757,0.281489648904839,0.958669773547566,2,3,immune response-activating signal transduction,BP,FADD;PSMB10
198,GO:0002758,0.281489648904839,0.958669773547566,2,3,innate immune response-activating signal transduction,BP,FADD;PSMB10
201,GO:0002764,0.281489648904839,0.958669773547566,2,3,immune response-regulating signaling pathway,BP,FADD;PSMB10
2270,GO:0045471,0.282335951081726,0.95844826680307,2,3,response to ethanol,BP,RBP4;TH
3138,GO:0097305,0.282335951081726,0.95844826680307,2,3,response to alcohol,BP,RBP4;TH
1615,GO:0032502,0.283564671696605,0.836602070022066,14,37,developmental process,BP,ACAT1;RBP4;ACADVL;TH;NUDT7;ALG5;ABCG1;KRT10;FADD;PSMB10;PTS;PLA2G16;LINGO1;FGF18
186,GO:0002697,0.285239561415535,0.957683617353296,2,3,regulation of immune effector process,BP,RBP4;FADD
21,GO:0000287,0.28640002319968,0.957375987360073,2,3,magnesium ion binding,MF,HACL1;NUDT7
2939,GO:0070851,0.287927713437314,0.956969236481552,2,3,growth factor receptor binding,MF,LINGO1;FGF18
2251,GO:0045202,0.288713715039304,0.941980817902894,2,4,synapse,CC,TH;CPT1C
515,GO:0006629,0.293602991500512,0.823230353270627,18,47,lipid metabolic process,BP,HACL1;ACAT1;RBP4;ACADVL;ACAA2;TH;NUDT7;ABCG1;ACAT2;ECI1;ETFDH;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB
1204,GO:0016835,0.29367129609484,0.92621987515914,3,5,carbon-oxygen lyase activity,MF,PUS1;ECI1;PTS
2536,GO:0050660,0.293824086051645,0.940171675923049,2,4,flavin adenine dinucleotide binding,MF,ACADVL;ETFDH
1291,GO:0019538,0.294381968580949,0.829692972076677,14,35,protein metabolic process,BP,MSRA;MRPL14;TSFM;ALG5;ABCG1;KRT10;DEPTOR;FADD;PSMB10;LYPLAL1;FGF18;DPM3;ETFB;PEPD
1428,GO:0030323,0.295832790699594,0.954832168494449,2,3,respiratory tube development,BP,RBP4;FGF18
1429,GO:0030324,0.295832790699594,0.954832168494449,2,3,lung development,BP,RBP4;FGF18
2835,GO:0060541,0.295832790699594,0.954832168494449,2,3,respiratory system development,BP,RBP4;FGF18
1201,GO:0016829,0.29765834117101,0.883305477500799,5,10,lyase activity,MF,HACL1;ACAT1;PUS1;ECI1;PTS
71,GO:0001655,0.29924235965339,0.953893594861726,2,3,urogenital system development,BP,ACAT1;RBP4
3033,GO:0072001,0.29924235965339,0.953893594861726,2,3,renal system development,BP,ACAT1;RBP4
2139,GO:0043933,0.29982000884633,0.860175295059014,7,15,macromolecular complex subunit organization,BP,HACL1;ACAT1;MRPL14;ABCG1;FADD;HNF1A;DECR1
2277,GO:0045595,0.300643831270471,0.889735679407096,4,9,regulation of cell differentiation,BP,ABCG1;FADD;LINGO1;FGF18
3250,GO:1901363,0.301243469833327,0.825056312236599,13,36,heterocyclic compound binding,MF,HACL1;MRPL14;ACADVL;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ABCG1;ETFDH;HNF1A;DECR1
1400,GO:0030163,0.305692886450305,0.95208993257878,2,3,protein catabolic process,BP,PSMB10;LYPLAL1
2185,GO:0044428,0.308406626606315,0.837343879753512,9,22,nuclear part,CC,MSRA;ACADVL;ARL6IP4;ACAT2;PSMB10;LAGE3;TBC1D14;DECR1;FGF18
2151,GO:0044238,0.309679587363802,0.821791515875367,33,92,primary metabolic process,BP,HACL1;MSRA;ACAT1;MRPL14;RBP4;ACADVL;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;ECI1;KRT10;ETFDH;DEPTOR;FADD;PSMB10;LYPLAL1;LAGE3;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;PEPD
467,GO:0006357,0.310161033760825,0.908341113107179,3,6,regulation of transcription from RNA polymerase II promoter,BP,FADD;PSMB10;HNF1A
2322,GO:0045944,0.310522637264544,0.934064300831365,2,4,positive regulation of transcription from RNA polymerase II promoter,BP,FADD;HNF1A
254,GO:0004174,0.312979377290271,1,1,1,electron-transferring-flavoprotein dehydrogenase activity,MF,ETFDH
1164,GO:0016649,0.312979377290271,1,1,1,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,ETFDH
1176,GO:0016722,0.312979377290271,1,1,1,oxidoreductase activity, oxidizing metal ions,MF,ETFDH
1233,GO:0017133,0.312979377290271,1,1,1,mitochondrial electron transfer flavoprotein complex,CC,ETFDH
1502,GO:0031300,0.312979377290271,1,1,1,intrinsic component of organelle membrane,CC,ETFDH
1503,GO:0031301,0.312979377290271,1,1,1,integral component of organelle membrane,CC,ETFDH
1504,GO:0031304,0.312979377290271,1,1,1,intrinsic component of mitochondrial inner membrane,CC,ETFDH
1505,GO:0031305,0.312979377290271,1,1,1,integral component of mitochondrial inner membrane,CC,ETFDH
1627,GO:0032592,0.312979377290271,1,1,1,integral component of mitochondrial membrane,CC,ETFDH
2135,GO:0043783,0.312979377290271,1,1,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,ETFDH
2254,GO:0045251,0.312979377290271,1,1,1,electron transfer flavoprotein complex,CC,ETFDH
2449,GO:0048038,0.312979377290271,1,1,1,quinone binding,MF,ETFDH
2450,GO:0048039,0.312979377290271,1,1,1,ubiquinone binding,MF,ETFDH
2718,GO:0051539,0.312979377290271,1,1,1,4 iron, 4 sulfur cluster binding,MF,ETFDH
3160,GO:0098573,0.312979377290271,1,1,1,intrinsic component of mitochondrial membrane,CC,ETFDH
3185,GO:0098798,0.312979377290271,1,1,1,mitochondrial protein complex,CC,ETFDH
2419,GO:0046907,0.314959312171726,0.881748937092626,4,9,intracellular transport,BP,CNIH4;ABCG1;TBC1D14;ZFYVE21
222,GO:0003674,0.315240321038606,0.89511100196388,41,119,molecular_function,MF,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;CNIH4;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;BOLA1;ECI1;KRT10;ETFDH;DEPTOR;FADD;PSMB10;LYPLAL1;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;LINGO1;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;PEPD;IFI30
474,GO:0006399,0.31787025251838,0.948584030270954,2,3,tRNA metabolic process,BP,PUS1;LAGE3
699,GO:0008033,0.31787025251838,0.948584030270954,2,3,tRNA processing,BP,PUS1;LAGE3
2677,GO:0051260,0.318907994998865,0.948279096324617,2,3,protein homooligomerization,BP,ACAT1;DECR1
73,GO:0001659,0.319501591732215,1,1,1,temperature homeostasis,BP,ACADVL
245,GO:0003995,0.319501591732215,1,1,1,acyl-CoA dehydrogenase activity,MF,ACADVL
273,GO:0004466,0.319501591732215,1,1,1,long-chain-acyl-CoA dehydrogenase activity,MF,ACADVL
622,GO:0006986,0.319501591732215,1,1,1,response to unfolded protein,BP,ACADVL
829,GO:0009266,0.319501591732215,1,1,1,response to temperature stimulus,BP,ACADVL
831,GO:0009295,0.319501591732215,1,1,1,nucleoid,CC,ACADVL
841,GO:0009409,0.319501591732215,1,1,1,response to cold,BP,ACADVL
1480,GO:0030968,0.319501591732215,1,1,1,endoplasmic reticulum unfolded protein response,BP,ACADVL
1782,GO:0034620,0.319501591732215,1,1,1,cellular response to unfolded protein,BP,ACADVL
1860,GO:0035966,0.319501591732215,1,1,1,response to topologically incorrect protein,BP,ACADVL
1861,GO:0035967,0.319501591732215,1,1,1,cellular response to topologically incorrect protein,BP,ACADVL
1882,GO:0036498,0.319501591732215,1,1,1,IRE1-mediated unfolded protein response,BP,ACADVL
2000,GO:0042645,0.319501591732215,1,1,1,mitochondrial nucleoid,CC,ACADVL
2337,GO:0046322,0.319501591732215,1,1,1,negative regulation of fatty acid oxidation,BP,ACADVL
747,GO:0008328,0.322370209371099,0.969627327824997,1,2,ionotropic glutamate receptor complex,CC,CPT1C
1582,GO:0032281,0.322370209371099,0.969627327824997,1,2,AMPA glutamate receptor complex,CC,CPT1C
1795,GO:0034703,0.322370209371099,0.969627327824997,1,2,cation channel complex,CC,CPT1C
3186,GO:0098802,0.322370209371099,0.969627327824997,1,2,plasma membrane receptor complex,CC,CPT1C
3190,GO:0098878,0.322370209371099,0.969627327824997,1,2,neurotransmitter receptor complex,CC,CPT1C
430,GO:0006066,0.325615083900273,0.862222283834364,5,11,alcohol metabolic process,BP,RBP4;ACADVL;ACAA2;ABCG1;ACAT2
400,GO:0005794,0.328429757896383,0.927176417932954,2,4,Golgi apparatus,CC,ABCG1;TBC1D14
329,GO:0005198,0.328967191789551,0.945272459650231,2,3,structural molecule activity,MF,MRPL14;KRT10
61,GO:0001533,0.329039794310478,1,1,1,cornified envelope,CC,KRT10
410,GO:0005882,0.329039794310478,1,1,1,intermediate filament,CC,KRT10
891,GO:0009913,0.329039794310478,1,1,1,epidermal cell differentiation,BP,KRT10
1244,GO:0018149,0.329039794310478,1,1,1,peptide cross-linking,BP,KRT10
1416,GO:0030216,0.329039794310478,1,1,1,keratinocyte differentiation,BP,KRT10
1424,GO:0030280,0.329039794310478,1,1,1,structural constituent of epidermis,MF,KRT10
1534,GO:0031424,0.329039794310478,1,1,1,keratinization,BP,KRT10
2245,GO:0045111,0.329039794310478,1,1,1,intermediate filament cytoskeleton,CC,KRT10
2898,GO:0070268,0.329039794310478,1,1,1,cornification,BP,KRT10
72,GO:0001656,0.32926439240092,1,1,1,metanephros development,BP,ACAT1
500,GO:0006550,0.32926439240092,1,1,1,isoleucine catabolic process,BP,ACAT1
1089,GO:0015937,0.32926439240092,1,1,1,coenzyme A biosynthetic process,BP,ACAT1
1216,GO:0016885,0.32926439240092,1,1,1,ligase activity, forming carbon-carbon bonds,MF,ACAT1
1723,GO:0033866,0.32926439240092,1,1,1,nucleoside bisphosphate biosynthetic process,BP,ACAT1
1727,GO:0034030,0.32926439240092,1,1,1,ribonucleoside bisphosphate biosynthetic process,BP,ACAT1
1730,GO:0034033,0.32926439240092,1,1,1,purine nucleoside bisphosphate biosynthetic process,BP,ACAT1
2429,GO:0046952,0.32926439240092,1,1,1,ketone body catabolic process,BP,ACAT1
2859,GO:0061326,0.32926439240092,1,1,1,renal tubule development,BP,ACAT1
3034,GO:0072006,0.32926439240092,1,1,1,nephron development,BP,ACAT1
3035,GO:0072009,0.32926439240092,1,1,1,nephron epithelium development,BP,ACAT1
3036,GO:0072014,0.32926439240092,1,1,1,proximal tubule development,BP,ACAT1
3037,GO:0072019,0.32926439240092,1,1,1,proximal convoluted tubule development,BP,ACAT1
3038,GO:0072073,0.32926439240092,1,1,1,kidney epithelium development,BP,ACAT1
3039,GO:0072080,0.32926439240092,1,1,1,nephron tubule development,BP,ACAT1
3040,GO:0072170,0.32926439240092,1,1,1,metanephric tubule development,BP,ACAT1
3041,GO:0072207,0.32926439240092,1,1,1,metanephric epithelium development,BP,ACAT1
3042,GO:0072229,0.32926439240092,1,1,1,metanephric proximal convoluted tubule development,BP,ACAT1
3043,GO:0072234,0.32926439240092,1,1,1,metanephric nephron tubule development,BP,ACAT1
3044,GO:0072237,0.32926439240092,1,1,1,metanephric proximal tubule development,BP,ACAT1
3045,GO:0072243,0.32926439240092,1,1,1,metanephric nephron epithelium development,BP,ACAT1
3335,GO:1902858,0.32926439240092,1,1,1,propionyl-CoA metabolic process,BP,ACAT1
3336,GO:1902860,0.32926439240092,1,1,1,propionyl-CoA biosynthetic process,BP,ACAT1
1875,GO:0036294,0.330311987319157,0.944863480006786,2,3,cellular response to decreased oxygen levels,BP,ACAA2;PSMB10
2996,GO:0071453,0.330311987319157,0.944863480006786,2,3,cellular response to oxygen levels,BP,ACAA2;PSMB10
2997,GO:0071456,0.330311987319157,0.944863480006786,2,3,cellular response to hypoxia,BP,ACAA2;PSMB10
812,GO:0009150,0.333360331890546,0.943930230091056,2,3,purine ribonucleotide metabolic process,BP,ACAT1;NUDT7
824,GO:0009259,0.333360331890546,0.943930230091056,2,3,ribonucleotide metabolic process,BP,ACAT1;NUDT7
477,GO:0006414,0.333769601518282,0.943804276818218,2,3,translational elongation,BP,MRPL14;TSFM
1620,GO:0032543,0.333769601518282,0.943804276818218,2,3,mitochondrial translation,BP,MRPL14;TSFM
2882,GO:0070125,0.333769601518282,0.943804276818218,2,3,mitochondrial translational elongation,BP,MRPL14;TSFM
1667,GO:0032787,0.334440084339626,0.806627200109946,11,30,monocarboxylic acid metabolic process,BP,HACL1;ACAT1;ACADVL;ACAA2;TH;ACAT2;ECI1;ETFDH;DECR1;CPT1C;ETFB
655,GO:0007275,0.335698790500719,0.807346236784842,11,28,multicellular organism development,BP,ACAT1;RBP4;TH;ALG5;KRT10;FADD;PSMB10;PTS;PLA2G16;LINGO1;FGF18
1481,GO:0030976,0.336708816861989,1,1,1,thiamine pyrophosphate binding,MF,HACL1
665,GO:0007399,0.33790172029701,0.868464833396264,4,9,nervous system development,BP,ACAT1;TH;PTS;LINGO1
2154,GO:0044248,0.338569157738505,0.797881996628939,13,34,cellular catabolic process,BP,HACL1;ACAT1;ACADVL;ACAA2;NUDT7;ACAT2;ECI1;ETFDH;PSMB10;TBC1D14;DECR1;CPT1C;ETFB
1344,GO:0022607,0.338922611735749,0.839776405335997,6,14,cellular component assembly,BP,HACL1;ACAT1;FADD;TBC1D14;HNF1A;DECR1
1562,GO:0031982,0.339738294404658,0.791829326251541,15,40,vesicle,CC,MSRA;ACAT1;RBP4;ACAA2;TH;ABCG1;ACAT2;ECI1;KRT10;LYPLAL1;TBC1D14;DECR1;ZFYVE21;ETFB;PEPD
233,GO:0003746,0.339921716182351,1,1,1,translation elongation factor activity,MF,TSFM
465,GO:0006354,0.339921716182351,1,1,1,DNA-templated transcription, elongation,BP,TSFM
712,GO:0008135,0.339921716182351,1,1,1,translation factor activity, RNA binding,MF,TSFM
1666,GO:0032784,0.339921716182351,1,1,1,regulation of DNA-templated transcription, elongation,BP,TSFM
2884,GO:0070129,0.339921716182351,1,1,1,regulation of mitochondrial translation,BP,TSFM
1397,GO:0030154,0.342792422436846,0.8164855653282,8,21,cell differentiation,BP,ACADVL;TH;NUDT7;ABCG1;KRT10;FADD;LINGO1;FGF18
2526,GO:0048869,0.342792422436846,0.8164855653282,8,21,cellular developmental process,BP,ACADVL;TH;NUDT7;ABCG1;KRT10;FADD;LINGO1;FGF18
1852,GO:0035794,0.344145170058976,1,1,1,positive regulation of mitochondrial membrane permeability,BP,ACAA2
3142,GO:0097345,0.344145170058976,1,1,1,mitochondrial outer membrane permeabilization,BP,ACAA2
3227,GO:1901028,0.344145170058976,1,1,1,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,ACAA2
3228,GO:1901029,0.344145170058976,1,1,1,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,ACAA2
3301,GO:1902110,0.344145170058976,1,1,1,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,ACAA2
3332,GO:1902686,0.344145170058976,1,1,1,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,ACAA2
3442,GO:1905710,0.344145170058976,1,1,1,positive regulation of membrane permeability,BP,ACAA2
3125,GO:0097159,0.345686592219666,0.790662070005586,13,37,organic cyclic compound binding,MF,HACL1;MRPL14;ACADVL;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ABCG1;ETFDH;HNF1A;DECR1
472,GO:0006396,0.346348356184252,0.890435852453652,3,6,RNA processing,BP,ARL6IP4;PUS1;LAGE3
83,GO:0001754,0.346484087360597,1,1,1,eye photoreceptor cell differentiation,BP,TH
119,GO:0001963,0.346484087360597,1,1,1,synaptic transmission, dopaminergic,BP,TH
121,GO:0001975,0.346484087360597,1,1,1,response to amphetamine,BP,TH
278,GO:0004511,0.346484087360597,1,1,1,tyrosine 3-monooxygenase activity,MF,TH
504,GO:0006570,0.346484087360597,1,1,1,tyrosine metabolic process,BP,TH
509,GO:0006584,0.346484087360597,1,1,1,catecholamine metabolic process,BP,TH
510,GO:0006585,0.346484087360597,1,1,1,dopamine biosynthetic process from tyrosine,BP,TH
619,GO:0006970,0.346484087360597,1,1,1,response to osmotic stress,BP,TH
653,GO:0007270,0.346484087360597,1,1,1,neuron-neuron synaptic transmission,BP,TH
686,GO:0007612,0.346484087360597,1,1,1,learning,BP,TH
694,GO:0007631,0.346484087360597,1,1,1,feeding behavior,BP,TH
698,GO:0008021,0.346484087360597,1,1,1,synaptic vesicle,CC,TH
843,GO:0009414,0.346484087360597,1,1,1,response to water deprivation,BP,TH
844,GO:0009415,0.346484087360597,1,1,1,response to water,BP,TH
862,GO:0009651,0.346484087360597,1,1,1,response to salt stress,BP,TH
864,GO:0009712,0.346484087360597,1,1,1,catechol-containing compound metabolic process,BP,TH
865,GO:0009713,0.346484087360597,1,1,1,catechol-containing compound biosynthetic process,BP,TH
877,GO:0009820,0.346484087360597,1,1,1,alkaloid metabolic process,BP,TH
890,GO:0009898,0.346484087360597,1,1,1,cytoplasmic side of plasma membrane,CC,TH
908,GO:0010042,0.346484087360597,1,1,1,response to manganese ion,BP,TH
909,GO:0010043,0.346484087360597,1,1,1,response to zinc ion,BP,TH
912,GO:0010259,0.346484087360597,1,1,1,multicellular organism aging,BP,TH
1022,GO:0014075,0.346484087360597,1,1,1,response to amine,BP,TH
1076,GO:0015837,0.346484087360597,1,1,1,amine transport,BP,TH
1077,GO:0015842,0.346484087360597,1,1,1,aminergic neurotransmitter loading into synaptic vesicle,BP,TH
1324,GO:0021537,0.346484087360597,1,1,1,telencephalon development,BP,TH
1325,GO:0021543,0.346484087360597,1,1,1,pallium development,BP,TH
1329,GO:0021987,0.346484087360597,1,1,1,cerebral cortex development,BP,TH
1477,GO:0030900,0.346484087360597,1,1,1,forebrain development,BP,TH
1483,GO:0031076,0.346484087360597,1,1,1,embryonic camera-type eye development,BP,TH
1697,GO:0033076,0.346484087360597,1,1,1,isoquinoline alkaloid metabolic process,BP,TH
1700,GO:0033162,0.346484087360597,1,1,1,melanosome membrane,CC,TH
1705,GO:0033267,0.346484087360597,1,1,1,axon part,CC,TH
1781,GO:0034617,0.346484087360597,1,1,1,tetrahydrobiopterin binding,MF,TH
1808,GO:0035176,0.346484087360597,1,1,1,social behavior,BP,TH
1810,GO:0035240,0.346484087360597,1,1,1,dopamine binding,MF,TH
1844,GO:0035690,0.346484087360597,1,1,1,cellular response to drug,BP,TH
1855,GO:0035900,0.346484087360597,1,1,1,response to isolation stress,BP,TH
1856,GO:0035902,0.346484087360597,1,1,1,response to immobilization stress,BP,TH
1916,GO:0042133,0.346484087360597,1,1,1,neurotransmitter metabolic process,BP,TH
1917,GO:0042136,0.346484087360597,1,1,1,neurotransmitter biosynthetic process,BP,TH
1927,GO:0042214,0.346484087360597,1,1,1,terpene metabolic process,BP,TH
1953,GO:0042414,0.346484087360597,1,1,1,epinephrine metabolic process,BP,TH
1954,GO:0042415,0.346484087360597,1,1,1,norepinephrine metabolic process,BP,TH
1955,GO:0042416,0.346484087360597,1,1,1,dopamine biosynthetic process,BP,TH
1956,GO:0042417,0.346484087360597,1,1,1,dopamine metabolic process,BP,TH
1957,GO:0042418,0.346484087360597,1,1,1,epinephrine biosynthetic process,BP,TH
1958,GO:0042421,0.346484087360597,1,1,1,norepinephrine biosynthetic process,BP,TH
1959,GO:0042423,0.346484087360597,1,1,1,catecholamine biosynthetic process,BP,TH
1967,GO:0042461,0.346484087360597,1,1,1,photoreceptor cell development,BP,TH
1968,GO:0042462,0.346484087360597,1,1,1,eye photoreceptor cell development,BP,TH
1969,GO:0042470,0.346484087360597,1,1,1,melanosome,CC,TH
2006,GO:0042755,0.346484087360597,1,1,1,eating behavior,BP,TH
2060,GO:0043195,0.346484087360597,1,1,1,terminal bouton,CC,TH
2062,GO:0043204,0.346484087360597,1,1,1,perikaryon,CC,TH
2103,GO:0043473,0.346484087360597,1,1,1,pigmentation,BP,TH
2133,GO:0043679,0.346484087360597,1,1,1,axon terminus,CC,TH
2171,GO:0044306,0.346484087360597,1,1,1,neuron projection terminus,CC,TH
2232,GO:0045009,0.346484087360597,1,1,1,chitosome,CC,TH
2271,GO:0045472,0.346484087360597,1,1,1,response to ether,BP,TH
2334,GO:0046189,0.346484087360597,1,1,1,phenol-containing compound biosynthetic process,BP,TH
2379,GO:0046530,0.346484087360597,1,1,1,photoreceptor cell differentiation,BP,TH
2397,GO:0046684,0.346484087360597,1,1,1,response to pyrethroid,BP,TH
2451,GO:0048048,0.346484087360597,1,1,1,embryonic eye morphogenesis,BP,TH
2493,GO:0048596,0.346484087360597,1,1,1,embryonic camera-type eye morphogenesis,BP,TH
2519,GO:0048770,0.346484087360597,1,1,1,pigment granule,CC,TH
2722,GO:0051602,0.346484087360597,1,1,1,response to electrical stimulus,BP,TH
2732,GO:0051703,0.346484087360597,1,1,1,intraspecies interaction between organisms,BP,TH
2734,GO:0051705,0.346484087360597,1,1,1,multi-organism behavior,BP,TH
2749,GO:0052314,0.346484087360597,1,1,1,phytoalexin metabolic process,BP,TH
2908,GO:0070382,0.346484087360597,1,1,1,exocytic vesicle,CC,TH
2965,GO:0071287,0.346484087360597,1,1,1,cellular response to manganese ion,BP,TH
2968,GO:0071316,0.346484087360597,1,1,1,cellular response to nicotine,BP,TH
3159,GO:0098562,0.346484087360597,1,1,1,cytoplasmic side of membrane,CC,TH
3173,GO:0098700,0.346484087360597,1,1,1,neurotransmitter loading into synaptic vesicle,BP,TH
3181,GO:0098793,0.346484087360597,1,1,1,presynapse,CC,TH
3196,GO:0099504,0.346484087360597,1,1,1,synaptic vesicle cycle,BP,TH
3246,GO:1901338,0.346484087360597,1,1,1,catecholamine binding,MF,TH
256,GO:0004177,0.347286193092548,1,1,1,aminopeptidase activity,MF,PEPD
257,GO:0004180,0.347286193092548,1,1,1,carboxypeptidase activity,MF,PEPD
258,GO:0004181,0.347286193092548,1,1,1,metallocarboxypeptidase activity,MF,PEPD
735,GO:0008235,0.347286193092548,1,1,1,metalloexopeptidase activity,MF,PEPD
737,GO:0008237,0.347286193092548,1,1,1,metallopeptidase activity,MF,PEPD
738,GO:0008238,0.347286193092548,1,1,1,exopeptidase activity,MF,PEPD
1195,GO:0016805,0.347286193092548,1,1,1,dipeptidase activity,MF,PEPD
1447,GO:0030574,0.347286193092548,1,1,1,collagen catabolic process,BP,PEPD
1686,GO:0032963,0.347286193092548,1,1,1,collagen metabolic process,BP,PEPD
2153,GO:0044243,0.347286193092548,1,1,1,multicellular organismal catabolic process,BP,PEPD
2158,GO:0044259,0.347286193092548,1,1,1,multicellular organismal macromolecule metabolic process,BP,PEPD
3206,GO:0102009,0.347286193092548,1,1,1,proline dipeptidase activity,MF,PEPD
129,GO:0002084,0.347577627647141,1,1,1,protein depalmitoylation,BP,LYPLAL1
292,GO:0004622,0.347577627647141,1,1,1,lysophospholipase activity,MF,LYPLAL1
759,GO:0008474,0.347577627647141,1,1,1,palmitoyl-(protein) hydrolase activity,MF,LYPLAL1
1839,GO:0035601,0.347577627647141,1,1,1,protein deacylation,BP,LYPLAL1
1921,GO:0042159,0.347577627647141,1,1,1,lipoprotein catabolic process,BP,LYPLAL1
3164,GO:0098599,0.347577627647141,1,1,1,palmitoyl hydrolase activity,MF,LYPLAL1
3174,GO:0098732,0.347577627647141,1,1,1,macromolecule deacylation,BP,LYPLAL1
3175,GO:0098734,0.347577627647141,1,1,1,macromolecule depalmitoylation,BP,LYPLAL1
3013,GO:0071822,0.347716803248063,0.837145357129708,6,13,protein complex subunit organization,BP,HACL1;ACAT1;MRPL14;FADD;HNF1A;DECR1
392,GO:0005776,0.349940951356212,0.963516434544428,1,2,autophagosome,CC,TBC1D14
919,GO:0010506,0.349940951356212,0.963516434544428,1,2,regulation of autophagy,BP,TBC1D14
86,GO:0001776,0.350557458141192,1,1,1,leukocyte homeostasis,BP,FADD
99,GO:0001906,0.350557458141192,1,1,1,cell killing,BP,FADD
100,GO:0001909,0.350557458141192,1,1,1,leukocyte mediated cytotoxicity,BP,FADD
101,GO:0001910,0.350557458141192,1,1,1,regulation of leukocyte mediated cytotoxicity,BP,FADD
102,GO:0001912,0.350557458141192,1,1,1,positive regulation of leukocyte mediated cytotoxicity,BP,FADD
103,GO:0001913,0.350557458141192,1,1,1,T cell mediated cytotoxicity,BP,FADD
104,GO:0001914,0.350557458141192,1,1,1,regulation of T cell mediated cytotoxicity,BP,FADD
105,GO:0001916,0.350557458141192,1,1,1,positive regulation of T cell mediated cytotoxicity,BP,FADD
118,GO:0001961,0.350557458141192,1,1,1,positive regulation of cytokine-mediated signaling pathway,BP,FADD
139,GO:0002260,0.350557458141192,1,1,1,lymphocyte homeostasis,BP,FADD
154,GO:0002449,0.350557458141192,1,1,1,lymphocyte mediated immunity,BP,FADD
155,GO:0002456,0.350557458141192,1,1,1,T cell mediated immunity,BP,FADD
156,GO:0002460,0.350557458141192,1,1,1,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD
165,GO:0002573,0.350557458141192,1,1,1,myeloid leukocyte differentiation,BP,FADD
182,GO:0002691,0.350557458141192,1,1,1,regulation of cellular extravasation,BP,FADD
183,GO:0002693,0.350557458141192,1,1,1,positive regulation of cellular extravasation,BP,FADD
190,GO:0002703,0.350557458141192,1,1,1,regulation of leukocyte mediated immunity,BP,FADD
191,GO:0002705,0.350557458141192,1,1,1,positive regulation of leukocyte mediated immunity,BP,FADD
192,GO:0002706,0.350557458141192,1,1,1,regulation of lymphocyte mediated immunity,BP,FADD
193,GO:0002708,0.350557458141192,1,1,1,positive regulation of lymphocyte mediated immunity,BP,FADD
194,GO:0002709,0.350557458141192,1,1,1,regulation of T cell mediated immunity,BP,FADD
195,GO:0002711,0.350557458141192,1,1,1,positive regulation of T cell mediated immunity,BP,FADD
199,GO:0002761,0.350557458141192,1,1,1,regulation of myeloid leukocyte differentiation,BP,FADD
200,GO:0002763,0.350557458141192,1,1,1,positive regulation of myeloid leukocyte differentiation,BP,FADD
208,GO:0002822,0.350557458141192,1,1,1,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD
209,GO:0002824,0.350557458141192,1,1,1,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD
608,GO:0006924,0.350557458141192,1,1,1,activation-induced cell death of T cells,BP,FADD
1020,GO:0014072,0.350557458141192,1,1,1,response to isoquinoline alkaloid,BP,FADD
1387,GO:0030099,0.350557458141192,1,1,1,myeloid cell differentiation,BP,FADD
1418,GO:0030225,0.350557458141192,1,1,1,macrophage differentiation,BP,FADD
1443,GO:0030534,0.350557458141192,1,1,1,adult behavior,BP,FADD
1500,GO:0031265,0.350557458141192,1,1,1,CD95 death-inducing signaling complex,CC,FADD
1518,GO:0031341,0.350557458141192,1,1,1,regulation of cell killing,BP,FADD
1519,GO:0031343,0.350557458141192,1,1,1,positive regulation of cell killing,BP,FADD
1537,GO:0031638,0.350557458141192,1,1,1,zymogen activation,BP,FADD
1698,GO:0033077,0.350557458141192,1,1,1,T cell differentiation in thymus,BP,FADD
1845,GO:0035697,0.350557458141192,1,1,1,CD8-positive, alpha-beta T cell extravasation,BP,FADD
1846,GO:0035698,0.350557458141192,1,1,1,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
1878,GO:0036462,0.350557458141192,1,1,1,TRAIL-activated apoptotic signaling pathway,BP,FADD
1884,GO:0038034,0.350557458141192,1,1,1,signal transduction in absence of ligand,BP,FADD
1929,GO:0042220,0.350557458141192,1,1,1,response to cocaine,BP,FADD
2033,GO:0043029,0.350557458141192,1,1,1,T cell homeostasis,BP,FADD
2082,GO:0043278,0.350557458141192,1,1,1,response to morphine,BP,FADD
2247,GO:0045123,0.350557458141192,1,1,1,cellular extravasation,BP,FADD
2282,GO:0045637,0.350557458141192,1,1,1,regulation of myeloid cell differentiation,BP,FADD
2283,GO:0045639,0.350557458141192,1,1,1,positive regulation of myeloid cell differentiation,BP,FADD
2284,GO:0045649,0.350557458141192,1,1,1,regulation of macrophage differentiation,BP,FADD
2285,GO:0045651,0.350557458141192,1,1,1,positive regulation of macrophage differentiation,BP,FADD
2455,GO:0048148,0.350557458141192,1,1,1,behavioral response to cocaine,BP,FADD
2481,GO:0048535,0.350557458141192,1,1,1,lymph node development,BP,FADD
2482,GO:0048536,0.350557458141192,1,1,1,spleen development,BP,FADD
2483,GO:0048538,0.350557458141192,1,1,1,thymus development,BP,FADD
2529,GO:0048872,0.350557458141192,1,1,1,homeostasis of number of cells,BP,FADD
2815,GO:0060338,0.350557458141192,1,1,1,regulation of type I interferon-mediated signaling pathway,BP,FADD
2816,GO:0060340,0.350557458141192,1,1,1,positive regulation of type I interferon-mediated signaling pathway,BP,FADD
2823,GO:0060359,0.350557458141192,1,1,1,response to ammonium ion,BP,FADD
2837,GO:0060546,0.350557458141192,1,1,1,negative regulation of necroptotic process,BP,FADD
2845,GO:0060760,0.350557458141192,1,1,1,positive regulation of response to cytokine stimulus,BP,FADD
2888,GO:0070227,0.350557458141192,1,1,1,lymphocyte apoptotic process,BP,FADD
2889,GO:0070228,0.350557458141192,1,1,1,regulation of lymphocyte apoptotic process,BP,FADD
2890,GO:0070229,0.350557458141192,1,1,1,negative regulation of lymphocyte apoptotic process,BP,FADD
2891,GO:0070231,0.350557458141192,1,1,1,T cell apoptotic process,BP,FADD
2892,GO:0070232,0.350557458141192,1,1,1,regulation of T cell apoptotic process,BP,FADD
2893,GO:0070233,0.350557458141192,1,1,1,negative regulation of T cell apoptotic process,BP,FADD
2894,GO:0070235,0.350557458141192,1,1,1,regulation of activation-induced cell death of T cells,BP,FADD
2895,GO:0070236,0.350557458141192,1,1,1,negative regulation of activation-induced cell death of T cells,BP,FADD
2953,GO:0071214,0.350557458141192,1,1,1,cellular response to abiotic stimulus,BP,FADD
2961,GO:0071260,0.350557458141192,1,1,1,cellular response to mechanical stimulus,BP,FADD
3026,GO:0071887,0.350557458141192,1,1,1,leukocyte apoptotic process,BP,FADD
3076,GO:0072683,0.350557458141192,1,1,1,T cell extravasation,BP,FADD
3121,GO:0097049,0.350557458141192,1,1,1,motor neuron apoptotic process,BP,FADD
3130,GO:0097192,0.350557458141192,1,1,1,extrinsic apoptotic signaling pathway in absence of ligand,BP,FADD
3134,GO:0097202,0.350557458141192,1,1,1,activation of cysteine-type endopeptidase activity,BP,FADD
3150,GO:0097527,0.350557458141192,1,1,1,necroptotic signaling pathway,BP,FADD
3295,GO:1902043,0.350557458141192,1,1,1,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD
3461,GO:2000106,0.350557458141192,1,1,1,regulation of leukocyte apoptotic process,BP,FADD
3462,GO:2000107,0.350557458141192,1,1,1,negative regulation of leukocyte apoptotic process,BP,FADD
3484,GO:2000407,0.350557458141192,1,1,1,regulation of T cell extravasation,BP,FADD
3485,GO:2000409,0.350557458141192,1,1,1,positive regulation of T cell extravasation,BP,FADD
3486,GO:2000449,0.350557458141192,1,1,1,regulation of CD8-positive, alpha-beta T cell extravasation,BP,FADD
3487,GO:2000451,0.350557458141192,1,1,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,FADD
3488,GO:2000452,0.350557458141192,1,1,1,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
3489,GO:2000454,0.350557458141192,1,1,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
2505,GO:0048646,0.350979836841289,0.938365662122279,2,3,anatomical structure formation involved in morphogenesis,BP,RBP4;FGF18
253,GO:0004165,0.353162846975316,1,1,1,dodecenoyl-CoA delta-isomerase activity,MF,ECI1
750,GO:0008361,0.353162846975316,1,1,1,regulation of cell size,BP,DEPTOR
1552,GO:0031929,0.353162846975316,1,1,1,TOR signaling,BP,DEPTOR
1564,GO:0032006,0.353162846975316,1,1,1,regulation of TOR signaling,BP,DEPTOR
1565,GO:0032007,0.353162846975316,1,1,1,negative regulation of TOR signaling,BP,DEPTOR
2298,GO:0045792,0.353162846975316,1,1,1,negative regulation of cell size,BP,DEPTOR
2633,GO:0051093,0.355864500492471,0.885475996111992,3,6,negative regulation of developmental process,BP,RBP4;ABCG1;LINGO1
1222,GO:0017016,0.35796236421886,0.96160671170881,1,2,Ras GTPase binding,MF,TBC1D14
1234,GO:0017137,0.35796236421886,0.96160671170881,1,2,Rab GTPase binding,MF,TBC1D14
1501,GO:0031267,0.35796236421886,0.96160671170881,1,2,small GTPase binding,MF,TBC1D14
2619,GO:0051020,0.35796236421886,0.96160671170881,1,2,GTPase binding,MF,TBC1D14
3126,GO:0097164,0.35958165906416,0.883509696691461,3,6,ammonium ion metabolic process,BP,TH;PLA2G16;CPT1C
394,GO:0005778,0.36116673541385,0.913652239322166,2,4,peroxisomal membrane,CC,PXMP2;PLA2G16
1550,GO:0031903,0.36116673541385,0.913652239322166,2,4,microbody membrane,CC,PXMP2;PLA2G16
2364,GO:0046474,0.362787023203491,0.93447104527093,2,3,glycerophospholipid biosynthetic process,BP,FGF18;DPM3
58,GO:0001522,0.363695128121521,1,1,1,pseudouridine synthesis,BP,PUS1
298,GO:0004730,0.363695128121521,1,1,1,pseudouridylate synthase activity,MF,PUS1
898,GO:0009982,0.363695128121521,1,1,1,pseudouridine synthase activity,MF,PUS1
1150,GO:0016556,0.363695128121521,1,1,1,mRNA modification,BP,PUS1
1212,GO:0016866,0.363695128121521,1,1,1,intramolecular transferase activity,MF,PUS1
1488,GO:0031119,0.363695128121521,1,1,1,tRNA pseudouridine synthesis,BP,PUS1
2945,GO:0070902,0.363695128121521,1,1,1,mitochondrial tRNA pseudouridine synthesis,BP,PUS1
3450,GO:1990481,0.363695128121521,1,1,1,mRNA pseudouridine synthesis,BP,PUS1
3262,GO:1901615,0.363946347046122,0.822634079401128,6,14,organic hydroxy compound metabolic process,BP,RBP4;ACADVL;ACAA2;TH;ABCG1;ACAT2
773,GO:0008643,0.364606739374387,0.959978325959028,1,2,carbohydrate transport,BP,HNF1A
774,GO:0008645,0.364606739374387,0.959978325959028,1,2,hexose transport,BP,HNF1A
1069,GO:0015749,0.364606739374387,0.959978325959028,1,2,monosaccharide transport,BP,HNF1A
1070,GO:0015758,0.364606739374387,0.959978325959028,1,2,glucose transport,BP,HNF1A
2338,GO:0046323,0.364606739374387,0.959978325959028,1,2,glucose import,BP,HNF1A
1312,GO:0019882,0.367478697923237,0.932885804652871,2,3,antigen processing and presentation,BP,PSMB10;IFI30
2441,GO:0048002,0.367478697923237,0.932885804652871,2,3,antigen processing and presentation of peptide antigen,BP,PSMB10;IFI30
2187,GO:0044430,0.369131524362419,0.910174581895667,2,4,cytoskeletal part,CC,PXK;KRT10
3161,GO:0098588,0.369157295918571,0.813741683145357,6,16,bounding membrane of organelle,CC,PXMP2;TH;ABCG1;PLA2G16;CPT1C;ZFYVE21
724,GO:0008203,0.369373488217094,0.849258604793271,4,9,cholesterol metabolic process,BP,ACADVL;ACAA2;ABCG1;ACAT2
3327,GO:1902652,0.369373488217094,0.849258604793271,4,9,secondary alcohol metabolic process,BP,ACADVL;ACAA2;ABCG1;ACAT2
2716,GO:0051536,0.369918046207412,0.958645851592348,1,2,iron-sulfur cluster binding,MF,ETFDH
2719,GO:0051540,0.369918046207412,0.958645851592348,1,2,metal cluster binding,MF,ETFDH
1302,GO:0019752,0.37311486726638,0.764700159517749,15,41,carboxylic acid metabolic process,BP,HACL1;MSRA;ACAT1;ACADVL;ACAA2;TH;ACAT2;ECI1;ETFDH;PSMB10;PTS;DECR1;CPT1C;ETFB;PEPD
2181,GO:0044421,0.374403153837027,0.769620159824976,13,34,extracellular region part,CC,MSRA;ACAT1;RBP4;ACAA2;ACAT2;ECI1;KRT10;LYPLAL1;LINGO1;DECR1;FGF18;ETFB;PEPD
54,GO:0001503,0.374477859015177,1,1,1,ossification,BP,FGF18
76,GO:0001667,0.374477859015177,1,1,1,ameboidal-type cell migration,BP,FGF18
114,GO:0001957,0.374477859015177,1,1,1,intramembranous ossification,BP,FGF18
115,GO:0001958,0.374477859015177,1,1,1,endochondral ossification,BP,FGF18
127,GO:0002062,0.374477859015177,1,1,1,chondrocyte differentiation,BP,FGF18
128,GO:0002063,0.374477859015177,1,1,1,chondrocyte development,BP,FGF18
295,GO:0004713,0.374477859015177,1,1,1,protein tyrosine kinase activity,MF,FGF18
316,GO:0005085,0.374477859015177,1,1,1,guanyl-nucleotide exchange factor activity,MF,FGF18
317,GO:0005088,0.374477859015177,1,1,1,Ras guanyl-nucleotide exchange factor activity,MF,FGF18
320,GO:0005104,0.374477859015177,1,1,1,fibroblast growth factor receptor binding,MF,FGF18
321,GO:0005105,0.374477859015177,1,1,1,type 1 fibroblast growth factor receptor binding,MF,FGF18
322,GO:0005111,0.374477859015177,1,1,1,type 2 fibroblast growth factor receptor binding,MF,FGF18
763,GO:0008543,0.374477859015177,1,1,1,fibroblast growth factor receptor signaling pathway,BP,FGF18
932,GO:0010594,0.374477859015177,1,1,1,regulation of endothelial cell migration,BP,FGF18
933,GO:0010595,0.374477859015177,1,1,1,positive regulation of endothelial cell migration,BP,FGF18
939,GO:0010631,0.374477859015177,1,1,1,epithelial cell migration,BP,FGF18
940,GO:0010632,0.374477859015177,1,1,1,regulation of epithelial cell migration,BP,FGF18
941,GO:0010634,0.374477859015177,1,1,1,positive regulation of epithelial cell migration,BP,FGF18
1017,GO:0014065,0.374477859015177,1,1,1,phosphatidylinositol 3-kinase signaling,BP,FGF18
1018,GO:0014066,0.374477859015177,1,1,1,regulation of phosphatidylinositol 3-kinase signaling,BP,FGF18
1127,GO:0016303,0.374477859015177,1,1,1,1-phosphatidylinositol-3-kinase activity,MF,FGF18
1478,GO:0030947,0.374477859015177,1,1,1,regulation of vascular endothelial growth factor receptor signaling pathway,BP,FGF18
1479,GO:0030949,0.374477859015177,1,1,1,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,FGF18
1571,GO:0032103,0.374477859015177,1,1,1,positive regulation of response to external stimulus,BP,FGF18
1584,GO:0032330,0.374477859015177,1,1,1,regulation of chondrocyte differentiation,BP,FGF18
1585,GO:0032332,0.374477859015177,1,1,1,positive regulation of chondrocyte differentiation,BP,FGF18
1804,GO:0035004,0.374477859015177,1,1,1,phosphatidylinositol 3-kinase activity,MF,FGF18
1848,GO:0035766,0.374477859015177,1,1,1,cell chemotaxis to fibroblast growth factor,BP,FGF18
1849,GO:0035767,0.374477859015177,1,1,1,endothelial cell chemotaxis,BP,FGF18
1850,GO:0035768,0.374477859015177,1,1,1,endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
1863,GO:0036072,0.374477859015177,1,1,1,direct ossification,BP,FGF18
1864,GO:0036075,0.374477859015177,1,1,1,replacement ossification,BP,FGF18
1865,GO:0036092,0.374477859015177,1,1,1,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGF18
2114,GO:0043542,0.374477859015177,1,1,1,endothelial cell migration,BP,FGF18
2423,GO:0046934,0.374477859015177,1,1,1,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,FGF18
2443,GO:0048010,0.374477859015177,1,1,1,vascular endothelial growth factor receptor signaling pathway,BP,FGF18
2444,GO:0048015,0.374477859015177,1,1,1,phosphatidylinositol-mediated signaling,BP,FGF18
2445,GO:0048017,0.374477859015177,1,1,1,inositol lipid-mediated signaling,BP,FGF18
2512,GO:0048705,0.374477859015177,1,1,1,skeletal system morphogenesis,BP,FGF18
2607,GO:0050920,0.374477859015177,1,1,1,regulation of chemotaxis,BP,FGF18
2608,GO:0050921,0.374477859015177,1,1,1,positive regulation of chemotaxis,BP,FGF18
2658,GO:0051216,0.374477859015177,1,1,1,cartilage development,BP,FGF18
2757,GO:0052742,0.374477859015177,1,1,1,phosphatidylinositol kinase activity,MF,FGF18
2758,GO:0052813,0.374477859015177,1,1,1,phosphatidylinositol bisphosphate kinase activity,MF,FGF18
2812,GO:0060326,0.374477859015177,1,1,1,cell chemotaxis,BP,FGF18
2821,GO:0060349,0.374477859015177,1,1,1,bone morphogenesis,BP,FGF18
2822,GO:0060350,0.374477859015177,1,1,1,endochondral bone morphogenesis,BP,FGF18
2852,GO:0061035,0.374477859015177,1,1,1,regulation of cartilage development,BP,FGF18
2853,GO:0061036,0.374477859015177,1,1,1,positive regulation of cartilage development,BP,FGF18
3088,GO:0090130,0.374477859015177,1,1,1,tissue migration,BP,FGF18
3089,GO:0090132,0.374477859015177,1,1,1,epithelium migration,BP,FGF18
3106,GO:0090287,0.374477859015177,1,1,1,regulation of cellular response to growth factor stimulus,BP,FGF18
3428,GO:1904847,0.374477859015177,1,1,1,regulation of cell chemotaxis to fibroblast growth factor,BP,FGF18
3429,GO:1904849,0.374477859015177,1,1,1,positive regulation of cell chemotaxis to fibroblast growth factor,BP,FGF18
3492,GO:2000544,0.374477859015177,1,1,1,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
3493,GO:2000546,0.374477859015177,1,1,1,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
3500,GO:2001026,0.374477859015177,1,1,1,regulation of endothelial cell chemotaxis,BP,FGF18
3501,GO:2001028,0.374477859015177,1,1,1,positive regulation of endothelial cell chemotaxis,BP,FGF18
2782,GO:0055114,0.3760960938503,0.767591277198665,13,35,oxidation-reduction process,BP,HACL1;MSRA;ACAT1;ACADVL;ACAA2;TH;ACAT2;ECI1;ETFDH;DECR1;CPT1C;ETFB;IFI30
709,GO:0008113,0.376640552601175,1,1,1,peptide-methionine (S)-S-oxide reductase activity,MF,MSRA
1167,GO:0016671,0.376640552601175,1,1,1,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,MSRA
1384,GO:0030091,0.376640552601175,1,1,1,protein repair,BP,MSRA
783,GO:0009055,0.376796736987959,0.90675684126812,2,4,electron carrier activity,MF,ETFDH;ETFB
480,GO:0006461,0.377412230371169,0.828744136338633,5,11,protein complex assembly,BP,HACL1;ACAT1;FADD;HNF1A;DECR1
2899,GO:0070271,0.377412230371169,0.828744136338633,5,11,protein complex biogenesis,BP,HACL1;ACAT1;FADD;HNF1A;DECR1
2141,GO:0044085,0.38061195702342,0.807884037313358,6,15,cellular component biogenesis,BP,HACL1;ACAT1;FADD;TBC1D14;HNF1A;DECR1
20,GO:0000285,0.383497991777104,1,1,1,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,ZFYVE21
414,GO:0005912,0.383497991777104,1,1,1,adherens junction,CC,ZFYVE21
415,GO:0005924,0.383497991777104,1,1,1,cell-substrate adherens junction,CC,ZFYVE21
416,GO:0005925,0.383497991777104,1,1,1,focal adhesion,CC,ZFYVE21
1128,GO:0016307,0.383497991777104,1,1,1,phosphatidylinositol phosphate kinase activity,MF,ZFYVE21
1379,GO:0030055,0.383497991777104,1,1,1,cell-substrate junction,CC,ZFYVE21
2885,GO:0070161,0.383497991777104,1,1,1,anchoring junction,CC,ZFYVE21
1538,GO:0031647,0.384662774930185,0.926892624994583,2,3,regulation of protein stability,BP,DPM3;IFI30
1156,GO:0016607,0.38480553693478,1,1,1,nuclear speck,CC,ARL6IP4
2202,GO:0044456,0.385382379670479,0.954606924810833,1,2,synapse part,CC,TH
778,GO:0008670,0.392254079150426,1,1,1,2,4-dienoyl-CoA reductase (NADPH) activity,MF,DECR1
1165,GO:0016651,0.392254079150426,1,1,1,oxidoreductase activity, acting on NAD(P)H,MF,DECR1
2909,GO:0070402,0.392254079150426,1,1,1,NADPH binding,MF,DECR1
3187,GO:0098805,0.393030736753744,0.796274645571303,6,16,whole membrane,CC,PXMP2;TH;FADD;PLA2G16;CPT1C;ZFYVE21
293,GO:0004623,0.393170397952915,1,1,1,phospholipase A2 activity,MF,PLA2G16
529,GO:0006658,0.393170397952915,1,1,1,phosphatidylserine metabolic process,BP,PLA2G16
531,GO:0006662,0.393170397952915,1,1,1,glycerol ether metabolic process,BP,PLA2G16
628,GO:0007031,0.393170397952915,1,1,1,peroxisome organization,BP,PLA2G16
781,GO:0008970,0.393170397952915,1,1,1,phosphatidylcholine 1-acylhydrolase activity,MF,PLA2G16
1254,GO:0018904,0.393170397952915,1,1,1,ether metabolic process,BP,PLA2G16
1868,GO:0036149,0.393170397952915,1,1,1,phosphatidylinositol acyl-chain remodeling,BP,PLA2G16
1869,GO:0036150,0.393170397952915,1,1,1,phosphatidylserine acyl-chain remodeling,BP,PLA2G16
1870,GO:0036151,0.393170397952915,1,1,1,phosphatidylcholine acyl-chain remodeling,BP,PLA2G16
1871,GO:0036152,0.393170397952915,1,1,1,phosphatidylethanolamine acyl-chain remodeling,BP,PLA2G16
2369,GO:0046485,0.393170397952915,1,1,1,ether lipid metabolic process,BP,PLA2G16
2755,GO:0052739,0.393170397952915,1,1,1,phosphatidylserine 1-acylhydrolase activity,MF,PLA2G16
2756,GO:0052740,0.393170397952915,1,1,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,PLA2G16
3413,GO:1904177,0.393170397952915,1,1,1,regulation of adipose tissue development,BP,PLA2G16
2676,GO:0051259,0.396506956900154,0.863078219219369,3,6,protein oligomerization,BP,HACL1;ACAT1;DECR1
286,GO:0004576,0.398034489737532,1,1,1,oligosaccharyl transferase activity,MF,ALG5
287,GO:0004581,0.398034489737532,1,1,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,ALG5
663,GO:0007368,0.398034489737532,1,1,1,determination of left/right symmetry,BP,ALG5
664,GO:0007389,0.398034489737532,1,1,1,pattern specification process,BP,ALG5
876,GO:0009799,0.398034489737532,1,1,1,specification of symmetry,BP,ALG5
878,GO:0009855,0.398034489737532,1,1,1,determination of bilateral symmetry,BP,ALG5
1811,GO:0035251,0.398034489737532,1,1,1,UDP-glucosyltransferase activity,MF,ALG5
2378,GO:0046527,0.398034489737532,1,1,1,glucosyltransferase activity,MF,ALG5
901,GO:0009991,0.398053560433891,0.884369255263042,2,5,response to extracellular stimulus,BP,ACAT1;TH
1540,GO:0031667,0.398053560433891,0.884369255263042,2,5,response to nutrient levels,BP,ACAT1;TH
1775,GO:0034470,0.39926103788029,0.896331880009073,2,4,ncRNA processing,BP,PUS1;LAGE3
1520,GO:0031344,0.399391601048116,0.95073732758892,1,2,regulation of cell projection organization,BP,LINGO1
715,GO:0008152,0.399808809576772,0.763852249839094,35,101,metabolic process,BP,HACL1;MSRA;ACAT1;MRPL14;RBP4;ACADVL;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;ECI1;KRT10;ETFDH;DEPTOR;FADD;PSMB10;LYPLAL1;LAGE3;TBC1D14;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;PEPD;IFI30
1105,GO:0016071,0.399883967005941,0.896033967973915,2,4,mRNA metabolic process,BP,ARL6IP4;PUS1
2214,GO:0044707,0.400848439624336,0.741343207149332,15,42,single-multicellular organism process,BP,ACAT1;RBP4;ACADVL;TH;ALG5;ABCG1;KRT10;FADD;PSMB10;HNF1A;PTS;PLA2G16;LINGO1;FGF18;PEPD
375,GO:0005730,0.400862661499049,0.828878279496714,4,9,nucleolus,CC,ACADVL;ARL6IP4;ACAT2;FGF18
2025,GO:0043005,0.401114832049683,0.850728262348276,3,7,neuron projection,CC,TH;FADD;CPT1C
485,GO:0006479,0.402225632562675,1,1,1,protein methylation,BP,ETFB
731,GO:0008213,0.402225632562675,1,1,1,protein alkylation,BP,ETFB
2279,GO:0045597,0.403693921178756,0.894201352359836,2,4,positive regulation of cell differentiation,BP,FADD;FGF18
629,GO:0007033,0.405018187037798,0.949125102456331,1,2,vacuole organization,BP,TBC1D14
681,GO:0007600,0.405390312771906,0.893379532044743,2,4,sensory perception,BP,RBP4;TH
2370,GO:0046486,0.406078890644256,0.833008169435776,4,8,glycerolipid metabolic process,BP,PLA2G16;FGF18;ZFYVE21;DPM3
1126,GO:0016301,0.406743754439159,0.879747813382432,2,5,kinase activity,MF,FGF18;ZFYVE21
1188,GO:0016773,0.406743754439159,0.879747813382432,2,5,phosphotransferase activity, alcohol group as acceptor,MF,FGF18;ZFYVE21
1314,GO:0019886,0.407150788461917,1,1,1,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,IFI30
2452,GO:0048144,0.407150788461917,1,1,1,fibroblast proliferation,BP,IFI30
2453,GO:0048145,0.407150788461917,1,1,1,regulation of fibroblast proliferation,BP,IFI30
2454,GO:0048147,0.407150788461917,1,1,1,negative regulation of fibroblast proliferation,BP,IFI30
2587,GO:0050821,0.407150788461917,1,1,1,protein stabilization,BP,IFI30
242,GO:0003986,0.408673420604557,1,1,1,acetyl-CoA hydrolase activity,MF,NUDT7
811,GO:0009132,0.408673420604557,1,1,1,nucleoside diphosphate metabolic process,BP,NUDT7
814,GO:0009154,0.408673420604557,1,1,1,purine ribonucleotide catabolic process,BP,NUDT7
826,GO:0009261,0.408673420604557,1,1,1,ribonucleotide catabolic process,BP,NUDT7
1090,GO:0015938,0.408673420604557,1,1,1,coenzyme A catabolic process,BP,NUDT7
1124,GO:0016289,0.408673420604557,1,1,1,CoA hydrolase activity,MF,NUDT7
1441,GO:0030515,0.408673420604557,1,1,1,snoRNA binding,MF,NUDT7
1724,GO:0033869,0.408673420604557,1,1,1,nucleoside bisphosphate catabolic process,BP,NUDT7
1728,GO:0034031,0.408673420604557,1,1,1,ribonucleoside bisphosphate catabolic process,BP,NUDT7
1731,GO:0034034,0.408673420604557,1,1,1,purine nucleoside bisphosphate catabolic process,BP,NUDT7
6,GO:0000086,0.410587770912021,1,1,1,G2/M transition of mitotic cell cycle,BP,PSMB10
19,GO:0000278,0.410587770912021,1,1,1,mitotic cell cycle,BP,PSMB10
31,GO:0000502,0.410587770912021,1,1,1,proteasome complex,CC,PSMB10
81,GO:0001736,0.410587770912021,1,1,1,establishment of planar polarity,BP,PSMB10
82,GO:0001738,0.410587770912021,1,1,1,morphogenesis of a polarized epithelium,BP,PSMB10
122,GO:0002009,0.410587770912021,1,1,1,morphogenesis of an epithelium,BP,PSMB10
131,GO:0002220,0.410587770912021,1,1,1,innate immune response activating cell surface receptor signaling pathway,BP,PSMB10
133,GO:0002223,0.410587770912021,1,1,1,stimulatory C-type lectin receptor signaling pathway,BP,PSMB10
149,GO:0002429,0.410587770912021,1,1,1,immune response-activating cell surface receptor signaling pathway,BP,PSMB10
159,GO:0002479,0.410587770912021,1,1,1,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,PSMB10
202,GO:0002768,0.410587770912021,1,1,1,immune response-regulating cell surface receptor signaling pathway,BP,PSMB10
261,GO:0004298,0.410587770912021,1,1,1,threonine-type endopeptidase activity,MF,PSMB10
405,GO:0005839,0.410587770912021,1,1,1,proteasome core complex,CC,PSMB10
493,GO:0006511,0.410587770912021,1,1,1,ubiquitin-dependent protein catabolic process,BP,PSMB10
496,GO:0006521,0.410587770912021,1,1,1,regulation of cellular amino acid metabolic process,BP,PSMB10
635,GO:0007164,0.410587770912021,1,1,1,establishment of tissue polarity,BP,PSMB10
662,GO:0007346,0.410587770912021,1,1,1,regulation of mitotic cell cycle,BP,PSMB10
914,GO:0010389,0.410587770912021,1,1,1,regulation of G2/M transition of mitotic cell cycle,BP,PSMB10
918,GO:0010498,0.410587770912021,1,1,1,proteasomal protein catabolic process,BP,PSMB10
930,GO:0010564,0.410587770912021,1,1,1,regulation of cell cycle process,BP,PSMB10
1001,GO:0010948,0.410587770912021,1,1,1,negative regulation of cell cycle process,BP,PSMB10
1007,GO:0010972,0.410587770912021,1,1,1,negative regulation of G2/M transition of mitotic cell cycle,BP,PSMB10
1103,GO:0016055,0.410587770912021,1,1,1,Wnt signaling pathway,BP,PSMB10
1152,GO:0016579,0.410587770912021,1,1,1,protein deubiquitination,BP,PSMB10
1321,GO:0019941,0.410587770912021,1,1,1,modification-dependent protein catabolic process,BP,PSMB10
1331,GO:0022402,0.410587770912021,1,1,1,cell cycle process,BP,PSMB10
1390,GO:0030111,0.410587770912021,1,1,1,regulation of Wnt signaling pathway,BP,PSMB10
1404,GO:0030177,0.410587770912021,1,1,1,positive regulation of Wnt signaling pathway,BP,PSMB10
1405,GO:0030178,0.410587770912021,1,1,1,negative regulation of Wnt signaling pathway,BP,PSMB10
1489,GO:0031145,0.410587770912021,1,1,1,anaphase-promoting complex-dependent catabolic process,BP,PSMB10
1490,GO:0031146,0.410587770912021,1,1,1,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,PSMB10
1526,GO:0031397,0.410587770912021,1,1,1,negative regulation of protein ubiquitination,BP,PSMB10
1704,GO:0033238,0.410587770912021,1,1,1,regulation of cellular amine metabolic process,BP,PSMB10
1832,GO:0035567,0.410587770912021,1,1,1,non-canonical Wnt signaling pathway,BP,PSMB10
1885,GO:0038061,0.410587770912021,1,1,1,NIK/NF-kappaB signaling,BP,PSMB10
1886,GO:0038093,0.410587770912021,1,1,1,Fc receptor signaling pathway,BP,PSMB10
1887,GO:0038095,0.410587770912021,1,1,1,Fc-epsilon receptor signaling pathway,BP,PSMB10
2011,GO:0042787,0.410587770912021,1,1,1,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,PSMB10
2053,GO:0043161,0.410587770912021,1,1,1,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,PSMB10
2123,GO:0043618,0.410587770912021,1,1,1,regulation of transcription from RNA polymerase II promoter in response to stress,BP,PSMB10
2124,GO:0043620,0.410587770912021,1,1,1,regulation of DNA-templated transcription in response to stress,BP,PSMB10
2128,GO:0043632,0.410587770912021,1,1,1,modification-dependent macromolecule catabolic process,BP,PSMB10
2226,GO:0044770,0.410587770912021,1,1,1,cell cycle phase transition,BP,PSMB10
2227,GO:0044772,0.410587770912021,1,1,1,mitotic cell cycle phase transition,BP,PSMB10
2230,GO:0044839,0.410587770912021,1,1,1,cell cycle G2/M phase transition,BP,PSMB10
2316,GO:0045930,0.410587770912021,1,1,1,negative regulation of mitotic cell cycle,BP,PSMB10
2515,GO:0048729,0.410587770912021,1,1,1,tissue morphogenesis,BP,PSMB10
2591,GO:0050851,0.410587770912021,1,1,1,antigen receptor-mediated signaling pathway,BP,PSMB10
2592,GO:0050852,0.410587770912021,1,1,1,T cell receptor signaling pathway,BP,PSMB10
2706,GO:0051436,0.410587770912021,1,1,1,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,PSMB10
2707,GO:0051437,0.410587770912021,1,1,1,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,BP,PSMB10
2708,GO:0051438,0.410587770912021,1,1,1,regulation of ubiquitin-protein transferase activity,BP,PSMB10
2709,GO:0051439,0.410587770912021,1,1,1,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,PSMB10
2710,GO:0051443,0.410587770912021,1,1,1,positive regulation of ubiquitin-protein transferase activity,BP,PSMB10
2711,GO:0051444,0.410587770912021,1,1,1,negative regulation of ubiquitin-protein transferase activity,BP,PSMB10
2792,GO:0060070,0.410587770912021,1,1,1,canonical Wnt signaling pathway,BP,PSMB10
2793,GO:0060071,0.410587770912021,1,1,1,Wnt signaling pathway, planar cell polarity pathway,BP,PSMB10
2847,GO:0060828,0.410587770912021,1,1,1,regulation of canonical Wnt signaling pathway,BP,PSMB10
2864,GO:0061418,0.410587770912021,1,1,1,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,PSMB10
2875,GO:0070003,0.410587770912021,1,1,1,threonine-type peptidase activity,MF,PSMB10
2923,GO:0070646,0.410587770912021,1,1,1,protein modification by small protein removal,BP,PSMB10
3087,GO:0090090,0.410587770912021,1,1,1,negative regulation of canonical Wnt signaling pathway,BP,PSMB10
3091,GO:0090175,0.410587770912021,1,1,1,regulation of establishment of planar polarity,BP,PSMB10
3103,GO:0090263,0.410587770912021,1,1,1,positive regulation of canonical Wnt signaling pathway,BP,PSMB10
3211,GO:0198738,0.410587770912021,1,1,1,cell-cell signaling by wnt,BP,PSMB10
3287,GO:1901987,0.410587770912021,1,1,1,regulation of cell cycle phase transition,BP,PSMB10
3288,GO:1901988,0.410587770912021,1,1,1,negative regulation of cell cycle phase transition,BP,PSMB10
3289,GO:1901990,0.410587770912021,1,1,1,regulation of mitotic cell cycle phase transition,BP,PSMB10
3290,GO:1901991,0.410587770912021,1,1,1,negative regulation of mitotic cell cycle phase transition,BP,PSMB10
3333,GO:1902749,0.410587770912021,1,1,1,regulation of cell cycle G2/M phase transition,BP,PSMB10
3334,GO:1902750,0.410587770912021,1,1,1,negative regulation of cell cycle G2/M phase transition,BP,PSMB10
3354,GO:1903047,0.410587770912021,1,1,1,mitotic cell cycle process,BP,PSMB10
3369,GO:1903321,0.410587770912021,1,1,1,negative regulation of protein modification by small protein conjugation or removal,BP,PSMB10
3422,GO:1904666,0.410587770912021,1,1,1,regulation of ubiquitin protein ligase activity,BP,PSMB10
3423,GO:1904667,0.410587770912021,1,1,1,negative regulation of ubiquitin protein ligase activity,BP,PSMB10
3424,GO:1904668,0.410587770912021,1,1,1,positive regulation of ubiquitin protein ligase activity,BP,PSMB10
3437,GO:1905330,0.410587770912021,1,1,1,regulation of morphogenesis of an epithelium,BP,PSMB10
3439,GO:1905368,0.410587770912021,1,1,1,peptidase complex,CC,PSMB10
3440,GO:1905369,0.410587770912021,1,1,1,endopeptidase complex,CC,PSMB10
3447,GO:1990111,0.410587770912021,1,1,1,spermatoproteasome complex,CC,PSMB10
3458,GO:2000027,0.410587770912021,1,1,1,regulation of organ morphogenesis,BP,PSMB10
3459,GO:2000058,0.410587770912021,1,1,1,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,PSMB10
3460,GO:2000060,0.410587770912021,1,1,1,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,PSMB10
1430,GO:0030334,0.411477202239428,0.890400886718768,2,4,regulation of cell migration,BP,FADD;FGF18
1431,GO:0030335,0.411477202239428,0.890400886718768,2,4,positive regulation of cell migration,BP,FADD;FGF18
1895,GO:0040017,0.411477202239428,0.890400886718768,2,4,positive regulation of locomotion,BP,FADD;FGF18
2682,GO:0051272,0.411477202239428,0.890400886718768,2,4,positive regulation of cellular component movement,BP,FADD;FGF18
3472,GO:2000147,0.411477202239428,0.890400886718768,2,4,positive regulation of cell motility,BP,FADD;FGF18
897,GO:0009968,0.411753159349891,0.82155278903013,4,9,negative regulation of signal transduction,BP,ACAA2;DEPTOR;FADD;PSMB10
946,GO:0010648,0.411753159349891,0.82155278903013,4,9,negative regulation of cell communication,BP,ACAA2;DEPTOR;FADD;PSMB10
1366,GO:0023057,0.411753159349891,0.82155278903013,4,9,negative regulation of signaling,BP,ACAA2;DEPTOR;FADD;PSMB10
239,GO:0003874,0.413808498635036,1,1,1,6-pyruvoyltetrahydropterin synthase activity,MF,PTS
1206,GO:0016838,0.413808498635036,1,1,1,carbon-oxygen lyase activity, acting on phosphates,MF,PTS
59,GO:0001523,0.414070648437515,1,1,1,retinoid metabolic process,BP,RBP4
148,GO:0002377,0.414070648437515,1,1,1,immunoglobulin production,BP,RBP4
150,GO:0002440,0.414070648437515,1,1,1,production of molecular mediator of immune response,BP,RBP4
174,GO:0002637,0.414070648437515,1,1,1,regulation of immunoglobulin production,BP,RBP4
175,GO:0002639,0.414070648437515,1,1,1,positive regulation of immunoglobulin production,BP,RBP4
188,GO:0002700,0.414070648437515,1,1,1,regulation of production of molecular mediator of immune response,BP,RBP4
189,GO:0002702,0.414070648437515,1,1,1,positive regulation of production of molecular mediator of immune response,BP,RBP4
219,GO:0003205,0.414070648437515,1,1,1,cardiac chamber development,BP,RBP4
220,GO:0003206,0.414070648437515,1,1,1,cardiac chamber morphogenesis,BP,RBP4
347,GO:0005501,0.414070648437515,1,1,1,retinoid binding,MF,RBP4
677,GO:0007586,0.414070648437515,1,1,1,digestion,BP,RBP4
875,GO:0009792,0.414070648437515,1,1,1,embryo development ending in birth or egg hatching,BP,RBP4
892,GO:0009914,0.414070648437515,1,1,1,hormone transport,BP,RBP4
956,GO:0010669,0.414070648437515,1,1,1,epithelial structure maintenance,BP,RBP4
1029,GO:0014855,0.414070648437515,1,1,1,striated muscle cell proliferation,BP,RBP4
1220,GO:0016918,0.414070648437515,1,1,1,retinal binding,MF,RBP4
1304,GO:0019840,0.414070648437515,1,1,1,isoprenoid binding,MF,RBP4
1305,GO:0019841,0.414070648437515,1,1,1,retinol binding,MF,RBP4
1340,GO:0022600,0.414070648437515,1,1,1,digestive system process,BP,RBP4
1367,GO:0023061,0.414070648437515,1,1,1,signal release,BP,RBP4
1382,GO:0030072,0.414070648437515,1,1,1,peptide hormone secretion,BP,RBP4
1383,GO:0030073,0.414070648437515,1,1,1,insulin secretion,BP,RBP4
1423,GO:0030277,0.414070648437515,1,1,1,maintenance of gastrointestinal epithelium,BP,RBP4
1445,GO:0030540,0.414070648437515,1,1,1,female genitalia development,BP,RBP4
1566,GO:0032024,0.414070648437515,1,1,1,positive regulation of insulin secretion,BP,RBP4
1618,GO:0032526,0.414070648437515,1,1,1,response to retinoic acid,BP,RBP4
1784,GO:0034632,0.414070648437515,1,1,1,retinol transporter activity,MF,RBP4
1785,GO:0034633,0.414070648437515,1,1,1,retinol transport,BP,RBP4
1807,GO:0035112,0.414070648437515,1,1,1,genitalia morphogenesis,BP,RBP4
1813,GO:0035265,0.414070648437515,1,1,1,organ growth,BP,RBP4
1985,GO:0042572,0.414070648437515,1,1,1,retinol metabolic process,BP,RBP4
2026,GO:0043009,0.414070648437515,1,1,1,chordate embryonic development,BP,RBP4
2314,GO:0045926,0.414070648437515,1,1,1,negative regulation of growth,BP,RBP4
2383,GO:0046620,0.414070648437515,1,1,1,regulation of organ growth,BP,RBP4
2384,GO:0046621,0.414070648437515,1,1,1,negative regulation of organ growth,BP,RBP4
2407,GO:0046864,0.414070648437515,1,1,1,isoprenoid transport,BP,RBP4
2408,GO:0046865,0.414070648437515,1,1,1,terpenoid transport,BP,RBP4
2411,GO:0046879,0.414070648437515,1,1,1,hormone secretion,BP,RBP4
2412,GO:0046883,0.414070648437515,1,1,1,regulation of hormone secretion,BP,RBP4
2413,GO:0046887,0.414070648437515,1,1,1,positive regulation of hormone secretion,BP,RBP4
2465,GO:0048305,0.414070648437515,1,1,1,immunoglobulin secretion,BP,RBP4
2502,GO:0048640,0.414070648437515,1,1,1,negative regulation of developmental growth,BP,RBP4
2513,GO:0048706,0.414070648437515,1,1,1,embryonic skeletal system development,BP,RBP4
2518,GO:0048738,0.414070648437515,1,1,1,cardiac muscle tissue development,BP,RBP4
2522,GO:0048807,0.414070648437515,1,1,1,female genitalia morphogenesis,BP,RBP4
2577,GO:0050796,0.414070648437515,1,1,1,regulation of insulin secretion,BP,RBP4
2620,GO:0051023,0.414070648437515,1,1,1,regulation of immunoglobulin secretion,BP,RBP4
2621,GO:0051024,0.414070648437515,1,1,1,positive regulation of immunoglobulin secretion,BP,RBP4
2649,GO:0051183,0.414070648437515,1,1,1,vitamin transporter activity,MF,RBP4
2759,GO:0055017,0.414070648437515,1,1,1,cardiac muscle tissue growth,BP,RBP4
2760,GO:0055021,0.414070648437515,1,1,1,regulation of cardiac muscle tissue growth,BP,RBP4
2761,GO:0055022,0.414070648437515,1,1,1,negative regulation of cardiac muscle tissue growth,BP,RBP4
2762,GO:0055024,0.414070648437515,1,1,1,regulation of cardiac muscle tissue development,BP,RBP4
2763,GO:0055026,0.414070648437515,1,1,1,negative regulation of cardiac muscle tissue development,BP,RBP4
2783,GO:0060038,0.414070648437515,1,1,1,cardiac muscle cell proliferation,BP,RBP4
2784,GO:0060041,0.414070648437515,1,1,1,retina development in camera-type eye,BP,RBP4
2785,GO:0060042,0.414070648437515,1,1,1,retina morphogenesis in camera-type eye,BP,RBP4
2786,GO:0060043,0.414070648437515,1,1,1,regulation of cardiac muscle cell proliferation,BP,RBP4
2787,GO:0060044,0.414070648437515,1,1,1,negative regulation of cardiac muscle cell proliferation,BP,RBP4
2789,GO:0060059,0.414070648437515,1,1,1,embryonic retina morphogenesis in camera-type eye,BP,RBP4
2790,GO:0060065,0.414070648437515,1,1,1,uterus development,BP,RBP4
2791,GO:0060068,0.414070648437515,1,1,1,vagina development,BP,RBP4
2798,GO:0060157,0.414070648437515,1,1,1,urinary bladder development,BP,RBP4
2818,GO:0060343,0.414070648437515,1,1,1,trabecula formation,BP,RBP4
2819,GO:0060347,0.414070648437515,1,1,1,heart trabecula formation,BP,RBP4
2829,GO:0060419,0.414070648437515,1,1,1,heart growth,BP,RBP4
2830,GO:0060420,0.414070648437515,1,1,1,regulation of heart growth,BP,RBP4
2856,GO:0061117,0.414070648437515,1,1,1,negative regulation of heart growth,BP,RBP4
2862,GO:0061383,0.414070648437515,1,1,1,trabecula morphogenesis,BP,RBP4
2863,GO:0061384,0.414070648437515,1,1,1,heart trabecula morphogenesis,BP,RBP4
3104,GO:0090276,0.414070648437515,1,1,1,regulation of peptide hormone secretion,BP,RBP4
3105,GO:0090277,0.414070648437515,1,1,1,positive regulation of peptide hormone secretion,BP,RBP4
1349,GO:0022804,0.415746191396778,0.9459565066341,1,2,active transmembrane transporter activity,MF,ABCG1
2278,GO:0045596,0.415755064075668,0.88827937024731,2,4,negative regulation of cell differentiation,BP,ABCG1;LINGO1
2142,GO:0044087,0.416184179058883,0.874613616697927,2,5,regulation of cellular component biogenesis,BP,TBC1D14;HNF1A
362,GO:0005575,0.418417298266436,1,43,125,cellular_component,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;TMEM160;CNIH4;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;BOLA1;ECI1;KRT10;ETFDH;CCDC51;DEPTOR;FADD;PSMB10;LYPLAL1;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;LINGO1;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;PEPD;IFI30
2516,GO:0048731,0.418718306868265,0.745805056310063,10,26,system development,BP,ACAT1;RBP4;TH;KRT10;FADD;PSMB10;PTS;PLA2G16;LINGO1;FGF18
75,GO:0001666,0.420613983121525,0.848833915728182,3,6,response to hypoxia,BP,ACAA2;TH;PSMB10
1874,GO:0036293,0.420613983121525,0.848833915728182,3,6,response to decreased oxygen levels,BP,ACAA2;TH;PSMB10
2911,GO:0070482,0.420613983121525,0.848833915728182,3,6,response to oxygen levels,BP,ACAA2;TH;PSMB10
407,GO:0005856,0.422959868005012,0.837010804024987,3,7,cytoskeleton,CC,MSRA;PXK;KRT10
2696,GO:0051347,0.424056049718393,0.884095685125915,2,4,positive regulation of transferase activity,BP,PSMB10;FGF18
499,GO:0006549,0.424679229564797,0.943221240443836,1,2,isoleucine metabolic process,BP,ACAT1
1202,GO:0016830,0.426060386392569,0.883072133236826,2,4,carbon-carbon lyase activity,MF,HACL1;ACAT1
11,GO:0000165,0.426792621976525,0.882696897665858,2,4,MAPK cascade,BP,PSMB10;FGF18
1362,GO:0023014,0.426792621976525,0.882696897665858,2,4,signal transduction by protein phosphorylation,BP,PSMB10;FGF18
525,GO:0006644,0.428850013592046,0.809759409088311,4,9,phospholipid metabolic process,BP,PLA2G16;FGF18;ZFYVE21;DPM3
3259,GO:1901605,0.428941317916933,0.826004431671225,3,8,alpha-amino acid metabolic process,BP,MSRA;ACAT1;TH
341,GO:0005319,0.429190464431474,0.881463211824171,2,4,lipid transporter activity,MF,RBP4;ABCG1
50,GO:0001101,0.43083337436963,0.880613584416227,2,4,response to acid chemical,BP,RBP4;TH
1184,GO:0016758,0.433751146949098,0.879095900389955,2,4,transferase activity, transferring hexosyl groups,MF,ALG5;DPM3
399,GO:0005793,0.434039784980362,1,1,1,endoplasmic reticulum-Golgi intermediate compartment,CC,CNIH4
598,GO:0006888,0.434039784980362,1,1,1,ER to Golgi vesicle-mediated transport,BP,CNIH4
1543,GO:0031730,0.434039784980362,1,1,1,CCR5 chemokine receptor binding,MF,CNIH4
1948,GO:0042379,0.434039784980362,1,1,1,chemokine receptor binding,MF,CNIH4
2446,GO:0048020,0.434039784980362,1,1,1,CCR chemokine receptor binding,MF,CNIH4
469,GO:0006366,0.437582142224788,0.827483134904901,3,7,transcription from RNA polymerase II promoter,BP,FADD;PSMB10;HNF1A
1990,GO:0042592,0.439841910725972,0.760214600524528,6,16,homeostatic process,BP,RBP4;ACADVL;TH;ABCG1;FADD;HNF1A
2149,GO:0044236,0.440199575198548,0.938253117834003,1,2,multicellular organism metabolic process,BP,PEPD
1317,GO:0019901,0.442651459810215,0.919280440458564,1,3,protein kinase binding,MF,TBC1D14
2166,GO:0044273,0.443194884323007,0.874106148461004,2,4,sulfur compound catabolic process,BP,ACAT1;NUDT7
2,GO:0000030,0.444921833344979,1,1,1,mannosyltransferase activity,MF,DPM3
288,GO:0004582,0.444921833344979,1,1,1,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,DPM3
488,GO:0006493,0.444921833344979,1,1,1,protein O-linked glycosylation,BP,DPM3
489,GO:0006497,0.444921833344979,1,1,1,protein lipidation,BP,DPM3
490,GO:0006505,0.444921833344979,1,1,1,GPI anchor metabolic process,BP,DPM3
491,GO:0006506,0.444921833344979,1,1,1,GPI anchor biosynthetic process,BP,DPM3
823,GO:0009247,0.444921833344979,1,1,1,glycolipid biosynthetic process,BP,DPM3
1241,GO:0018103,0.444921833344979,1,1,1,protein C-linked glycosylation,BP,DPM3
1247,GO:0018211,0.444921833344979,1,1,1,peptidyl-tryptophan modification,BP,DPM3
1250,GO:0018317,0.444921833344979,1,1,1,protein C-linked glycosylation via tryptophan,BP,DPM3
1251,GO:0018406,0.444921833344979,1,1,1,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,DPM3
1535,GO:0031501,0.444921833344979,1,1,1,mannosyltransferase complex,CC,DPM3
1701,GO:0033185,0.444921833344979,1,1,1,dolichol-phosphate-mannose synthase complex,CC,DPM3
1814,GO:0035268,0.444921833344979,1,1,1,protein mannosylation,BP,DPM3
1815,GO:0035269,0.444921833344979,1,1,1,protein O-linked mannosylation,BP,DPM3
1920,GO:0042158,0.444921833344979,1,1,1,lipoprotein biosynthetic process,BP,DPM3
2362,GO:0046467,0.444921833344979,1,1,1,membrane lipid biosynthetic process,BP,DPM3
3149,GO:0097502,0.444921833344979,1,1,1,mannosylation,BP,DPM3
3436,GO:1905114,0.445826029161682,0.936382547085167,1,2,cell surface receptor signaling pathway involved in cell-cell signaling,BP,PSMB10
2067,GO:0043228,0.446854529713495,0.735254777979942,8,21,non-membrane-bounded organelle,CC,MSRA;MRPL14;PXK;ACADVL;ARL6IP4;ACAT2;KRT10;FGF18
2071,GO:0043232,0.446854529713495,0.735254777979942,8,21,intracellular non-membrane-bounded organelle,CC,MSRA;MRPL14;PXK;ACADVL;ARL6IP4;ACAT2;KRT10;FGF18
3009,GO:0071704,0.447046554296475,0.714222180982045,33,95,organic substance metabolic process,BP,HACL1;MSRA;ACAT1;MRPL14;RBP4;ACADVL;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;ECI1;KRT10;ETFDH;DEPTOR;FADD;PSMB10;LYPLAL1;LAGE3;HNF1A;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;PEPD
466,GO:0006355,0.448162114911372,0.765621709941715,5,14,regulation of transcription, DNA-templated,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
3010,GO:0071705,0.448578592962943,0.768556758367816,5,13,nitrogen compound transport,BP,RBP4;CNIH4;TH;ABCG1;TBC1D14
2257,GO:0045333,0.449179733105659,0.870881859757412,2,4,cellular respiration,BP,ETFDH;ETFB
2195,GO:0044444,0.449241810862663,0.729976402427407,36,103,cytoplasmic part,CC,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;TMEM160;CNIH4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;BOLA1;ECI1;KRT10;ETFDH;CCDC51;FADD;PSMB10;LYPLAL1;TBC1D14;NUDT6;PTS;PLA2G16;DECR1;CPT1C;ZFYVE21;DPM3;ETFB;IFI30
395,GO:0005782,0.449791747821688,0.870549397912834,2,4,peroxisomal matrix,CC,HACL1;NUDT7
1551,GO:0031907,0.449791747821688,0.870549397912834,2,4,microbody lumen,CC,HACL1;NUDT7
1079,GO:0015850,0.449891769019434,0.870495015255327,2,4,organic hydroxy compound transport,BP,RBP4;ABCG1
3198,GO:0099513,0.450088169391677,0.934940353523092,1,2,polymeric cytoskeletal fiber,CC,KRT10
2069,GO:0043230,0.450270225115871,0.713730893399263,11,29,extracellular organelle,CC,MSRA;ACAT1;RBP4;ACAA2;ACAT2;ECI1;KRT10;LYPLAL1;DECR1;ETFB;PEPD
2879,GO:0070062,0.450270225115871,0.713730893399263,11,29,extracellular exosome,CC,MSRA;ACAT1;RBP4;ACAA2;ACAT2;ECI1;KRT10;LYPLAL1;DECR1;ETFB;PEPD
3389,GO:1903561,0.450270225115871,0.713730893399263,11,29,extracellular vesicle,CC,MSRA;ACAT1;RBP4;ACAA2;ACAT2;ECI1;KRT10;LYPLAL1;DECR1;ETFB;PEPD
2473,GO:0048513,0.450642789756554,0.734032567486473,8,20,animal organ development,BP,ACAT1;RBP4;TH;KRT10;FADD;PSMB10;PLA2G16;FGF18
1342,GO:0022603,0.452883011778178,0.868862314684698,2,4,regulation of anatomical structure morphogenesis,BP,PSMB10;LINGO1
2203,GO:0044459,0.455194022257473,0.779768339482423,4,11,plasma membrane part,CC,TH;ABCG1;FADD;CPT1C
402,GO:0005815,0.456342357334622,0.932784183203375,1,2,microtubule organizing center,CC,PXK
1060,GO:0015630,0.456342357334622,0.932784183203375,1,2,microtubule cytoskeleton,CC,PXK
2101,GO:0043436,0.457061500528393,0.692364631953139,15,43,oxoacid metabolic process,BP,HACL1;MSRA;ACAT1;ACADVL;ACAA2;TH;ACAT2;ECI1;ETFDH;PSMB10;PTS;DECR1;CPT1C;ETFB;PEPD
2753,GO:0052689,0.460945145055145,0.86440033822272,2,4,carboxylic ester hydrolase activity,MF,LYPLAL1;PLA2G16
1306,GO:0019842,0.461964522437713,0.863829728997769,2,4,vitamin binding,MF,HACL1;RBP4
1614,GO:0032501,0.462148169913325,0.687832204695379,15,43,multicellular organismal process,BP,ACAT1;RBP4;ACADVL;TH;ALG5;ABCG1;KRT10;FADD;PSMB10;HNF1A;PTS;PLA2G16;LINGO1;FGF18;PEPD
3510,GO:2001234,0.462505493278113,0.863526323055128,2,4,negative regulation of apoptotic signaling pathway,BP,ACAA2;FADD
1242,GO:0018108,0.463613678115219,0.930216652871322,1,2,peptidyl-tyrosine phosphorylation,BP,FGF18
1248,GO:0018212,0.463613678115219,0.930216652871322,1,2,peptidyl-tyrosine modification,BP,FGF18
2092,GO:0043405,0.463613678115219,0.930216652871322,1,2,regulation of MAP kinase activity,BP,FGF18
2093,GO:0043406,0.463613678115219,0.930216652871322,1,2,positive regulation of MAP kinase activity,BP,FGF18
3030,GO:0071902,0.463613678115219,0.930216652871322,1,2,positive regulation of protein serine/threonine kinase activity,BP,FGF18
250,GO:0004095,0.464059413362821,0.930057111084058,1,2,carnitine O-palmitoyltransferase activity,MF,CPT1C
752,GO:0008374,0.464059413362821,0.930057111084058,1,2,O-acyltransferase activity,MF,CPT1C
1134,GO:0016406,0.464059413362821,0.930057111084058,1,2,carnitine O-acyltransferase activity,MF,CPT1C
1137,GO:0016409,0.464059413362821,0.930057111084058,1,2,palmitoyltransferase activity,MF,CPT1C
1138,GO:0016416,0.464059413362821,0.930057111084058,1,2,O-palmitoyltransferase activity,MF,CPT1C
434,GO:0006085,0.465950843296089,0.929377322865901,1,2,acetyl-CoA biosynthetic process,BP,ACAT1
1108,GO:0016125,0.468249762489278,0.774657083146864,4,10,sterol metabolic process,BP,ACADVL;ACAA2;ABCG1;ACAT2
130,GO:0002218,0.469670228861513,0.859469073702076,2,4,activation of innate immune response,BP,FADD;PSMB10
1524,GO:0031349,0.469670228861513,0.859469073702076,2,4,positive regulation of defense response,BP,FADD;PSMB10
2244,GO:0045089,0.469670228861513,0.859469073702076,2,4,positive regulation of innate immune response,BP,FADD;PSMB10
776,GO:0008654,0.469745738651491,0.805518097719752,3,7,phospholipid biosynthetic process,BP,PLA2G16;FGF18;DPM3
1104,GO:0016070,0.470871939840197,0.713170001224034,8,22,RNA metabolic process,BP,ARL6IP4;PUS1;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A
455,GO:0006163,0.471278490197769,0.858548346729831,2,4,purine nucleotide metabolic process,BP,ACAT1;NUDT7
1163,GO:0016645,0.476244616802222,0.925597573219066,1,2,oxidoreductase activity, acting on the CH-NH group of donors,MF,ETFDH
346,GO:0005496,0.476802252022843,0.925388903201123,1,2,steroid binding,MF,ABCG1
988,GO:0010893,0.476802252022843,0.925388903201123,1,2,positive regulation of steroid biosynthetic process,BP,ABCG1
1049,GO:0015248,0.476802252022843,0.925388903201123,1,2,sterol transporter activity,MF,ABCG1
1058,GO:0015485,0.476802252022843,0.925388903201123,1,2,cholesterol binding,MF,ABCG1
1232,GO:0017127,0.476802252022843,0.925388903201123,1,2,cholesterol transporter activity,MF,ABCG1
1589,GO:0032366,0.476802252022843,0.925388903201123,1,2,intracellular sterol transport,BP,ABCG1
1590,GO:0032367,0.476802252022843,0.925388903201123,1,2,intracellular cholesterol transport,BP,ABCG1
1680,GO:0032934,0.476802252022843,0.925388903201123,1,2,sterol binding,MF,ABCG1
1129,GO:0016310,0.477395927558106,0.762547720580824,4,11,phosphorylation,BP,DEPTOR;PSMB10;FGF18;ZFYVE21
2273,GO:0045540,0.477682111766953,0.925058827829476,1,2,regulation of cholesterol biosynthetic process,BP,ABCG1
3346,GO:1902930,0.477682111766953,0.925058827829476,1,2,regulation of alcohol biosynthetic process,BP,ABCG1
2563,GO:0050767,0.480108779330887,0.924143206619632,1,2,regulation of neurogenesis,BP,LINGO1
2745,GO:0051960,0.480108779330887,0.924143206619632,1,2,regulation of nervous system development,BP,LINGO1
2809,GO:0060284,0.480108779330887,0.924143206619632,1,2,regulation of cell development,BP,LINGO1
2431,GO:0046983,0.481334026222577,0.742348709989997,5,13,protein dimerization activity,MF,ACAT1;RBP4;ABCG1;HNF1A;PTS
2689,GO:0051338,0.481592659310189,0.797067880148975,3,7,regulation of transferase activity,BP,DEPTOR;PSMB10;FGF18
56,GO:0001505,0.482352161902126,0.923289825963935,1,2,regulation of neurotransmitter levels,BP,TH
585,GO:0006836,0.482352161902126,0.923289825963935,1,2,neurotransmitter transport,BP,TH
845,GO:0009416,0.482352161902126,0.923289825963935,1,2,response to light stimulus,BP,TH
1154,GO:0016597,0.482352161902126,0.923289825963935,1,2,amino acid binding,MF,TH
179,GO:0002684,0.483172791032628,0.795925793849201,3,7,positive regulation of immune system process,BP,RBP4;FADD;PSMB10
856,GO:0009612,0.485595577419377,0.922044194397298,1,2,response to mechanical stimulus,BP,FADD
2476,GO:0048519,0.486055825586662,0.681154478835704,11,30,negative regulation of biological process,BP,RBP4;ACADVL;ACAA2;ABCG1;DEPTOR;FADD;PSMB10;TBC1D14;PLA2G16;LINGO1;IFI30
2478,GO:0048523,0.486055825586662,0.681154478835704,11,30,negative regulation of cellular process,BP,RBP4;ACADVL;ACAA2;ABCG1;DEPTOR;FADD;PSMB10;TBC1D14;PLA2G16;LINGO1;IFI30
2310,GO:0045893,0.488117074997505,0.831398644899426,2,5,positive regulation of transcription, DNA-templated,BP,FADD;HNF1A
2674,GO:0051254,0.488117074997505,0.831398644899426,2,5,positive regulation of RNA metabolic process,BP,FADD;HNF1A
3331,GO:1902680,0.488117074997505,0.831398644899426,2,5,positive regulation of RNA biosynthetic process,BP,FADD;HNF1A
3379,GO:1903508,0.488117074997505,0.831398644899426,2,5,positive regulation of nucleic acid-templated transcription,BP,FADD;HNF1A
1315,GO:0019899,0.488467219209709,0.753719574295061,4,11,enzyme binding,MF,ACAT1;TH;FADD;TBC1D14
2870,GO:0065003,0.49220033221361,0.737801206353791,5,12,macromolecular complex assembly,BP,HACL1;ACAT1;FADD;HNF1A;DECR1
1205,GO:0016836,0.49334605881478,0.845536075376424,2,4,hydro-lyase activity,MF,PUS1;ECI1
1529,GO:0031400,0.494804289064075,0.844650896616971,2,4,negative regulation of protein modification process,BP,DEPTOR;PSMB10
2697,GO:0051348,0.494804289064075,0.844650896616971,2,4,negative regulation of transferase activity,BP,DEPTOR;PSMB10
1890,GO:0040008,0.497698638842613,0.917270268612088,1,2,regulation of growth,BP,RBP4
2500,GO:0048638,0.497698638842613,0.917270268612088,1,2,regulation of developmental growth,BP,RBP4
235,GO:0003824,0.501707871747643,0.645577340134519,25,72,catalytic activity,MF,HACL1;MSRA;ACAT1;ACADVL;ACAA2;TH;PUS1;NUDT7;ALG5;ABCG1;ACAT2;ECI1;ETFDH;PSMB10;LYPLAL1;NUDT6;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;PEPD;IFI30
1805,GO:0035091,0.502434764613434,0.915347056868125,1,2,phosphatidylinositol binding,MF,PXK
1556,GO:0031967,0.504694577868837,0.693409602614687,7,19,organelle envelope,CC,ACAT1;MRPL14;ACADVL;ACAA2;ECI1;ETFDH;CPT1C
1560,GO:0031975,0.504694577868837,0.693409602614687,7,19,envelope,CC,ACAT1;MRPL14;ACADVL;ACAA2;ECI1;ETFDH;CPT1C
432,GO:0006082,0.505869383819594,0.647491817617116,15,44,organic acid metabolic process,BP,HACL1;MSRA;ACAT1;ACADVL;ACAA2;TH;ACAT2;ECI1;ETFDH;PSMB10;PTS;DECR1;CPT1C;ETFB;PEPD
2104,GO:0043487,0.506752716857318,0.913566059326242,1,2,regulation of RNA stability,BP,PSMB10
2105,GO:0043488,0.506752716857318,0.913566059326242,1,2,regulation of mRNA stability,BP,PSMB10
2637,GO:0051128,0.508263573476148,0.737524646587948,4,11,regulation of cellular component organization,BP,ACAA2;TBC1D14;HNF1A;LINGO1
1406,GO:0030182,0.508409720452671,0.817814302524506,2,5,neuron differentiation,BP,TH;LINGO1
2509,GO:0048666,0.508409720452671,0.817814302524506,2,5,neuron development,BP,TH;LINGO1
2427,GO:0046950,0.510498518784004,0.91199945031121,1,2,cellular ketone body metabolic process,BP,ACAT1
2428,GO:0046951,0.510498518784004,0.91199945031121,1,2,ketone body biosynthetic process,BP,ACAT1
3307,GO:1902224,0.510498518784004,0.91199945031121,1,2,ketone body metabolic process,BP,ACAT1
2201,GO:0044455,0.512610240167834,0.911107323456065,1,2,mitochondrial membrane part,CC,ETFDH
3059,GO:0072521,0.51392738070808,0.814007613630145,2,5,purine-containing compound metabolic process,BP,ACAT1;NUDT7
623,GO:0006996,0.51626915641638,0.736309352731112,4,10,organelle organization,BP,ACAA2;PUS1;TBC1D14;PLA2G16
358,GO:0005543,0.516804988630268,0.81200275044093,2,5,phospholipid binding,MF,PXK;ABCG1
2489,GO:0048585,0.51764819388368,0.735161400260414,4,10,negative regulation of response to stimulus,BP,ACAA2;DEPTOR;FADD;PSMB10
2215,GO:0044708,0.51765434607863,0.811408411110481,2,5,single-organism behavior,BP,TH;FADD
1319,GO:0019915,0.519731472033354,0.908050684706202,1,2,lipid storage,BP,ABCG1
1019,GO:0014070,0.521147565407936,0.758244140830368,3,8,response to organic cyclic compound,BP,ACAT1;TH;FADD
1265,GO:0019218,0.523024555103688,0.80762317063901,2,5,regulation of steroid metabolic process,BP,ACADVL;ABCG1
1161,GO:0016627,0.524830056788233,0.806339843743222,2,5,oxidoreductase activity, acting on the CH-CH group of donors,MF,ACADVL;DECR1
936,GO:0010608,0.528267443247407,0.803881587791387,2,5,posttranscriptional regulation of gene expression,BP,TSFM;PSMB10
363,GO:0005576,0.528618484485732,0.629732856413473,14,39,extracellular region,CC,MSRA;ACAT1;RBP4;ACAA2;ACAT2;ECI1;KRT10;LYPLAL1;LINGO1;DECR1;FGF18;ETFB;PEPD;IFI30
1286,GO:0019438,0.528653924006749,0.659852790584474,8,23,aromatic compound biosynthetic process,BP,ACAT1;TH;TSFM;ABCG1;FADD;PSMB10;HNF1A;PTS
3147,GO:0097458,0.531196716615442,0.750112390606407,3,8,neuron part,CC,TH;FADD;CPT1C
3210,GO:0120025,0.531196716615442,0.750112390606407,3,8,plasma membrane bounded cell projection,CC,TH;FADD;CPT1C
3509,GO:2001233,0.53245518751644,0.758465671605205,3,7,regulation of apoptotic signaling pathway,BP,ACAA2;DEPTOR;FADD
98,GO:0001894,0.533801635394015,0.901787422970033,1,2,tissue homeostasis,BP,RBP4
2805,GO:0060249,0.533801635394015,0.901787422970033,1,2,anatomical structure homeostasis,BP,RBP4
612,GO:0006950,0.534953766503548,0.637555787730915,10,31,response to stress,BP,MSRA;ACAT1;PXK;ACADVL;ACAA2;TH;ETFDH;FADD;PSMB10;IFI30
7,GO:0000096,0.535863762100876,0.900843860953816,1,2,sulfur amino acid metabolic process,BP,MSRA
501,GO:0006555,0.535863762100876,0.900843860953816,1,2,methionine metabolic process,BP,MSRA
792,GO:0009066,0.535863762100876,0.900843860953816,1,2,aspartate family amino acid metabolic process,BP,MSRA
79,GO:0001678,0.536539166283668,0.90053336805454,1,2,cellular glucose homeostasis,BP,TH
691,GO:0007622,0.536539166283668,0.90053336805454,1,2,rhythmic behavior,BP,TH
692,GO:0007623,0.536539166283668,0.90053336805454,1,2,circadian rhythm,BP,TH
840,GO:0009404,0.536539166283668,0.90053336805454,1,2,toxin metabolic process,BP,TH
860,GO:0009635,0.536539166283668,0.90053336805454,1,2,response to herbicide,BP,TH
870,GO:0009743,0.536539166283668,0.90053336805454,1,2,response to carbohydrate,BP,TH
871,GO:0009746,0.536539166283668,0.90053336805454,1,2,response to hexose,BP,TH
872,GO:0009749,0.536539166283668,0.90053336805454,1,2,response to glucose,BP,TH
1028,GO:0014823,0.536539166283668,0.90053336805454,1,2,response to activity,BP,TH
1230,GO:0017085,0.536539166283668,0.90053336805454,1,2,response to insecticide,BP,TH
1255,GO:0018958,0.536539166283668,0.90053336805454,1,2,phenol-containing compound metabolic process,BP,TH
1256,GO:0018963,0.536539166283668,0.90053336805454,1,2,phthalate metabolic process,BP,TH
1745,GO:0034284,0.536539166283668,0.90053336805454,1,2,response to monosaccharide,BP,TH
1806,GO:0035094,0.536539166283668,0.90053336805454,1,2,response to nicotine,BP,TH
1979,GO:0042537,0.536539166283668,0.90053336805454,1,2,benzene-containing compound metabolic process,BP,TH
2004,GO:0042745,0.536539166283668,0.90053336805454,1,2,circadian sleep/wake cycle,BP,TH
2472,GO:0048512,0.536539166283668,0.90053336805454,1,2,circadian behavior,BP,TH
2702,GO:0051385,0.536539166283668,0.90053336805454,1,2,response to mineralocorticoid,BP,TH
2705,GO:0051412,0.536539166283668,0.90053336805454,1,2,response to corticosterone,BP,TH
2959,GO:0071241,0.536539166283668,0.90053336805454,1,2,cellular response to inorganic substance,BP,TH
2960,GO:0071248,0.536539166283668,0.90053336805454,1,2,cellular response to metal ion,BP,TH
2967,GO:0071312,0.536539166283668,0.90053336805454,1,2,cellular response to alkaloid,BP,TH
2970,GO:0071322,0.536539166283668,0.90053336805454,1,2,cellular response to carbohydrate stimulus,BP,TH
2971,GO:0071326,0.536539166283668,0.90053336805454,1,2,cellular response to monosaccharide stimulus,BP,TH
2972,GO:0071331,0.536539166283668,0.90053336805454,1,2,cellular response to hexose stimulus,BP,TH
2973,GO:0071333,0.536539166283668,0.90053336805454,1,2,cellular response to glucose stimulus,BP,TH
2991,GO:0071407,0.536539166283668,0.90053336805454,1,2,cellular response to organic cyclic compound,BP,TH
3267,GO:1901654,0.536539166283668,0.90053336805454,1,2,response to ketone,BP,TH
1095,GO:0016032,0.537177303429889,0.79741707661775,2,5,viral process,BP,FADD;PSMB10
2178,GO:0044403,0.537177303429889,0.79741707661775,2,5,symbiosis, encompassing mutualism through parasitism,BP,FADD;PSMB10
2179,GO:0044419,0.537177303429889,0.79741707661775,2,5,interspecies interaction between organisms,BP,FADD;PSMB10
2223,GO:0044764,0.537177303429889,0.79741707661775,2,5,multi-organism cellular process,BP,FADD;PSMB10
132,GO:0002221,0.537969898697751,0.899873266137572,1,2,pattern recognition receptor signaling pathway,BP,FADD
134,GO:0002224,0.537969898697751,0.899873266137572,1,2,toll-like receptor signaling pathway,BP,FADD
196,GO:0002756,0.537969898697751,0.899873266137572,1,2,MyD88-independent toll-like receptor signaling pathway,BP,FADD
1843,GO:0035666,0.537969898697751,0.899873266137572,1,2,TRIF-dependent toll-like receptor signaling pathway,BP,FADD
3141,GO:0097342,0.537969898697751,0.899873266137572,1,2,ripoptosome,CC,FADD
3377,GO:1903506,0.539206717164789,0.685641188127782,5,15,regulation of nucleic acid-templated transcription,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
2703,GO:0051402,0.539447789817486,0.899188006572994,1,2,neuron apoptotic process,BP,FADD
2950,GO:0070997,0.539447789817486,0.899188006572994,1,2,neuron death,BP,FADD
1992,GO:0042594,0.539539411770421,0.871217982306965,1,3,response to starvation,BP,ACAT1
652,GO:0007268,0.540749023206138,0.782816131992662,2,6,chemical synaptic transmission,BP,PXK;TH
3191,GO:0098916,0.540749023206138,0.782816131992662,2,6,anterograde trans-synaptic signaling,BP,PXK;TH
3199,GO:0099536,0.540749023206138,0.782816131992662,2,6,synaptic signaling,BP,PXK;TH
3200,GO:0099537,0.540749023206138,0.782816131992662,2,6,trans-synaptic signaling,BP,PXK;TH
1391,GO:0030133,0.540817534766903,0.898549791934122,1,2,transport vesicle,CC,TH
1696,GO:0033043,0.541374826012113,0.794324675517611,2,5,regulation of organelle organization,BP,ACAA2;TBC1D14
319,GO:0005102,0.541723730291746,0.662258948997128,7,18,receptor binding,MF,HACL1;CNIH4;NUDT7;FADD;NUDT6;LINGO1;FGF18
944,GO:0010646,0.541815178351668,0.657483844724845,7,20,regulation of cell communication,BP,PXK;RBP4;ACAA2;DEPTOR;FADD;PSMB10;FGF18
1587,GO:0032355,0.543622493488396,0.897233494301817,1,2,response to estradiol,BP,TH
3107,GO:0090304,0.549613496050992,0.640150374632606,8,23,nucleic acid metabolic process,BP,ARL6IP4;PUS1;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A
1892,GO:0040012,0.549996599220893,0.787876985277683,2,5,regulation of locomotion,BP,FADD;FGF18
2680,GO:0051270,0.549996599220893,0.787876985277683,2,5,regulation of cellular component movement,BP,FADD;FGF18
3470,GO:2000145,0.549996599220893,0.787876985277683,2,5,regulation of cell motility,BP,FADD;FGF18
900,GO:0009987,0.550318071435655,0.656435569269904,37,109,cellular process,BP,HACL1;MSRA;ACAT1;MRPL14;PXK;RBP4;ACADVL;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;ECI1;KRT10;ETFDH;DEPTOR;FADD;PSMB10;LYPLAL1;LAGE3;TBC1D14;HNF1A;PTS;PLA2G16;LINGO1;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;PEPD;IFI30
916,GO:0010467,0.550628081245965,0.629867195419066,9,27,gene expression,BP,MRPL14;ARL6IP4;PUS1;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A
834,GO:0009308,0.551058455571386,0.89368228950938,1,2,amine metabolic process,BP,PSMB10
2147,GO:0044106,0.551058455571386,0.89368228950938,1,2,cellular amine metabolic process,BP,PSMB10
745,GO:0008289,0.55227578585335,0.732542575552498,3,8,lipid binding,MF,PXK;RBP4;ABCG1
1386,GO:0030098,0.552541040082659,0.892963395080449,1,2,lymphocyte differentiation,BP,FADD
1417,GO:0030217,0.552541040082659,0.892963395080449,1,2,T cell differentiation,BP,FADD
3298,GO:1902107,0.552541040082659,0.892963395080449,1,2,positive regulation of leukocyte differentiation,BP,FADD
3402,GO:1903708,0.552541040082659,0.892963395080449,1,2,positive regulation of hemopoiesis,BP,FADD
3000,GO:0071496,0.554289707802849,0.86247893861361,1,3,cellular response to external stimulus,BP,FADD
1183,GO:0016757,0.555505546325062,0.783688673142465,2,5,transferase activity, transferring glycosyl groups,MF,ALG5;DPM3
2174,GO:0044344,0.556525813333958,0.891013060182761,1,2,cellular response to fibroblast growth factor stimulus,BP,FGF18
3012,GO:0071774,0.556525813333958,0.891013060182761,1,2,response to fibroblast growth factor,BP,FGF18
1516,GO:0031334,0.558991283293224,0.88979297598355,1,2,positive regulation of protein complex assembly,BP,HNF1A
2144,GO:0044089,0.558991283293224,0.88979297598355,1,2,positive regulation of cellular component biogenesis,BP,HNF1A
2639,GO:0051130,0.558991283293224,0.88979297598355,1,2,positive regulation of cellular component organization,BP,HNF1A
1035,GO:0015031,0.559735218967403,0.69285051910753,4,11,protein transport,BP,RBP4;CNIH4;ABCG1;TBC1D14
1075,GO:0015833,0.559735218967403,0.69285051910753,4,11,peptide transport,BP,RBP4;CNIH4;ABCG1;TBC1D14
2015,GO:0042886,0.559735218967403,0.69285051910753,4,11,amide transport,BP,RBP4;CNIH4;ABCG1;TBC1D14
2250,GO:0045184,0.559735218967403,0.69285051910753,4,11,establishment of protein localization,BP,RBP4;CNIH4;ABCG1;TBC1D14
1678,GO:0032879,0.560527276389965,0.652579963871822,6,17,regulation of localization,BP,RBP4;ACAA2;ABCG1;FADD;TBC1D14;FGF18
1187,GO:0016772,0.56084168007758,0.76695110061198,2,6,transferase activity, transferring phosphorus-containing groups,MF,FGF18;ZFYVE21
1996,GO:0042632,0.561636460375145,0.888472477376704,1,2,cholesterol homeostasis,BP,ABCG1
2772,GO:0055081,0.561636460375145,0.888472477376704,1,2,anion homeostasis,BP,ABCG1
2776,GO:0055088,0.561636460375145,0.888472477376704,1,2,lipid homeostasis,BP,ABCG1
2777,GO:0055091,0.561636460375145,0.888472477376704,1,2,phospholipid homeostasis,BP,ABCG1
2778,GO:0055092,0.561636460375145,0.888472477376704,1,2,sterol homeostasis,BP,ABCG1
800,GO:0009100,0.561908599830583,0.778752331359546,2,5,glycoprotein metabolic process,BP,ALG5;DPM3
91,GO:0001822,0.562372066825373,0.888103128562478,1,2,kidney development,BP,ACAT1
96,GO:0001889,0.562372066825373,0.888103128562478,1,2,liver development,BP,ACAT1
2849,GO:0061008,0.562372066825373,0.888103128562478,1,2,hepaticobiliary system development,BP,ACAT1
1791,GO:0034660,0.567057111358473,0.774729171328023,2,5,ncRNA metabolic process,BP,PUS1;LAGE3
2600,GO:0050877,0.567816166519788,0.7741319158118,2,5,neurological system process,BP,RBP4;TH
1296,GO:0019693,0.56793167903833,0.774040932717028,2,5,ribose phosphate metabolic process,BP,ACAT1;NUDT7
1093,GO:0016020,0.567955430582183,0.580383804672192,22,66,membrane,CC,MSRA;ACAT1;MRPL14;PXMP2;PXK;ACADVL;TMEM160;CNIH4;ACAA2;TH;ALG5;ABCG1;ECI1;KRT10;ETFDH;CCDC51;FADD;PLA2G16;LINGO1;CPT1C;ZFYVE21;DPM3
1208,GO:0016853,0.569046796672495,0.773161346226903,2,5,isomerase activity,MF,PUS1;ECI1
364,GO:0005578,0.570208225786456,0.88411038399598,1,2,proteinaceous extracellular matrix,CC,LINGO1
1482,GO:0031012,0.570208225786456,0.88411038399598,1,2,extracellular matrix,CC,LINGO1
675,GO:0007568,0.573697496772545,0.882297771360683,1,2,aging,BP,TH
688,GO:0007617,0.574632147842108,0.881808550156383,1,2,mating behavior,BP,TH
689,GO:0007618,0.574632147842108,0.881808550156383,1,2,mating,BP,TH
693,GO:0007626,0.574632147842108,0.881808550156383,1,2,locomotory behavior,BP,TH
1260,GO:0019098,0.574632147842108,0.881808550156383,1,2,reproductive behavior,BP,TH
1303,GO:0019825,0.576400048722542,0.880878891836931,1,2,oxygen binding,MF,TH
3313,GO:1902494,0.576445840359258,0.721823783377361,3,7,catalytic complex,CC,FADD;PSMB10;DPM3
224,GO:0003677,0.577245398184066,0.848029011822319,1,3,DNA binding,MF,HNF1A
3233,GO:1901135,0.578990963823464,0.65186733367705,5,14,carbohydrate derivative metabolic process,BP,ACAT1;TH;NUDT7;ALG5;DPM3
64,GO:0001561,0.579867047440698,0.879039330236316,1,2,fatty acid alpha-oxidation,BP,HACL1
138,GO:0002253,0.581066052901267,0.763533273867695,2,5,activation of immune response,BP,FADD;PSMB10
2570,GO:0050778,0.581066052901267,0.763533273867695,2,5,positive regulation of immune response,BP,FADD;PSMB10
550,GO:0006720,0.581527614505801,0.763158092105629,2,5,isoprenoid metabolic process,BP,RBP4;TH
398,GO:0005790,0.582342876085291,0.877712235123143,1,2,smooth endoplasmic reticulum,CC,TH
764,GO:0008544,0.583634463686828,0.877015433463699,1,2,epidermis development,BP,KRT10
2119,GO:0043588,0.583634463686828,0.877015433463699,1,2,skin development,BP,KRT10
3179,GO:0098773,0.583634463686828,0.877015433463699,1,2,skin epidermis development,BP,KRT10
618,GO:0006959,0.58377677403426,0.876938469172498,1,2,humoral immune response,BP,PSMB10
294,GO:0004672,0.583817350053503,0.843692750645803,1,3,protein kinase activity,MF,FGF18
605,GO:0006914,0.58393387801018,0.843615037434644,1,3,autophagy,BP,TBC1D14
1803,GO:0034976,0.584711681906388,0.876431917026687,1,2,response to endoplasmic reticulum stress,BP,ACADVL
785,GO:0009057,0.585578419141899,0.759847848389781,2,5,macromolecule catabolic process,BP,PSMB10;LYPLAL1
721,GO:0008199,0.589962101658191,0.873556739457091,1,2,ferric iron binding,MF,TH
3110,GO:0090407,0.59050318522308,0.664266972413821,4,11,organophosphate biosynthetic process,BP,ACAT1;PLA2G16;FGF18;DPM3
2694,GO:0051345,0.591498504272376,0.697910323631556,3,8,positive regulation of hydrolase activity,BP,FADD;TBC1D14;FGF18
978,GO:0010872,0.591923603346343,0.872469230340461,1,2,regulation of cholesterol esterification,BP,ABCG1
1068,GO:0015748,0.591923603346343,0.872469230340461,1,2,organophosphate ester transport,BP,ABCG1
1083,GO:0015914,0.591923603346343,0.872469230340461,1,2,phospholipid transport,BP,ABCG1
1591,GO:0032368,0.591923603346343,0.872469230340461,1,2,regulation of lipid transport,BP,ABCG1
1594,GO:0032371,0.591923603346343,0.872469230340461,1,2,regulation of sterol transport,BP,ABCG1
1597,GO:0032374,0.591923603346343,0.872469230340461,1,2,regulation of cholesterol transport,BP,ABCG1
1708,GO:0033344,0.591923603346343,0.872469230340461,1,2,cholesterol efflux,BP,ABCG1
1720,GO:0033700,0.591923603346343,0.872469230340461,1,2,phospholipid efflux,BP,ABCG1
1755,GO:0034367,0.591923603346343,0.872469230340461,1,2,macromolecular complex remodeling,BP,ABCG1
1756,GO:0034368,0.591923603346343,0.872469230340461,1,2,protein-lipid complex remodeling,BP,ABCG1
1757,GO:0034369,0.591923603346343,0.872469230340461,1,2,plasma lipoprotein particle remodeling,BP,ABCG1
1759,GO:0034375,0.591923603346343,0.872469230340461,1,2,high-density lipoprotein particle remodeling,BP,ABCG1
1768,GO:0034433,0.591923603346343,0.872469230340461,1,2,steroid esterification,BP,ABCG1
1769,GO:0034434,0.591923603346343,0.872469230340461,1,2,sterol esterification,BP,ABCG1
1770,GO:0034435,0.591923603346343,0.872469230340461,1,2,cholesterol esterification,BP,ABCG1
3014,GO:0071825,0.591923603346343,0.872469230340461,1,2,protein-lipid complex subunit organization,BP,ABCG1
3016,GO:0071827,0.591923603346343,0.872469230340461,1,2,plasma lipoprotein particle organization,BP,ABCG1
3119,GO:0097006,0.591923603346343,0.872469230340461,1,2,regulation of plasma lipoprotein particle levels,BP,ABCG1
3443,GO:1905952,0.591923603346343,0.872469230340461,1,2,regulation of lipid localization,BP,ABCG1
3444,GO:1905953,0.591923603346343,0.872469230340461,1,2,negative regulation of lipid localization,BP,ABCG1
2820,GO:0060348,0.592103923012243,0.872368887822701,1,2,bone development,BP,FGF18
458,GO:0006195,0.592862306476044,0.87194618840045,1,2,purine nucleotide catabolic process,BP,NUDT7
520,GO:0006637,0.592952923335586,0.740053959950834,2,6,acyl-CoA metabolic process,BP,ACAT1;NUDT7
1826,GO:0035383,0.592952923335586,0.740053959950834,2,6,thioester metabolic process,BP,ACAT1;NUDT7
610,GO:0006935,0.593868876683943,0.871383452208538,1,2,chemotaxis,BP,FGF18
1941,GO:0042330,0.593868876683943,0.871383452208538,1,2,taxis,BP,FGF18
482,GO:0006468,0.595919466529483,0.68621147292558,3,9,protein phosphorylation,BP,DEPTOR;PSMB10;FGF18
787,GO:0009059,0.596605033508065,0.592501748521727,8,24,macromolecule biosynthetic process,BP,MRPL14;TSFM;ALG5;ABCG1;FADD;PSMB10;HNF1A;DPM3
1788,GO:0034645,0.596605033508065,0.592501748521727,8,24,cellular macromolecule biosynthetic process,BP,MRPL14;TSFM;ALG5;ABCG1;FADD;PSMB10;HNF1A;DPM3
328,GO:0005164,0.597104042959504,0.869561536036334,1,2,tumor necrosis factor receptor binding,MF,FADD
769,GO:0008625,0.597104042959504,0.869561536036334,1,2,extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD
1499,GO:0031264,0.597104042959504,0.869561536036334,1,2,death-inducing signaling complex,CC,FADD
2246,GO:0045121,0.597104042959504,0.869561536036334,1,2,membrane raft,CC,FADD
2836,GO:0060544,0.597104042959504,0.869561536036334,1,2,regulation of necroptotic process,BP,FADD
3003,GO:0071550,0.597104042959504,0.869561536036334,1,2,death-inducing signaling complex assembly,BP,FADD
3136,GO:0097296,0.597104042959504,0.869561536036334,1,2,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD
3162,GO:0098589,0.597104042959504,0.869561536036334,1,2,membrane region,CC,FADD
3183,GO:0098796,0.597104042959504,0.869561536036334,1,2,membrane protein complex,CC,FADD
3184,GO:0098797,0.597104042959504,0.869561536036334,1,2,plasma membrane protein complex,CC,FADD
3188,GO:0098857,0.597104042959504,0.869561536036334,1,2,membrane microdomain,CC,FADD
3293,GO:1902041,0.597104042959504,0.869561536036334,1,2,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD
3294,GO:1902042,0.597104042959504,0.869561536036334,1,2,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD
3518,GO:2001267,0.597104042959504,0.869561536036334,1,2,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD
3519,GO:2001269,0.597104042959504,0.869561536036334,1,2,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD
2055,GO:0043168,0.597124910569279,0.598606726855619,7,23,anion binding,MF,HACL1;PXK;ACADVL;TH;ABCG1;ETFDH;DECR1
1114,GO:0016137,0.597376288040298,0.869407290970257,1,2,glycoside metabolic process,BP,TH
625,GO:0007006,0.59769367382698,0.869227288011869,1,2,mitochondrial membrane organization,BP,ACAA2
972,GO:0010823,0.59769367382698,0.869227288011869,1,2,negative regulation of mitochondrion organization,BP,ACAA2
1853,GO:0035795,0.59769367382698,0.869227288011869,1,2,negative regulation of mitochondrial membrane permeability,BP,ACAA2
2416,GO:0046902,0.59769367382698,0.869227288011869,1,2,regulation of mitochondrial membrane permeability,BP,ACAA2
3115,GO:0090559,0.59769367382698,0.869227288011869,1,2,regulation of membrane permeability,BP,ACAA2
3299,GO:1902108,0.59769367382698,0.869227288011869,1,2,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,ACAA2
3300,GO:1902109,0.59769367382698,0.869227288011869,1,2,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,ACAA2
3441,GO:1905709,0.59769367382698,0.869227288011869,1,2,negative regulation of membrane permeability,BP,ACAA2
323,GO:0005123,0.601662482181509,0.866959708088214,1,2,death receptor binding,MF,FADD
1672,GO:0032845,0.601662482181509,0.866959708088214,1,2,negative regulation of homeostatic process,BP,FADD
1854,GO:0035877,0.601662482181509,0.866959708088214,1,2,death effector domain binding,MF,FADD
2838,GO:0060547,0.601662482181509,0.866959708088214,1,2,negative regulation of necrotic cell death,BP,FADD
3083,GO:0089720,0.601662482181509,0.866959708088214,1,2,caspase binding,MF,FADD
2024,GO:0042995,0.604125310626085,0.678451717624355,3,9,cell projection,CC,TH;FADD;CPT1C
2634,GO:0051094,0.607375725967841,0.727320645118075,2,6,positive regulation of developmental process,BP,FADD;FGF18
797,GO:0009083,0.607963689084008,0.863295114871315,1,2,branched-chain amino acid catabolic process,BP,ACAT1
524,GO:0006643,0.60862863953185,0.740397022801889,2,5,membrane lipid metabolic process,BP,TH;DPM3
2638,GO:0051129,0.60925735266437,0.73985145562703,2,5,negative regulation of cellular component organization,BP,ACAA2;LINGO1
685,GO:0007611,0.610188332945702,0.861982148832317,1,2,learning or memory,BP,TH
687,GO:0007613,0.610188332945702,0.861982148832317,1,2,memory,BP,TH
2603,GO:0050890,0.610188332945702,0.861982148832317,1,2,cognition,BP,TH
2511,GO:0048699,0.610434303826132,0.724566089359837,2,6,generation of neurons,BP,TH;LINGO1
3273,GO:1901681,0.611197611164006,0.861383139777233,1,2,sulfur compound binding,MF,HACL1
1588,GO:0032365,0.611717426899544,0.824231879975586,1,3,intracellular lipid transport,BP,ABCG1
262,GO:0004300,0.612204138620134,0.860783674547587,1,2,enoyl-CoA hydratase activity,MF,ECI1
2243,GO:0045088,0.612633836526653,0.736907495355705,2,5,regulation of innate immune response,BP,FADD;PSMB10
456,GO:0006164,0.61412292972039,0.859635077110349,1,2,purine nucleotide biosynthetic process,BP,ACAT1
813,GO:0009152,0.61412292972039,0.859635077110349,1,2,purine ribonucleotide biosynthetic process,BP,ACAT1
825,GO:0009260,0.61412292972039,0.859635077110349,1,2,ribonucleotide biosynthetic process,BP,ACAT1
2348,GO:0046390,0.61412292972039,0.859635077110349,1,2,ribose phosphate biosynthetic process,BP,ACAT1
794,GO:0009072,0.615772082464467,0.858641760863091,1,2,aromatic amino acid family metabolic process,BP,TH
1174,GO:0016714,0.615772082464467,0.858641760863091,1,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,TH
1924,GO:0042176,0.615837053962693,0.858602510789268,1,2,regulation of protein catabolic process,BP,PSMB10
2157,GO:0044257,0.615837053962693,0.858602510789268,1,2,cellular protein catabolic process,BP,PSMB10
2161,GO:0044265,0.615837053962693,0.858602510789268,1,2,cellular macromolecule catabolic process,BP,PSMB10
2293,GO:0045732,0.615837053962693,0.858602510789268,1,2,positive regulation of protein catabolic process,BP,PSMB10
2723,GO:0051603,0.615837053962693,0.858602510789268,1,2,proteolysis involved in cellular protein catabolic process,BP,PSMB10
3355,GO:1903050,0.615837053962693,0.858602510789268,1,2,regulation of proteolysis involved in cellular protein catabolic process,BP,PSMB10
3356,GO:1903052,0.615837053962693,0.858602510789268,1,2,positive regulation of proteolysis involved in cellular protein catabolic process,BP,PSMB10
3371,GO:1903362,0.615837053962693,0.858602510789268,1,2,regulation of cellular protein catabolic process,BP,PSMB10
3372,GO:1903364,0.615837053962693,0.858602510789268,1,2,positive regulation of cellular protein catabolic process,BP,PSMB10
2672,GO:0051252,0.616388274554115,0.608506983050333,5,16,regulation of RNA metabolic process,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
3504,GO:2001141,0.616388274554115,0.608506983050333,5,16,regulation of RNA biosynthetic process,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
733,GO:0008233,0.616975692977016,0.733086825393498,2,5,peptidase activity,MF,PSMB10;PEPD
2876,GO:0070011,0.616975692977016,0.733086825393498,2,5,peptidase activity, acting on L-amino acid peptides,MF,PSMB10;PEPD
2204,GO:0044463,0.616982983660115,0.857908783685631,1,2,cell projection part,CC,TH
476,GO:0006412,0.618367211490774,0.731853934065589,2,5,translation,BP,MRPL14;TSFM
1292,GO:0019637,0.619800849002801,0.59408484023836,6,17,organophosphate metabolic process,BP,ACAT1;NUDT7;PLA2G16;FGF18;ZFYVE21;DPM3
1059,GO:0015629,0.620165293958355,0.85596771757345,1,2,actin cytoskeleton,CC,MSRA
1746,GO:0034308,0.620293605860611,0.85588900176032,1,2,primary alcohol metabolic process,BP,RBP4
1794,GO:0034702,0.622556128701408,0.816188186320381,1,3,ion channel complex,CC,CPT1C
3314,GO:1902495,0.622556128701408,0.816188186320381,1,3,transmembrane transporter complex,CC,CPT1C
3449,GO:1990351,0.622556128701408,0.816188186320381,1,3,transporter complex,CC,CPT1C
754,GO:0008380,0.622853915462028,0.854310951050621,1,2,RNA splicing,BP,ARL6IP4
136,GO:0002250,0.622938802463903,0.854258389469281,1,2,adaptive immune response,BP,FADD
180,GO:0002685,0.622938802463903,0.854258389469281,1,2,regulation of leukocyte migration,BP,FADD
181,GO:0002687,0.622938802463903,0.854258389469281,1,2,positive regulation of leukocyte migration,BP,FADD
206,GO:0002819,0.622938802463903,0.854258389469281,1,2,regulation of adaptive immune response,BP,FADD
207,GO:0002821,0.622938802463903,0.854258389469281,1,2,positive regulation of adaptive immune response,BP,FADD
1632,GO:0032609,0.622938802463903,0.854258389469281,1,2,interferon-gamma production,BP,FADD
1638,GO:0032637,0.622938802463903,0.854258389469281,1,2,interleukin-8 production,BP,FADD
1643,GO:0032649,0.622938802463903,0.854258389469281,1,2,regulation of interferon-gamma production,BP,FADD
1648,GO:0032677,0.622938802463903,0.854258389469281,1,2,regulation of interleukin-8 production,BP,FADD
1654,GO:0032729,0.622938802463903,0.854258389469281,1,2,positive regulation of interferon-gamma production,BP,FADD
1659,GO:0032757,0.622938802463903,0.854258389469281,1,2,positive regulation of interleukin-8 production,BP,FADD
1716,GO:0033612,0.622938802463903,0.854258389469281,1,2,receptor serine/threonine kinase binding,MF,FADD
1907,GO:0042104,0.622938802463903,0.854258389469281,1,2,positive regulation of activated T cell proliferation,BP,FADD
2324,GO:0046006,0.622938802463903,0.854258389469281,1,2,regulation of activated T cell proliferation,BP,FADD
2578,GO:0050798,0.622938802463903,0.854258389469281,1,2,activated T cell proliferation,BP,FADD
2605,GO:0050900,0.622938802463903,0.854258389469281,1,2,leukocyte migration,BP,FADD
3074,GO:0072676,0.622938802463903,0.854258389469281,1,2,lymphocyte migration,BP,FADD
3075,GO:0072678,0.622938802463903,0.854258389469281,1,2,T cell migration,BP,FADD
3480,GO:2000401,0.622938802463903,0.854258389469281,1,2,regulation of lymphocyte migration,BP,FADD
3481,GO:2000403,0.622938802463903,0.854258389469281,1,2,positive regulation of lymphocyte migration,BP,FADD
3482,GO:2000404,0.622938802463903,0.854258389469281,1,2,regulation of T cell migration,BP,FADD
3483,GO:2000406,0.622938802463903,0.854258389469281,1,2,positive regulation of T cell migration,BP,FADD
2290,GO:0045717,0.623597808040149,0.85384980744126,1,2,negative regulation of fatty acid biosynthetic process,BP,ACADVL
2302,GO:0045833,0.623597808040149,0.85384980744126,1,2,negative regulation of lipid metabolic process,BP,ACADVL
2312,GO:0045922,0.623597808040149,0.85384980744126,1,2,negative regulation of fatty acid metabolic process,BP,ACADVL
2629,GO:0051055,0.623597808040149,0.85384980744126,1,2,negative regulation of lipid biosynthetic process,BP,ACADVL
2999,GO:0071495,0.626741028103296,0.699857870005274,2,7,cellular response to endogenous stimulus,BP,TH;FGF18
3061,GO:0072523,0.627278258697988,0.812594780648098,1,3,purine-containing compound catabolic process,BP,NUDT7
36,GO:0000959,0.628279734602819,0.850919826403274,1,2,mitochondrial RNA metabolic process,BP,PUS1
37,GO:0000963,0.628279734602819,0.850919826403274,1,2,mitochondrial RNA processing,BP,PUS1
475,GO:0006400,0.628279734602819,0.850919826403274,1,2,tRNA modification,BP,PUS1
850,GO:0009451,0.628279734602819,0.850919826403274,1,2,RNA modification,BP,PUS1
2914,GO:0070525,0.628279734602819,0.850919826403274,1,2,tRNA threonylcarbamoyladenosine metabolic process,BP,PUS1
2943,GO:0070900,0.628279734602819,0.850919826403274,1,2,mitochondrial tRNA modification,BP,PUS1
3118,GO:0090646,0.628279734602819,0.850919826403274,1,2,mitochondrial tRNA processing,BP,PUS1
3224,GO:1900864,0.628279734602819,0.850919826403274,1,2,mitochondrial RNA modification,BP,PUS1
1363,GO:0023051,0.62947522377459,0.568652905667636,7,21,regulation of signaling,BP,PXK;RBP4;ACAA2;DEPTOR;FADD;PSMB10;FGF18
2583,GO:0050810,0.630395853572265,0.810192110904411,1,3,regulation of steroid biosynthetic process,BP,ABCG1
2573,GO:0050790,0.630511820147467,0.582983502403233,6,17,regulation of catalytic activity,BP,DEPTOR;FADD;PSMB10;TBC1D14;PTS;FGF18
3008,GO:0071702,0.631076330667197,0.577418383527064,6,19,organic substance transport,BP,RBP4;CNIH4;TH;ABCG1;TBC1D14;HNF1A
463,GO:0006351,0.632119019579272,0.592259154335206,5,16,transcription, DNA-templated,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
3152,GO:0097659,0.632119019579272,0.592259154335206,5,16,nucleic acid-templated transcription,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
2813,GO:0060333,0.632511217900006,0.848230174840857,1,2,interferon-gamma-mediated signaling pathway,BP,IFI30
2467,GO:0048468,0.633207347867355,0.649958935404902,3,9,cell development,BP,TH;LINGO1;FGF18
60,GO:0001525,0.633546122623507,0.847566271700408,1,2,angiogenesis,BP,FGF18
2474,GO:0048514,0.633546122623507,0.847566271700408,1,2,blood vessel morphogenesis,BP,FGF18
838,GO:0009314,0.633723311064193,0.807600780243306,1,3,response to radiation,BP,TH
886,GO:0009894,0.634017211644178,0.702665034960952,2,6,regulation of catabolic process,BP,PSMB10;TBC1D14
1512,GO:0031329,0.634017211644178,0.702665034960952,2,6,regulation of cellular catabolic process,BP,PSMB10;TBC1D14
14,GO:0000209,0.634660613104831,0.846848613826368,1,2,protein polyubiquitination,BP,PSMB10
216,GO:0003013,0.635730546246968,0.846157002235338,1,2,circulatory system process,BP,TH
218,GO:0003015,0.635730546246968,0.846157002235338,1,2,heart process,BP,TH
696,GO:0008015,0.635730546246968,0.846157002235338,1,2,blood circulation,BP,TH
697,GO:0008016,0.635730546246968,0.846157002235338,1,2,regulation of heart contraction,BP,TH
2788,GO:0060047,0.635730546246968,0.846157002235338,1,2,heart contraction,BP,TH
3383,GO:1903522,0.635730546246968,0.846157002235338,1,2,regulation of blood circulation,BP,TH
2905,GO:0070371,0.636961488561428,0.845358091899505,1,2,ERK1 and ERK2 cascade,BP,FGF18
2906,GO:0070372,0.636961488561428,0.845358091899505,1,2,regulation of ERK1 and ERK2 cascade,BP,FGF18
2907,GO:0070374,0.636961488561428,0.845358091899505,1,2,positive regulation of ERK1 and ERK2 cascade,BP,FGF18
2626,GO:0051051,0.637370762590701,0.845091697056978,1,2,negative regulation of transport,BP,ACAA2
684,GO:0007610,0.638514085591601,0.698351728361327,2,6,behavior,BP,TH;FADD
2910,GO:0070405,0.638677674035351,0.84423846222639,1,2,ammonium ion binding,MF,TH
1661,GO:0032768,0.639207406778312,0.843891500100868,1,2,regulation of monooxygenase activity,BP,PTS
2614,GO:0050999,0.639207406778312,0.843891500100868,1,2,regulation of nitric-oxide synthase activity,BP,PTS
624,GO:0007005,0.64038682257784,0.711785701825086,2,5,mitochondrion organization,BP,ACAA2;PUS1
2074,GO:0043235,0.640516152463537,0.783576379495674,1,4,receptor complex,CC,CPT1C
632,GO:0007154,0.64063761588787,0.525001030631127,11,35,cell communication,BP,PXK;RBP4;ACADVL;ACAA2;TH;DEPTOR;FADD;PSMB10;LINGO1;FGF18;IFI30
2318,GO:0045935,0.642605901024786,0.694387555462487,2,6,positive regulation of nucleobase-containing compound metabolic process,BP,FADD;HNF1A
2679,GO:0051262,0.642933631567075,0.841432530765317,1,2,protein tetramerization,BP,DECR1
2686,GO:0051289,0.642933631567075,0.841432530765317,1,2,protein homotetramerization,BP,DECR1
1094,GO:0016021,0.64356603060051,0.521861904550494,11,35,integral component of membrane,CC,PXMP2;TMEM160;CNIH4;ALG5;ABCG1;ETFDH;CCDC51;PLA2G16;LINGO1;CPT1C;DPM3
1889,GO:0040007,0.645258457152881,0.798397432232124,1,3,growth,BP,RBP4
2490,GO:0048589,0.645258457152881,0.798397432232124,1,3,developmental growth,BP,RBP4
438,GO:0006094,0.645343318908867,0.839825054925756,1,2,gluconeogenesis,BP,RBP4
1272,GO:0019319,0.645343318908867,0.839825054925756,1,2,hexose biosynthetic process,BP,RBP4
1364,GO:0023052,0.645883731850371,0.519370050723663,11,35,signaling,BP,PXK;RBP4;ACADVL;ACAA2;TH;DEPTOR;FADD;PSMB10;LINGO1;FGF18;IFI30
2210,GO:0044700,0.645883731850371,0.519370050723663,11,35,single organism signaling,BP,PXK;RBP4;ACADVL;ACAA2;TH;DEPTOR;FADD;PSMB10;LINGO1;FGF18;IFI30
2966,GO:0071310,0.646555853537137,0.560992056696409,6,19,cellular response to organic substance,BP,ACADVL;TH;FADD;PSMB10;FGF18;IFI30
2521,GO:0048806,0.650588375798037,0.836278382769368,1,2,genitalia development,BP,RBP4
672,GO:0007517,0.650864378712121,0.836089918235585,1,2,muscle organ development,BP,RBP4
1023,GO:0014706,0.650864378712121,0.836089918235585,1,2,striated muscle tissue development,BP,RBP4
1118,GO:0016202,0.650864378712121,0.836089918235585,1,2,regulation of striated muscle tissue development,BP,RBP4
2304,GO:0045843,0.650864378712121,0.836089918235585,1,2,negative regulation of striated muscle tissue development,BP,RBP4
2498,GO:0048634,0.650864378712121,0.836089918235585,1,2,regulation of muscle organ development,BP,RBP4
2499,GO:0048635,0.650864378712121,0.836089918235585,1,2,negative regulation of muscle organ development,BP,RBP4
2833,GO:0060537,0.650864378712121,0.836089918235585,1,2,muscle tissue development,BP,RBP4
2855,GO:0061061,0.650864378712121,0.836089918235585,1,2,muscle structure development,BP,RBP4
3280,GO:1901861,0.650864378712121,0.836089918235585,1,2,regulation of muscle tissue development,BP,RBP4
3281,GO:1901862,0.650864378712121,0.836089918235585,1,2,negative regulation of muscle tissue development,BP,RBP4
2098,GO:0043414,0.651002298806182,0.835995672281997,1,2,macromolecule methylation,BP,ETFB
899,GO:0009986,0.651477559176192,0.773978835730853,1,4,cell surface,CC,ABCG1
1243,GO:0018130,0.655142810028986,0.539407495997727,7,22,heterocycle biosynthetic process,BP,ACAT1;TSFM;ABCG1;FADD;PSMB10;HNF1A;PTS
25,GO:0000313,0.655173474046077,0.833123404484587,1,2,organellar ribosome,CC,MRPL14
26,GO:0000315,0.655173474046077,0.833123404484587,1,2,organellar large ribosomal subunit,CC,MRPL14
232,GO:0003735,0.655173474046077,0.833123404484587,1,2,structural constituent of ribosome,MF,MRPL14
383,GO:0005761,0.655173474046077,0.833123404484587,1,2,mitochondrial ribosome,CC,MRPL14
384,GO:0005762,0.655173474046077,0.833123404484587,1,2,mitochondrial large ribosomal subunit,CC,MRPL14
406,GO:0005840,0.655173474046077,0.833123404484587,1,2,ribosome,CC,MRPL14
478,GO:0006415,0.655173474046077,0.833123404484587,1,2,translational termination,BP,MRPL14
1087,GO:0015934,0.655173474046077,0.833123404484587,1,2,large ribosomal subunit,CC,MRPL14
2177,GO:0044391,0.655173474046077,0.833123404484587,1,2,ribosomal subunit,CC,MRPL14
2883,GO:0070126,0.655173474046077,0.833123404484587,1,2,mitochondrial translational termination,BP,MRPL14
324,GO:0005126,0.655291545223637,0.697580845489602,2,5,cytokine receptor binding,MF,CNIH4;FADD
1316,GO:0019900,0.655329778486755,0.770526675749044,1,4,kinase binding,MF,TBC1D14
553,GO:0006729,0.655718123826112,0.832745200361646,1,2,tetrahydrobiopterin biosynthetic process,BP,PTS
1982,GO:0042558,0.655718123826112,0.832745200361646,1,2,pteridine-containing compound metabolic process,BP,PTS
1983,GO:0042559,0.655718123826112,0.832745200361646,1,2,pteridine-containing compound biosynthetic process,BP,PTS
2332,GO:0046146,0.655718123826112,0.832745200361646,1,2,tetrahydrobiopterin metabolic process,BP,PTS
866,GO:0009719,0.65588924524465,0.566961622450711,5,16,response to endogenous stimulus,BP,ACAT1;TH;ABCG1;FADD;FGF18
160,GO:0002495,0.656106646399331,0.832474961540022,1,2,antigen processing and presentation of peptide antigen via MHC class II,BP,IFI30
161,GO:0002504,0.656106646399331,0.832474961540022,1,2,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,IFI30
2530,GO:0048878,0.656359038752765,0.588262554440599,4,13,chemical homeostasis,BP,RBP4;TH;ABCG1;HNF1A
1693,GO:0033002,0.656959873952337,0.83188017858474,1,2,muscle cell proliferation,BP,RBP4
12,GO:0000166,0.657264334624385,0.580913492153103,4,15,nucleotide binding,MF,ACADVL;ABCG1;ETFDH;DECR1
3241,GO:1901265,0.657264334624385,0.580913492153103,4,15,nucleoside phosphate binding,MF,ACADVL;ABCG1;ETFDH;DECR1
2599,GO:0050873,0.660236889168406,0.829578850714571,1,2,brown fat cell differentiation,BP,NUDT7
1190,GO:0016787,0.661200342185459,0.53463035533771,7,21,hydrolase activity,MF,NUDT7;ABCG1;PSMB10;LYPLAL1;NUDT6;PLA2G16;PEPD
743,GO:0008285,0.661612567938757,0.691398010762142,2,5,negative regulation of cell proliferation,BP,RBP4;IFI30
2233,GO:0045017,0.661696228815106,0.691315530103019,2,5,glycerolipid biosynthetic process,BP,FGF18;DPM3
1301,GO:0019748,0.6627801777837,0.783736483214174,1,3,secondary metabolic process,BP,TH
706,GO:0008104,0.662816714475501,0.585555012124868,4,12,protein localization,BP,RBP4;CNIH4;ABCG1;TBC1D14
683,GO:0007605,0.663981228492809,0.782700237688072,1,3,sensory perception of sound,BP,TH
2610,GO:0050954,0.663981228492809,0.782700237688072,1,3,sensory perception of mechanical stimulus,BP,TH
796,GO:0009081,0.664573490167941,0.78218772854861,1,3,branched-chain amino acid metabolic process,BP,ACAT1
3192,GO:0099080,0.66561393194881,0.781284955976928,1,3,supramolecular complex,CC,KRT10
3193,GO:0099081,0.66561393194881,0.781284955976928,1,3,supramolecular polymer,CC,KRT10
3197,GO:0099512,0.66561393194881,0.781284955976928,1,3,supramolecular fiber,CC,KRT10
887,GO:0009895,0.671004770596381,0.776557265783939,1,3,negative regulation of catabolic process,BP,TBC1D14
1513,GO:0031330,0.671004770596381,0.776557265783939,1,3,negative regulation of cellular catabolic process,BP,TBC1D14
1528,GO:0031399,0.671774661104971,0.609624925164771,3,9,regulation of protein modification process,BP,DEPTOR;PSMB10;FGF18
904,GO:0010008,0.672151646183954,0.775540511874541,1,3,endosome membrane,CC,ZFYVE21
2194,GO:0044440,0.672151646183954,0.775540511874541,1,3,endosomal part,CC,ZFYVE21
2216,GO:0044710,0.673450146304418,0.471073216357327,24,72,single-organism metabolic process,BP,HACL1;MSRA;ACAT1;RBP4;ACADVL;ACAA2;TH;NUDT7;ALG5;ABCG1;ACAT2;ECI1;ETFDH;PSMB10;PTS;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;PEPD;IFI30
74,GO:0001664,0.674955000821304,0.818902028723363,1,2,G-protein coupled receptor binding,MF,CNIH4
1015,GO:0012506,0.677645691722397,0.74967900265852,1,4,vesicle membrane,CC,TH
1450,GO:0030659,0.677645691722397,0.74967900265852,1,4,cytoplasmic vesicle membrane,CC,TH
719,GO:0008194,0.677856179551477,0.770425097033795,1,3,UDP-glycosyltransferase activity,MF,ALG5
926,GO:0010557,0.677930581198219,0.647817204100899,2,7,positive regulation of macromolecule biosynthetic process,BP,FADD;HNF1A
3448,GO:1990234,0.678226285392494,0.816450738664129,1,2,transferase complex,CC,DPM3
937,GO:0010628,0.678611536824065,0.647082793123814,2,7,positive regulation of gene expression,BP,FADD;HNF1A
106,GO:0001932,0.678682034902526,0.657734501343027,2,6,regulation of protein phosphorylation,BP,DEPTOR;FGF18
1938,GO:0042325,0.678682034902526,0.657734501343027,2,6,regulation of phosphorylation,BP,DEPTOR;FGF18
2117,GO:0043549,0.678682034902526,0.657734501343027,2,6,regulation of kinase activity,BP,DEPTOR;FGF18
2305,GO:0045859,0.678682034902526,0.657734501343027,2,6,regulation of protein kinase activity,BP,DEPTOR;FGF18
2336,GO:0046320,0.67902045666903,0.769369034684819,1,3,regulation of fatty acid oxidation,BP,ACADVL
53,GO:0001501,0.679596062906829,0.656764332068151,2,6,skeletal system development,BP,RBP4;FGF18
3324,GO:1902589,0.680546550968337,0.655753192899458,2,6,single-organism organelle organization,BP,ACAA2;TBC1D14
3463,GO:2000112,0.681160913139382,0.536371696992478,5,17,regulation of cellular macromolecule biosynthetic process,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
1671,GO:0032844,0.68383617172544,0.764956910146602,1,3,regulation of homeostatic process,BP,FADD
214,GO:0003008,0.683972066097508,0.596217501101466,3,9,system process,BP,RBP4;TH;HNF1A
590,GO:0006869,0.684684412348188,0.651324129378158,2,6,lipid transport,BP,RBP4;ABCG1
473,GO:0006397,0.685124625037265,0.763764293814576,1,3,mRNA processing,BP,ARL6IP4
1719,GO:0033674,0.686548886958274,0.762439940083182,1,3,positive regulation of kinase activity,BP,FGF18
2306,GO:0045860,0.686548886958274,0.762439940083182,1,3,positive regulation of protein kinase activity,BP,FGF18
905,GO:0010033,0.686911404937717,0.486556584616475,9,28,response to organic substance,BP,ACAT1;RBP4;ACADVL;TH;ABCG1;FADD;PSMB10;FGF18;IFI30
1141,GO:0016477,0.687726104400672,0.64803993420745,2,6,cell migration,BP,FADD;FGF18
1213,GO:0016874,0.687994474440006,0.76108924253561,1,3,ligase activity,MF,ACAT1
2041,GO:0043085,0.68801648501226,0.557606311337842,4,12,positive regulation of catalytic activity,BP,FADD;PSMB10;TBC1D14;FGF18
1494,GO:0031224,0.68854071546091,0.471624957273073,11,36,intrinsic component of membrane,CC,PXMP2;TMEM160;CNIH4;ALG5;ABCG1;ETFDH;CCDC51;PLA2G16;LINGO1;CPT1C;DPM3
2094,GO:0043408,0.689482230932638,0.759692248093055,1,3,regulation of MAPK cascade,BP,FGF18
2095,GO:0043410,0.689482230932638,0.759692248093055,1,3,positive regulation of MAPK cascade,BP,FGF18
3028,GO:0071900,0.689482230932638,0.759692248093055,1,3,regulation of protein serine/threonine kinase activity,BP,FGF18
2664,GO:0051239,0.690374172942014,0.500150984800775,7,22,regulation of multicellular organismal process,BP,RBP4;TH;FADD;PSMB10;PLA2G16;LINGO1;FGF18
1749,GO:0034340,0.693778592943115,0.755618305842654,1,3,response to type I interferon,BP,FADD
2814,GO:0060337,0.693778592943115,0.755618305842654,1,3,type I interferon signaling pathway,BP,FADD
2979,GO:0071357,0.693778592943115,0.755618305842654,1,3,cellular response to type I interferon,BP,FADD
2222,GO:0044763,0.695486944189036,0.459840264345237,30,91,single-organism cellular process,BP,HACL1;MSRA;ACAT1;MRPL14;PXK;RBP4;ACADVL;ACAA2;TH;NUDT7;ALG5;ABCG1;ACAT2;ECI1;KRT10;ETFDH;DEPTOR;FADD;PSMB10;TBC1D14;PTS;PLA2G16;LINGO1;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;PEPD
1663,GO:0032774,0.700233072157169,0.514509794280385,5,17,RNA biosynthetic process,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
2568,GO:0050776,0.700258933156871,0.634247586241822,2,6,regulation of immune response,BP,FADD;PSMB10
3260,GO:1901606,0.700417770744655,0.749204747262074,1,3,alpha-amino acid catabolic process,BP,ACAT1
1191,GO:0016788,0.700686217802621,0.577301048783833,3,9,hydrolase activity, acting on ester bonds,MF,NUDT7;LYPLAL1;PLA2G16
945,GO:0010647,0.701738062606265,0.537411863512978,4,13,positive regulation of cell communication,BP,RBP4;FADD;PSMB10;FGF18
1365,GO:0023056,0.701738062606265,0.537411863512978,4,13,positive regulation of signaling,BP,RBP4;FADD;PSMB10;FGF18
586,GO:0006839,0.701924165372807,0.747729213705607,1,3,mitochondrial transport,BP,ACAA2
1403,GO:0030176,0.702635043481589,0.747030252539017,1,3,integral component of endoplasmic reticulum membrane,CC,DPM3
1497,GO:0031227,0.702635043481589,0.747030252539017,1,3,intrinsic component of endoplasmic reticulum membrane,CC,DPM3
868,GO:0009725,0.702656182025647,0.563231186555589,3,11,response to hormone,BP,ACAT1;TH;ABCG1
1266,GO:0019219,0.702660116922826,0.511679836445337,5,17,regulation of nucleobase-containing compound metabolic process,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
895,GO:0009966,0.703285734805799,0.513640287531807,5,16,regulation of signal transduction,BP,ACAA2;DEPTOR;FADD;PSMB10;FGF18
2662,GO:0051235,0.706501005945509,0.743199111341473,1,3,maintenance of location,BP,ABCG1
2537,GO:0050661,0.707497157995574,0.742203653077964,1,3,NADP binding,MF,DECR1
1084,GO:0015918,0.711730561499101,0.737934821269327,1,3,sterol transport,BP,ABCG1
1426,GO:0030301,0.711730561499101,0.737934821269327,1,3,cholesterol transport,BP,ABCG1
2321,GO:0045940,0.711730561499101,0.737934821269327,1,3,positive regulation of steroid metabolic process,BP,ABCG1
1330,GO:0022008,0.712812524721954,0.608633337450744,2,7,neurogenesis,BP,TH;LINGO1
741,GO:0008283,0.714253345794604,0.527141162625228,4,12,cell proliferation,BP,RBP4;FADD;FGF18;IFI30
1914,GO:0042127,0.714253345794604,0.527141162625228,4,12,regulation of cell proliferation,BP,RBP4;FADD;FGF18;IFI30
2897,GO:0070266,0.714493977144211,0.735114341739491,1,3,necroptotic process,BP,FADD
3137,GO:0097300,0.714493977144211,0.735114341739491,1,3,programmed necrotic cell death,BP,FADD
2873,GO:0065008,0.715421246873297,0.440721952857153,11,36,regulation of biological quality,BP,RBP4;ACADVL;ACAA2;TH;ABCG1;DEPTOR;FADD;PSMB10;HNF1A;DPM3;IFI30
1866,GO:0036094,0.715693982464921,0.466326914294729,7,25,small molecule binding,MF,HACL1;RBP4;ACADVL;TH;ABCG1;ETFDH;DECR1
1343,GO:0022604,0.716463456648276,0.733087599578071,1,3,regulation of cell morphogenesis,BP,LINGO1
2268,GO:0045444,0.716467813434089,0.733083100694771,1,3,fat cell differentiation,BP,NUDT7
666,GO:0007409,0.717073931745173,0.732456547322326,1,3,axonogenesis,BP,LINGO1
1491,GO:0031175,0.717073931745173,0.732456547322326,1,3,neuron projection development,BP,LINGO1
1690,GO:0032990,0.717073931745173,0.732456547322326,1,3,cell part morphogenesis,BP,LINGO1
2523,GO:0048812,0.717073931745173,0.732456547322326,1,3,neuron projection morphogenesis,BP,LINGO1
2525,GO:0048858,0.717073931745173,0.732456547322326,1,3,cell projection morphogenesis,BP,LINGO1
2867,GO:0061564,0.717073931745173,0.732456547322326,1,3,axon development,BP,LINGO1
1143,GO:0016485,0.719661110599646,0.729767187519279,1,3,protein processing,BP,FADD
2724,GO:0051604,0.719661110599646,0.729767187519279,1,3,protein maturation,BP,FADD
2167,GO:0044281,0.722723190015338,0.414621470438462,19,60,small molecule metabolic process,BP,HACL1;MSRA;ACAT1;RBP4;ACADVL;ACAA2;TH;NUDT7;ABCG1;ACAT2;ECI1;ETFDH;PSMB10;PTS;PLA2G16;DECR1;CPT1C;ETFB;PEPD
2409,GO:0046872,0.723545572579653,0.45045063833918,8,26,metal ion binding,MF,HACL1;ACAT1;TH;NUDT7;ETFDH;PTS;ZFYVE21;PEPD
479,GO:0006417,0.723844903350376,0.725366261638032,1,3,regulation of translation,BP,TSFM
1741,GO:0034248,0.723844903350376,0.725366261638032,1,3,regulation of cellular amide metabolic process,BP,TSFM
638,GO:0007167,0.72448065381274,0.700730673669769,1,4,enzyme linked receptor protein signaling pathway,BP,FGF18
639,GO:0007169,0.72448065381274,0.700730673669769,1,4,transmembrane receptor protein tyrosine kinase signaling pathway,BP,FGF18
1553,GO:0031960,0.724720722690921,0.724436769618945,1,3,response to corticosteroid,BP,TH
2701,GO:0051384,0.724720722690921,0.724436769618945,1,3,response to glucocorticoid,BP,TH
1714,GO:0033554,0.725559533426574,0.541100117945225,3,10,cellular response to stress,BP,ACADVL;ACAA2;PSMB10
1827,GO:0035384,0.72725144653148,0.697591119726477,1,4,thioester biosynthetic process,BP,ACAT1
3007,GO:0071616,0.72725144653148,0.697591119726477,1,4,acyl-CoA biosynthetic process,BP,ACAT1
888,GO:0009896,0.727858444972113,0.721083085911248,1,3,positive regulation of catabolic process,BP,PSMB10
1514,GO:0031331,0.727858444972113,0.721083085911248,1,3,positive regulation of cellular catabolic process,BP,PSMB10
412,GO:0005887,0.729127432821317,0.580991137605062,2,8,integral component of plasma membrane,CC,ABCG1;CPT1C
1496,GO:0031226,0.729127432821317,0.580991137605062,2,8,intrinsic component of plasma membrane,CC,ABCG1;CPT1C
2471,GO:0048511,0.729552127249728,0.719257303828198,1,3,rhythmic process,BP,TH
1576,GO:0032268,0.731883813151112,0.479432107880324,5,16,regulation of cellular protein metabolic process,BP,TSFM;DEPTOR;FADD;PSMB10;FGF18
551,GO:0006721,0.731905965541905,0.716701579853505,1,3,terpenoid metabolic process,BP,RBP4
1107,GO:0016101,0.731905965541905,0.716701579853505,1,3,diterpenoid metabolic process,BP,RBP4
2078,GO:0043254,0.732379180750157,0.716185188845752,1,3,regulation of protein complex assembly,BP,HNF1A
723,GO:0008202,0.732638405676113,0.500367235930252,4,13,steroid metabolic process,BP,ACADVL;ACAA2;ABCG1;ACAT2
90,GO:0001819,0.732923808863481,0.715589790470416,1,3,positive regulation of cytokine production,BP,FADD
1639,GO:0032640,0.732923808863481,0.715589790470416,1,3,tumor necrosis factor production,BP,FADD
1649,GO:0032680,0.732923808863481,0.715589790470416,1,3,regulation of tumor necrosis factor production,BP,FADD
1660,GO:0032760,0.732923808863481,0.715589790470416,1,3,positive regulation of tumor necrosis factor production,BP,FADD
3011,GO:0071706,0.732923808863481,0.715589790470416,1,3,tumor necrosis factor superfamily cytokine production,BP,FADD
3387,GO:1903555,0.732923808863481,0.715589790470416,1,3,regulation of tumor necrosis factor superfamily cytokine production,BP,FADD
3388,GO:1903557,0.732923808863481,0.715589790470416,1,3,positive regulation of tumor necrosis factor superfamily cytokine production,BP,FADD
907,GO:0010038,0.73434522328777,0.714030410765593,1,3,response to metal ion,BP,TH
3060,GO:0072522,0.735338343310595,0.712936187087303,1,3,purine-containing compound biosynthetic process,BP,ACAT1
1881,GO:0036477,0.735979034922963,0.58071901208227,2,7,somatodendritic compartment,CC,TH;CPT1C
2037,GO:0043066,0.736831344549496,0.579661008738461,2,7,negative regulation of apoptotic process,BP,ACAA2;FADD
2040,GO:0043069,0.736831344549496,0.579661008738461,2,7,negative regulation of programmed cell death,BP,ACAA2;FADD
2839,GO:0060548,0.736831344549496,0.579661008738461,2,7,negative regulation of cell death,BP,ACAA2;FADD
163,GO:0002521,0.737105513922689,0.710979462642413,1,3,leukocyte differentiation,BP,FADD
3296,GO:1902105,0.737105513922689,0.710979462642413,1,3,regulation of leukocyte differentiation,BP,FADD
3400,GO:1903706,0.737105513922689,0.710979462642413,1,3,regulation of hemopoiesis,BP,FADD
367,GO:0005615,0.738374840164822,0.493254799379627,4,13,extracellular space,CC,RBP4;KRT10;LINGO1;FGF18
1750,GO:0034341,0.74059140467875,0.707083049041315,1,3,response to interferon-gamma,BP,IFI30
2975,GO:0071346,0.74059140467875,0.707083049041315,1,3,cellular response to interferon-gamma,BP,IFI30
1151,GO:0016567,0.741283028083752,0.706304138784611,1,3,protein ubiquitination,BP,PSMB10
1525,GO:0031396,0.741283028083752,0.706304138784611,1,3,regulation of protein ubiquitination,BP,PSMB10
1527,GO:0031398,0.741283028083752,0.706304138784611,1,3,positive regulation of protein ubiquitination,BP,PSMB10
1609,GO:0032446,0.741283028083752,0.706304138784611,1,3,protein modification by small protein conjugation,BP,PSMB10
2924,GO:0070647,0.741283028083752,0.706304138784611,1,3,protein modification by small protein conjugation or removal,BP,PSMB10
3368,GO:1903320,0.741283028083752,0.706304138784611,1,3,regulation of protein modification by small protein conjugation or removal,BP,PSMB10
3370,GO:1903322,0.741283028083752,0.706304138784611,1,3,positive regulation of protein modification by small protein conjugation or removal,BP,PSMB10
633,GO:0007155,0.741429110931598,0.706139370376152,1,3,cell adhesion,BP,FADD
634,GO:0007159,0.741429110931598,0.706139370376152,1,3,leukocyte cell-cell adhesion,BP,FADD
1131,GO:0016337,0.741429110931598,0.706139370376152,1,3,single organismal cell-cell adhesion,BP,FADD
1334,GO:0022407,0.741429110931598,0.706139370376152,1,3,regulation of cell-cell adhesion,BP,FADD
1335,GO:0022409,0.741429110931598,0.706139370376152,1,3,positive regulation of cell-cell adhesion,BP,FADD
1345,GO:0022610,0.741429110931598,0.706139370376152,1,3,biological adhesion,BP,FADD
1398,GO:0030155,0.741429110931598,0.706139370376152,1,3,regulation of cell adhesion,BP,FADD
1904,GO:0042098,0.741429110931598,0.706139370376152,1,3,T cell proliferation,BP,FADD
1906,GO:0042102,0.741429110931598,0.706139370376152,1,3,positive regulation of T cell proliferation,BP,FADD
1910,GO:0042110,0.741429110931598,0.706139370376152,1,3,T cell activation,BP,FADD
1915,GO:0042129,0.741429110931598,0.706139370376152,1,3,regulation of T cell proliferation,BP,FADD
2296,GO:0045785,0.741429110931598,0.706139370376152,1,3,positive regulation of cell adhesion,BP,FADD
2593,GO:0050863,0.741429110931598,0.706139370376152,1,3,regulation of T cell activation,BP,FADD
2597,GO:0050870,0.741429110931598,0.706139370376152,1,3,positive regulation of T cell activation,BP,FADD
3165,GO:0098602,0.741429110931598,0.706139370376152,1,3,single organism cell adhesion,BP,FADD
3166,GO:0098609,0.741429110931598,0.706139370376152,1,3,cell-cell adhesion,BP,FADD
3352,GO:1903037,0.741429110931598,0.706139370376152,1,3,regulation of leukocyte cell-cell adhesion,BP,FADD
3353,GO:1903039,0.741429110931598,0.706139370376152,1,3,positive regulation of leukocyte cell-cell adhesion,BP,FADD
720,GO:0008198,0.741575283668077,0.705974413485587,1,3,ferrous iron binding,MF,TH
817,GO:0009166,0.741605309720663,0.705940518096279,1,3,nucleotide catabolic process,BP,NUDT7
3242,GO:1901292,0.741605309720663,0.705940518096279,1,3,nucleoside phosphate catabolic process,BP,NUDT7
65,GO:0001568,0.741767369991095,0.705757510230827,1,3,blood vessel development,BP,FGF18
113,GO:0001944,0.741767369991095,0.705757510230827,1,3,vasculature development,BP,FGF18
3052,GO:0072358,0.741767369991095,0.705757510230827,1,3,cardiovascular system development,BP,FGF18
552,GO:0006725,0.742384273550248,0.404683831700014,12,39,cellular aromatic compound metabolic process,BP,ACAT1;ARL6IP4;TH;PUS1;NUDT7;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A;PTS
2146,GO:0044093,0.744185675716942,0.485971135826353,4,13,positive regulation of molecular function,BP,FADD;PSMB10;TBC1D14;FGF18
3129,GO:0097191,0.745316230284423,0.580919776816042,2,6,extrinsic apoptotic signaling pathway,BP,DEPTOR;FADD
3512,GO:2001236,0.745316230284423,0.580919776816042,2,6,regulation of extrinsic apoptotic signaling pathway,BP,DEPTOR;FADD
177,GO:0002682,0.745681333341232,0.516044514846026,3,10,regulation of immune system process,BP,RBP4;FADD;PSMB10
2054,GO:0043167,0.748583233119182,0.396680331507632,12,40,ion binding,MF,HACL1;ACAT1;PXK;ACADVL;TH;NUDT7;ABCG1;ETFDH;PTS;DECR1;ZFYVE21;PEPD
925,GO:0010556,0.748975204088499,0.453124501307193,5,18,regulation of macromolecule biosynthetic process,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
2184,GO:0044425,0.7493302826749,0.392574657739656,13,43,membrane part,CC,PXMP2;TMEM160;CNIH4;TH;ALG5;ABCG1;ETFDH;CCDC51;FADD;PLA2G16;LINGO1;CPT1C;DPM3
1268,GO:0019221,0.753686019859296,0.505772977118417,3,10,cytokine-mediated signaling pathway,BP,FADD;PSMB10;IFI30
1211,GO:0016863,0.754137095212977,0.691465337360233,1,3,intramolecular oxidoreductase activity, transposing C=C bonds,MF,ECI1
998,GO:0010939,0.754179084860091,0.691415709248747,1,3,regulation of necrotic cell death,BP,FADD
1668,GO:0032813,0.754179084860091,0.691415709248747,1,3,tumor necrosis factor receptor superfamily binding,MF,FADD
3513,GO:2001237,0.754179084860091,0.691415709248747,1,3,negative regulation of extrinsic apoptotic signaling pathway,BP,FADD
2170,GO:0044297,0.754312498744962,0.557446720697161,2,7,cell body,CC,TH;FADD
2942,GO:0070887,0.755291705930011,0.419353098414958,7,24,cellular response to chemical stimulus,BP,ACADVL;ACAA2;TH;FADD;PSMB10;FGF18;IFI30
2806,GO:0060255,0.755686461403441,0.416421070727777,7,26,regulation of macromolecule metabolic process,BP,TSFM;ABCG1;DEPTOR;FADD;PSMB10;HNF1A;FGF18
943,GO:0010639,0.756072149392033,0.689170246007985,1,3,negative regulation of organelle organization,BP,ACAA2
107,GO:0001933,0.756335368449984,0.688856779520634,1,3,negative regulation of protein phosphorylation,BP,DEPTOR
483,GO:0006469,0.756335368449984,0.688856779520634,1,3,negative regulation of protein kinase activity,BP,DEPTOR
1718,GO:0033673,0.756335368449984,0.688856779520634,1,3,negative regulation of kinase activity,BP,DEPTOR
1939,GO:0042326,0.756335368449984,0.688856779520634,1,3,negative regulation of phosphorylation,BP,DEPTOR
2308,GO:0045862,0.75664704800105,0.566496667444154,2,6,positive regulation of proteolysis,BP,FADD;PSMB10
621,GO:0006979,0.759521419257011,0.550631175822217,2,7,response to oxidative stress,BP,MSRA;ETFDH
1789,GO:0034654,0.760602808738341,0.423769146485659,6,21,nucleobase-containing compound biosynthetic process,BP,ACAT1;TSFM;ABCG1;FADD;PSMB10;HNF1A
3249,GO:1901362,0.762340829267998,0.388953751725869,10,33,organic cyclic compound biosynthetic process,BP,ACAT1;ACAA2;TH;TSFM;ABCG1;ACAT2;FADD;PSMB10;HNF1A;PTS
2368,GO:0046483,0.763058620470975,0.378936262977672,12,40,heterocycle metabolic process,BP,ACAT1;ARL6IP4;TH;PUS1;NUDT7;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A;PTS
3322,GO:1902580,0.76339715869171,0.653789229321081,1,4,single-organism cellular localization,BP,ABCG1
3323,GO:1902582,0.76339715869171,0.653789229321081,1,4,single-organism intracellular transport,BP,ABCG1
234,GO:0003779,0.764307455987892,0.679215670760422,1,3,actin binding,MF,PXK
2691,GO:0051341,0.765977185756819,0.677159596058283,1,3,regulation of oxidoreductase activity,BP,PTS
2469,GO:0048471,0.766402776675155,0.676633454915503,1,3,perinuclear region of cytoplasm,CC,PLA2G16
379,GO:0005741,0.766842319052922,0.676089176431389,1,3,mitochondrial outer membrane,CC,CPT1C
2393,GO:0046660,0.767079917998537,0.675794584119707,1,3,female sex differentiation,BP,RBP4
772,GO:0008637,0.767767474016654,0.674940607160906,1,3,apoptotic mitochondrial changes,BP,ACAA2
970,GO:0010821,0.767767474016654,0.674940607160906,1,3,regulation of mitochondrion organization,BP,ACAA2
884,GO:0009892,0.769024293198541,0.453897979987773,4,13,negative regulation of metabolic process,BP,ACADVL;DEPTOR;PSMB10;TBC1D14
1507,GO:0031324,0.769024293198541,0.453897979987773,4,13,negative regulation of cellular metabolic process,BP,ACADVL;DEPTOR;PSMB10;TBC1D14
1373,GO:0030030,0.769257045226881,0.64615132702882,1,4,cell projection organization,BP,LINGO1
1099,GO:0016051,0.769989634284462,0.672165285264279,1,3,carbohydrate biosynthetic process,BP,RBP4
2345,GO:0046364,0.769989634284462,0.672165285264279,1,3,monosaccharide biosynthetic process,BP,RBP4
123,GO:0002020,0.770081213764864,0.672050404787065,1,3,protease binding,MF,FADD
3317,GO:1902532,0.771021191235961,0.670868942644106,1,3,negative regulation of intracellular signal transduction,BP,DEPTOR
982,GO:0010876,0.771437430767831,0.534682779616736,2,7,lipid localization,BP,RBP4;ABCG1
931,GO:0010565,0.772094346679923,0.53378870261307,2,7,regulation of cellular ketone metabolic process,BP,ACADVL;PSMB10
2648,GO:0051179,0.772152027990076,0.371375649121814,11,37,localization,BP,RBP4;CNIH4;ACAA2;TH;ABCG1;FADD;PSMB10;TBC1D14;HNF1A;FGF18;ZFYVE21
1619,GO:0032535,0.772449959914902,0.66906497321132,1,3,regulation of cellular component size,BP,DEPTOR
3084,GO:0090066,0.772449959914902,0.66906497321132,1,3,regulation of anatomical structure size,BP,DEPTOR
2527,GO:0048870,0.773456409089456,0.531929846322701,2,7,cell motility,BP,FADD;FGF18
2729,GO:0051674,0.773456409089456,0.531929846322701,2,7,localization of cell,BP,FADD;FGF18
637,GO:0007166,0.775126291657039,0.419347327182358,5,18,cell surface receptor signaling pathway,BP,DEPTOR;FADD;PSMB10;FGF18;IFI30
1530,GO:0031401,0.775533405366203,0.529082063691828,2,7,positive regulation of protein modification process,BP,PSMB10;FGF18
3316,GO:1902531,0.776243408058843,0.470403608145788,3,11,regulation of intracellular signal transduction,BP,DEPTOR;FADD;FGF18
33,GO:0000904,0.777091854871079,0.635684005663288,1,4,cell morphogenesis involved in differentiation,BP,LINGO1
2510,GO:0048667,0.777091854871079,0.635684005663288,1,4,cell morphogenesis involved in neuron differentiation,BP,LINGO1
411,GO:0005886,0.777279630517968,0.389993056162794,7,25,plasma membrane,CC,PXK;TH;ABCG1;KRT10;FADD;LINGO1;CPT1C
636,GO:0007165,0.777412346469624,0.381459172259246,8,28,signal transduction,BP,ACADVL;ACAA2;DEPTOR;FADD;PSMB10;LINGO1;FGF18;IFI30
857,GO:0009615,0.777448342555929,0.63520060683392,1,4,response to virus,BP,FADD
2726,GO:0051607,0.777448342555929,0.63520060683392,1,4,defense response to virus,BP,FADD
3157,GO:0098542,0.777448342555929,0.63520060683392,1,4,defense response to other organism,BP,FADD
2140,GO:0044057,0.777951355187771,0.662025702996862,1,3,regulation of system process,BP,TH
1506,GO:0031323,0.778256957628273,0.372876217911539,9,32,regulation of cellular metabolic process,BP,ACADVL;TSFM;ABCG1;DEPTOR;FADD;PSMB10;TBC1D14;HNF1A;FGF18
2667,GO:0051246,0.779078985859,0.416424855209933,5,17,regulation of protein metabolic process,BP,TSFM;DEPTOR;FADD;PSMB10;FGF18
532,GO:0006664,0.779098692623605,0.660538686066805,1,3,glycolipid metabolic process,BP,DPM3
3380,GO:1903509,0.779098692623605,0.660538686066805,1,3,liposaccharide metabolic process,BP,DPM3
1269,GO:0019222,0.779351018396421,0.365546140591991,10,36,regulation of metabolic process,BP,ACADVL;TSFM;ABCG1;DEPTOR;FADD;PSMB10;TBC1D14;HNF1A;PTS;FGF18
596,GO:0006886,0.779421606356448,0.63251340927351,1,4,intracellular protein transport,BP,TBC1D14
2581,GO:0050804,0.779807785867849,0.631985228752784,1,4,modulation of synaptic transmission,BP,PXK
3514,GO:2001238,0.780864897276523,0.658236577930237,1,3,positive regulation of extrinsic apoptotic signaling pathway,BP,FADD
1574,GO:0032259,0.782567742799558,0.656001984641273,1,3,methylation,BP,ETFB
2646,GO:0051173,0.785134564289636,0.507018859253015,2,8,positive regulation of nitrogen compound metabolic process,BP,FADD;HNF1A
2056,GO:0043169,0.786916693148332,0.370152270703603,8,27,cation binding,MF,HACL1;ACAT1;TH;NUDT7;ETFDH;PTS;ZFYVE21;PEPD
1570,GO:0032101,0.787665592586297,0.605368419627782,1,5,regulation of response to external stimulus,BP,FGF18
449,GO:0006139,0.79103094006636,0.351743508932269,10,34,nucleobase-containing compound metabolic process,BP,ACAT1;ARL6IP4;PUS1;NUDT7;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A
1337,GO:0022411,0.791221433505812,0.64441151703262,1,3,cellular component disassembly,BP,MRPL14
1688,GO:0032984,0.791221433505812,0.64441151703262,1,3,macromolecular complex disassembly,BP,MRPL14
2075,GO:0043241,0.791221433505812,0.64441151703262,1,3,protein complex disassembly,BP,MRPL14
2126,GO:0043624,0.791221433505812,0.64441151703262,1,3,cellular protein complex disassembly,BP,MRPL14
917,GO:0010468,0.793086609791969,0.39148844385879,5,20,regulation of gene expression,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
613,GO:0006952,0.793710086488706,0.413582660977507,4,15,defense response,BP,PXK;FADD;PSMB10;IFI30
2624,GO:0051049,0.793826289801611,0.416504927178903,4,14,regulation of transport,BP,RBP4;ACAA2;ABCG1;TBC1D14
3318,GO:1902533,0.794187987678096,0.494008816986041,2,8,positive regulation of intracellular signal transduction,BP,FADD;FGF18
2665,GO:0051240,0.794294385160522,0.493853988964271,2,8,positive regulation of multicellular organismal process,BP,FADD;FGF18
896,GO:0009967,0.794738646203041,0.444640535251248,3,11,positive regulation of signal transduction,BP,FADD;PSMB10;FGF18
2842,GO:0060627,0.795823434099347,0.609398988565204,1,4,regulation of vesicle-mediated transport,BP,TBC1D14
540,GO:0006694,0.796983791719124,0.441437021977068,3,11,steroid biosynthetic process,BP,ACAA2;ABCG1;ACAT2
1162,GO:0016628,0.798701077751466,0.605194136709139,1,4,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,DECR1
573,GO:0006807,0.799172393944609,0.322792926961898,17,56,nitrogen compound metabolic process,BP,MSRA;ACAT1;MRPL14;ARL6IP4;TH;PUS1;NUDT7;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A;PTS;PLA2G16;CPT1C;PEPD
2414,GO:0046889,0.799458606681289,0.604079495194044,1,4,positive regulation of lipid biosynthetic process,BP,ABCG1
742,GO:0008284,0.799720890256743,0.494684824418685,2,7,positive regulation of cell proliferation,BP,FADD;FGF18
2035,GO:0043043,0.800837012486594,0.49304003270654,2,7,peptide biosynthetic process,BP,MRPL14;TSFM
2121,GO:0043604,0.800837012486594,0.49304003270654,2,7,amide biosynthetic process,BP,MRPL14;TSFM
3128,GO:0097190,0.801151643609739,0.440903789496312,3,10,apoptotic signaling pathway,BP,ACAA2;DEPTOR;FADD
3031,GO:0071944,0.801514298226429,0.356761810764067,7,26,cell periphery,CC,PXK;TH;ABCG1;KRT10;FADD;LINGO1;CPT1C
2363,GO:0046470,0.802327774057179,0.628934695880626,1,3,phosphatidylcholine metabolic process,BP,PLA2G16
2013,GO:0042803,0.802926822414113,0.432874010560867,3,11,protein homodimerization activity,MF,ACAT1;ABCG1;PTS
802,GO:0009108,0.803788030217988,0.479852255322039,2,8,coenzyme biosynthetic process,BP,ACAT1;PTS
883,GO:0009891,0.805400226925526,0.424956432903242,3,12,positive regulation of biosynthetic process,BP,ABCG1;FADD;HNF1A
1936,GO:0042304,0.806736851762147,0.593202124776759,1,4,regulation of fatty acid biosynthetic process,BP,ACADVL
570,GO:0006796,0.807417990152667,0.342868450372584,8,27,phosphate-containing compound metabolic process,BP,ACAT1;NUDT7;DEPTOR;PSMB10;PLA2G16;FGF18;ZFYVE21;DPM3
1787,GO:0034641,0.808867581271616,0.314832563829085,14,47,cellular nitrogen compound metabolic process,BP,ACAT1;MRPL14;ARL6IP4;TH;PUS1;NUDT7;TSFM;ABCG1;FADD;PSMB10;LAGE3;HNF1A;PTS;CPT1C
2484,GO:0048545,0.813538493121665,0.582752869952118,1,4,response to steroid hormone,BP,TH
1577,GO:0032269,0.814835317925063,0.471947689245774,2,7,negative regulation of cellular protein metabolic process,BP,DEPTOR;PSMB10
1318,GO:0019904,0.815577156886748,0.461930127239623,2,8,protein domain specific binding,MF,TH;FADD
185,GO:0002696,0.817452868592767,0.576609735700601,1,4,positive regulation of leukocyte activation,BP,FADD
1682,GO:0032943,0.817452868592767,0.576609735700601,1,4,mononuclear cell proliferation,BP,FADD
1683,GO:0032944,0.817452868592767,0.576609735700601,1,4,regulation of mononuclear cell proliferation,BP,FADD
1684,GO:0032946,0.817452868592767,0.576609735700601,1,4,positive regulation of mononuclear cell proliferation,BP,FADD
2391,GO:0046649,0.817452868592767,0.576609735700601,1,4,lymphocyte activation,BP,FADD
2392,GO:0046651,0.817452868592767,0.576609735700601,1,4,lymphocyte proliferation,BP,FADD
2540,GO:0050670,0.817452868592767,0.576609735700601,1,4,regulation of lymphocyte proliferation,BP,FADD
2541,GO:0050671,0.817452868592767,0.576609735700601,1,4,positive regulation of lymphocyte proliferation,BP,FADD
2596,GO:0050867,0.817452868592767,0.576609735700601,1,4,positive regulation of cell activation,BP,FADD
2670,GO:0051249,0.817452868592767,0.576609735700601,1,4,regulation of lymphocyte activation,BP,FADD
2671,GO:0051251,0.817452868592767,0.576609735700601,1,4,positive regulation of lymphocyte activation,BP,FADD
2925,GO:0070661,0.817452868592767,0.576609735700601,1,4,leukocyte proliferation,BP,FADD
2926,GO:0070663,0.817452868592767,0.576609735700601,1,4,regulation of leukocyte proliferation,BP,FADD
2927,GO:0070665,0.817452868592767,0.576609735700601,1,4,positive regulation of leukocyte proliferation,BP,FADD
2874,GO:0065009,0.817598299171514,0.349107246693346,6,20,regulation of molecular function,BP,DEPTOR;FADD;PSMB10;TBC1D14;PTS;FGF18
355,GO:0005524,0.817904039998267,0.548654453572741,1,6,ATP binding,MF,ABCG1
1228,GO:0017076,0.817904039998267,0.548654453572741,1,6,purine nucleotide binding,MF,ABCG1
1446,GO:0030554,0.817904039998267,0.548654453572741,1,6,adenyl nucleotide binding,MF,ABCG1
1623,GO:0032553,0.817904039998267,0.548654453572741,1,6,ribonucleotide binding,MF,ABCG1
1624,GO:0032555,0.817904039998267,0.548654453572741,1,6,purine ribonucleotide binding,MF,ABCG1
1625,GO:0032559,0.817904039998267,0.548654453572741,1,6,adenyl ribonucleotide binding,MF,ABCG1
1842,GO:0035639,0.817904039998267,0.548654453572741,1,6,purine ribonucleoside triphosphate binding,MF,ABCG1
421,GO:0006006,0.818048790126978,0.575665993223805,1,4,glucose metabolic process,BP,RBP4
1209,GO:0016860,0.818203446379967,0.575420697112873,1,4,intramolecular oxidoreductase activity,MF,ECI1
108,GO:0001934,0.819697722603931,0.573042732727993,1,4,positive regulation of protein phosphorylation,BP,FGF18
1940,GO:0042327,0.819697722603931,0.573042732727993,1,4,positive regulation of phosphorylation,BP,FGF18
2164,GO:0044271,0.820085823701952,0.324540548828256,8,28,cellular nitrogen compound biosynthetic process,BP,ACAT1;MRPL14;TSFM;ABCG1;FADD;PSMB10;HNF1A;PTS
2169,GO:0044283,0.822222949580924,0.337923715205054,6,23,small molecule biosynthetic process,BP,ACAT1;RBP4;ACADVL;ACAA2;ABCG1;ACAT2
533,GO:0006665,0.822497720118908,0.568547746279493,1,4,sphingolipid metabolic process,BP,TH
853,GO:0009605,0.824557894646312,0.362635755635755,4,18,response to external stimulus,BP,ACAT1;TH;FADD;FGF18
3254,GO:1901566,0.82504606947012,0.350125699555509,5,18,organonitrogen compound biosynthetic process,BP,ACAT1;MRPL14;TH;TSFM;PTS
3269,GO:1901657,0.825419136265582,0.563802518044355,1,4,glycosyl compound metabolic process,BP,TH
2896,GO:0070265,0.826515336830517,0.562007152998845,1,4,necrotic cell death,BP,FADD
790,GO:0009063,0.826635791767823,0.5618093730347,1,4,cellular amino acid catabolic process,BP,ACAT1
1522,GO:0031347,0.827791024459514,0.442695342651611,2,8,regulation of defense response,BP,FADD;PSMB10
906,GO:0010035,0.82826403708415,0.559126146124009,1,4,response to inorganic substance,BP,TH
1442,GO:0030529,0.829384874914153,0.55726847033716,1,4,intracellular ribonucleoprotein complex,CC,MRPL14
3455,GO:1990904,0.829384874914153,0.55726847033716,1,4,ribonucleoprotein complex,CC,MRPL14
2050,GO:0043123,0.831372206461193,0.553953130555481,1,4,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,FADD
1116,GO:0016192,0.831865126101268,0.385042723081794,3,12,vesicle-mediated transport,BP,CNIH4;TBC1D14;ZFYVE21
178,GO:0002683,0.833158782094311,0.550948900298702,1,4,negative regulation of immune system process,BP,FADD
2063,GO:0043207,0.833465152456868,0.426971908381614,2,9,response to external biotic stimulus,BP,TH;FADD
2735,GO:0051707,0.833465152456868,0.426971908381614,2,9,response to other organism,BP,TH;FADD
700,GO:0008047,0.833621510791492,0.550167082026195,1,4,enzyme activator activity,MF,TBC1D14
2688,GO:0051336,0.834773213995792,0.384776915243365,3,11,regulation of hydrolase activity,BP,FADD;TBC1D14;FGF18
1831,GO:0035556,0.835211533784284,0.353182949519675,4,15,intracellular signal transduction,BP,DEPTOR;FADD;PSMB10;FGF18
816,GO:0009165,0.835662221552582,0.546700707020212,1,4,nucleotide biosynthetic process,BP,ACAT1
3243,GO:1901293,0.835662221552582,0.546700707020212,1,4,nucleoside phosphate biosynthetic process,BP,ACAT1
88,GO:0001817,0.835925965298802,0.546250501138496,1,4,regulation of cytokine production,BP,FADD
3252,GO:1901564,0.835986275170645,0.286755233291994,11,38,organonitrogen compound metabolic process,BP,MSRA;ACAT1;MRPL14;TH;NUDT7;TSFM;PSMB10;PTS;PLA2G16;CPT1C;PEPD
1311,GO:0019867,0.836330585367193,0.545558832711226,1,4,outer membrane,CC,CPT1C
1557,GO:0031968,0.836330585367193,0.545558832711226,1,4,organelle outer membrane,CC,CPT1C
396,GO:0005783,0.83689924442287,0.309692021509731,7,24,endoplasmic reticulum,CC,CNIH4;TH;ALG5;ABCG1;PLA2G16;CPT1C;DPM3
2625,GO:0051050,0.838023207429728,0.426020678359018,2,8,positive regulation of transport,BP,RBP4;ABCG1
2196,GO:0044445,0.838712633233542,0.541462423152766,1,4,cytosolic part,CC,FADD
609,GO:0006928,0.838891241033583,0.424581368020817,2,8,movement of cell or subcellular component,BP,FADD;FGF18
1891,GO:0040011,0.838891241033583,0.424581368020817,2,8,locomotion,BP,FADD;FGF18
275,GO:0004497,0.839117831835097,0.540761404204673,1,4,monooxygenase activity,MF,TH
1322,GO:0019953,0.83976185506549,0.539644668969526,1,4,sexual reproduction,BP,TH
1616,GO:0032504,0.83976185506549,0.539644668969526,1,4,multicellular organism reproduction,BP,TH
2212,GO:0044703,0.83976185506549,0.539644668969526,1,4,multi-organism reproductive process,BP,TH
2497,GO:0048609,0.83976185506549,0.539644668969526,1,4,multicellular organismal reproductive process,BP,TH
2992,GO:0071417,0.841863900370293,0.507659646756214,1,6,cellular response to organonitrogen compound,BP,TH
3277,GO:1901699,0.841863900370293,0.507659646756214,1,6,cellular response to nitrogen compound,BP,TH
2061,GO:0043202,0.842719087945183,0.534476456685201,1,4,lysosomal lumen,CC,IFI30
1601,GO:0032403,0.84288112607141,0.534191334994235,1,4,protein complex binding,MF,FADD
162,GO:0002520,0.84445876320362,0.531404687117496,1,4,immune system development,BP,FADD
1385,GO:0030097,0.84445876320362,0.531404687117496,1,4,hemopoiesis,BP,FADD
2480,GO:0048534,0.84445876320362,0.531404687117496,1,4,hematopoietic or lymphoid organ development,BP,FADD
492,GO:0006508,0.845970918700166,0.366891043564893,3,11,proteolysis,BP,FADD;PSMB10;PEPD
2100,GO:0043434,0.846109493525319,0.499977257958574,1,6,response to peptide hormone,BP,TH
506,GO:0006575,0.847455709543503,0.508554074874634,1,5,cellular modified amino acid metabolic process,BP,PLA2G16
2652,GO:0051188,0.848364428223285,0.402066663689875,2,9,cofactor biosynthetic process,BP,ACAT1;PTS
1263,GO:0019216,0.850073954404416,0.399133214466702,2,9,regulation of lipid metabolic process,BP,ACADVL;ABCG1
2415,GO:0046890,0.850073954404416,0.399133214466702,2,9,regulation of lipid biosynthetic process,BP,ACADVL;ABCG1
184,GO:0002694,0.853501915173817,0.497394963987062,1,5,regulation of leukocyte activation,BP,FADD
2595,GO:0050865,0.853501915173817,0.497394963987062,1,5,regulation of cell activation,BP,FADD
494,GO:0006518,0.854003983394853,0.398863658188082,2,8,peptide metabolic process,BP,MRPL14;TSFM
3247,GO:1901360,0.854983318585669,0.250527638245168,15,51,organic cyclic compound metabolic process,BP,ACAT1;ACADVL;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ABCG1;ACAT2;FADD;PSMB10;LAGE3;HNF1A;PTS
255,GO:0004175,0.854996441504893,0.51227929695622,1,4,endopeptidase activity,MF,PSMB10
575,GO:0006810,0.855268668931828,0.267280392286246,9,33,transport,BP,RBP4;CNIH4;ACAA2;TH;ABCG1;PSMB10;TBC1D14;HNF1A;ZFYVE21
2661,GO:0051234,0.855268668931828,0.267280392286246,9,33,establishment of localization,BP,RBP4;CNIH4;ACAA2;TH;ABCG1;PSMB10;TBC1D14;HNF1A;ZFYVE21
1358,GO:0022892,0.855714738477453,0.389337201015695,2,9,substrate-specific transporter activity,MF,RBP4;ABCG1
568,GO:0006790,0.856542652835328,0.339056562287703,3,14,sulfur compound metabolic process,BP,MSRA;ACAT1;NUDT7
32,GO:0000902,0.856552018980164,0.491652810663375,1,5,cell morphogenesis,BP,LINGO1
1689,GO:0032989,0.856552018980164,0.491652810663375,1,5,cellular component morphogenesis,BP,LINGO1
116,GO:0001959,0.858944495276914,0.504873614751499,1,4,regulation of cytokine-mediated signaling pathway,BP,FADD
2844,GO:0060759,0.858944495276914,0.504873614751499,1,4,regulation of response to cytokine stimulus,BP,FADD
2572,GO:0050789,0.859648875049046,0.241661024031195,17,60,regulation of biological process,BP,PXK;RBP4;ACADVL;ACAA2;TH;TSFM;ABCG1;DEPTOR;FADD;PSMB10;TBC1D14;HNF1A;PTS;PLA2G16;LINGO1;FGF18;IFI30
1065,GO:0015711,0.860226480037252,0.484631163633092,1,5,organic anion transport,BP,ABCG1
2420,GO:0046914,0.862087987343519,0.335945541381046,3,12,transition metal ion binding,MF,TH;NUDT7;PEPD
204,GO:0002791,0.862448565398388,0.498185206499684,1,4,regulation of peptide secretion,BP,RBP4
205,GO:0002793,0.862448565398388,0.498185206499684,1,4,positive regulation of peptide secretion,BP,RBP4
2552,GO:0050708,0.862448565398388,0.498185206499684,1,4,regulation of protein secretion,BP,RBP4
2553,GO:0050714,0.862448565398388,0.498185206499684,1,4,positive regulation of protein secretion,BP,RBP4
2622,GO:0051046,0.862448565398388,0.498185206499684,1,4,regulation of secretion,BP,RBP4
2623,GO:0051047,0.862448565398388,0.498185206499684,1,4,positive regulation of secretion,BP,RBP4
2659,GO:0051222,0.862448565398388,0.498185206499684,1,4,positive regulation of protein transport,BP,RBP4
3384,GO:1903530,0.862448565398388,0.498185206499684,1,4,regulation of secretion by cell,BP,RBP4
3385,GO:1903532,0.862448565398388,0.498185206499684,1,4,positive regulation of secretion by cell,BP,RBP4
3433,GO:1904951,0.862448565398388,0.498185206499684,1,4,positive regulation of establishment of protein localization,BP,RBP4
768,GO:0008610,0.865018286692433,0.265780191687466,7,26,lipid biosynthetic process,BP,ACADVL;ACAA2;ABCG1;ACAT2;PLA2G16;FGF18;DPM3
3258,GO:1901576,0.865566389007178,0.233443090777418,17,57,organic substance biosynthetic process,BP,ACAT1;MRPL14;RBP4;ACADVL;ACAA2;TH;TSFM;ALG5;ABCG1;ACAT2;FADD;PSMB10;HNF1A;PTS;PLA2G16;FGF18;DPM3
3511,GO:2001235,0.865618858821411,0.49203720682717,1,4,positive regulation of apoptotic signaling pathway,BP,FADD
2736,GO:0051716,0.866076611723165,0.25033672547846,9,35,cellular response to stimulus,BP,ACADVL;ACAA2;TH;DEPTOR;FADD;PSMB10;LINGO1;FGF18;IFI30
929,GO:0010563,0.86699384429636,0.489341484811043,1,4,negative regulation of phosphorus metabolic process,BP,DEPTOR
2319,GO:0045936,0.86699384429636,0.489341484811043,1,4,negative regulation of phosphate metabolic process,BP,DEPTOR
2576,GO:0050794,0.867981359557553,0.231761377273972,15,54,regulation of cellular process,BP,PXK;RBP4;ACADVL;ACAA2;TSFM;ABCG1;DEPTOR;FADD;PSMB10;TBC1D14;HNF1A;PLA2G16;LINGO1;FGF18;IFI30
1578,GO:0032270,0.868488897682409,0.324995034400324,3,12,positive regulation of cellular protein metabolic process,BP,FADD;PSMB10;FGF18
2668,GO:0051247,0.868488897682409,0.324995034400324,3,12,positive regulation of protein metabolic process,BP,FADD;PSMB10;FGF18
397,GO:0005789,0.868658818695197,0.297608279418104,4,16,endoplasmic reticulum membrane,CC,ALG5;ABCG1;CPT1C;DPM3
1923,GO:0042175,0.868658818695197,0.297608279418104,4,16,nuclear outer membrane-endoplasmic reticulum membrane network,CC,ALG5;ABCG1;CPT1C;DPM3
2189,GO:0044432,0.868658818695197,0.297608279418104,4,16,endoplasmic reticulum part,CC,ALG5;ABCG1;CPT1C;DPM3
2242,GO:0045087,0.869175675816954,0.323807564158484,3,12,innate immune response,BP,FADD;PSMB10;IFI30
2231,GO:0044877,0.869439592917349,0.466501596937572,1,5,macromolecular complex binding,MF,FADD
607,GO:0006919,0.870307738622169,0.482769817469476,1,4,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,FADD
1002,GO:0010950,0.870307738622169,0.482769817469476,1,4,positive regulation of endopeptidase activity,BP,FADD
1004,GO:0010952,0.870307738622169,0.482769817469476,1,4,positive regulation of peptidase activity,BP,FADD
2084,GO:0043280,0.870307738622169,0.482769817469476,1,4,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,FADD
3502,GO:2001056,0.870307738622169,0.482769817469476,1,4,positive regulation of cysteine-type endopeptidase activity,BP,FADD
1726,GO:0033993,0.870645296930512,0.317911887541876,3,13,response to lipid,BP,RBP4;TH;ABCG1
390,GO:0005773,0.871853447997152,0.360258695700282,2,9,vacuole,CC,TBC1D14;IFI30
2012,GO:0042802,0.872000637880225,0.276210883634319,5,19,identical protein binding,MF,HACL1;ACAT1;ABCG1;FADD;PTS
1702,GO:0033209,0.872334748871664,0.478696992705569,1,4,tumor necrosis factor-mediated signaling pathway,BP,PSMB10
1778,GO:0034612,0.872334748871664,0.478696992705569,1,4,response to tumor necrosis factor,BP,PSMB10
2978,GO:0071356,0.872334748871664,0.478696992705569,1,4,cellular response to tumor necrosis factor,BP,PSMB10
523,GO:0006641,0.872525423424053,0.478311761728045,1,4,triglyceride metabolic process,BP,PLA2G16
1734,GO:0034097,0.872600810086233,0.314511436360643,3,13,response to cytokine,BP,FADD;PSMB10;IFI30
2974,GO:0071345,0.872600810086233,0.314511436360643,3,13,cellular response to cytokine stimulus,BP,FADD;PSMB10;IFI30
2669,GO:0051248,0.874239075546297,0.362290364464637,2,8,negative regulation of protein metabolic process,BP,DEPTOR;PSMB10
2733,GO:0051704,0.874266425499383,0.31159908897026,3,13,multi-organism process,BP,TH;FADD;PSMB10
1779,GO:0034613,0.87491831594803,0.455345072586628,1,5,cellular protein localization,BP,TBC1D14
2932,GO:0070727,0.87491831594803,0.455345072586628,1,5,cellular macromolecule localization,BP,TBC1D14
2042,GO:0043086,0.880344029106012,0.350718631823334,2,8,negative regulation of catalytic activity,BP,DEPTOR;PSMB10
2145,GO:0044092,0.880344029106012,0.350718631823334,2,8,negative regulation of molecular function,BP,DEPTOR;PSMB10
911,GO:0010243,0.880709564675212,0.338693209298089,2,10,response to organonitrogen compound,BP,TH;FADD
854,GO:0009607,0.88286592144809,0.334561025065014,2,10,response to biotic stimulus,BP,TH;FADD
562,GO:0006753,0.88395743357444,0.337327920943411,2,9,nucleoside phosphate metabolic process,BP,ACAT1;NUDT7
808,GO:0009117,0.88395743357444,0.337327920943411,2,9,nucleotide metabolic process,BP,ACAT1;NUDT7
2209,GO:0044699,0.884863061299992,0.227607931502828,32,102,single-organism process,BP,HACL1;MSRA;ACAT1;MRPL14;PXK;RBP4;ACADVL;ACAA2;TH;NUDT7;ALG5;ABCG1;ACAT2;ECI1;KRT10;ETFDH;DEPTOR;FADD;PSMB10;TBC1D14;HNF1A;PTS;PLA2G16;LINGO1;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;PEPD;IFI30
714,GO:0008150,0.88585959946168,0.355135713748584,40,122,biological_process,BP,HACL1;MSRA;ACAT1;MRPL14;PXMP2;PXK;RBP4;ACADVL;CNIH4;ARL6IP4;ACAA2;TH;PUS1;NUDT7;TSFM;ALG5;ABCG1;ACAT2;ECI1;KRT10;ETFDH;DEPTOR;FADD;PSMB10;LYPLAL1;LAGE3;TBC1D14;NUDT6;HNF1A;PTS;PLA2G16;LINGO1;DECR1;FGF18;CPT1C;ZFYVE21;DPM3;ETFB;PEPD;IFI30
1532,GO:0031410,0.886847178896833,0.263072618461615,4,18,cytoplasmic vesicle,CC,TH;ABCG1;TBC1D14;ZFYVE21
3154,GO:0097708,0.886847178896833,0.263072618461615,4,18,intracellular vesicle,CC,TH;ABCG1;TBC1D14;ZFYVE21
1264,GO:0019217,0.886882609346193,0.429921144495729,1,5,regulation of fatty acid metabolic process,BP,ACADVL
87,GO:0001816,0.888347118076938,0.42670254606425,1,5,cytokine production,BP,FADD
732,GO:0008219,0.888800308631569,0.263323570320083,4,16,cell death,BP,ACAA2;KRT10;DEPTOR;FADD
1013,GO:0012501,0.888800308631569,0.263323570320083,4,16,programmed cell death,BP,ACAA2;KRT10;DEPTOR;FADD
1271,GO:0019318,0.890549711990037,0.421815606899054,1,5,hexose metabolic process,BP,RBP4
2303,GO:0045834,0.89088996753732,0.421055650077157,1,5,positive regulation of lipid metabolic process,BP,ABCG1
861,GO:0009636,0.893361846512454,0.415493604748427,1,5,response to toxic substance,BP,TH
934,GO:0010604,0.893399380484235,0.253270633747472,4,17,positive regulation of macromolecule metabolic process,BP,FADD;PSMB10;HNF1A;FGF18
1925,GO:0042180,0.893748991783964,0.317990326930525,2,9,cellular ketone metabolic process,BP,ACADVL;PSMB10
3077,GO:0080090,0.894136785198459,0.211996014919259,8,32,regulation of primary metabolic process,BP,ACADVL;TSFM;ABCG1;DEPTOR;FADD;PSMB10;HNF1A;FGF18
2775,GO:0055086,0.894179615558844,0.312319823622779,2,10,nucleobase-containing small molecule metabolic process,BP,ACAT1;NUDT7
1531,GO:0031406,0.895303985555863,0.411071894414219,1,5,carboxylic acid binding,MF,TH
2058,GO:0043177,0.895303985555863,0.411071894414219,1,5,organic acid binding,MF,TH
2487,GO:0048583,0.897008237383113,0.230487055400264,5,22,regulation of response to stimulus,BP,ACAA2;DEPTOR;FADD;PSMB10;FGF18
1,GO:0000003,0.897908679854164,0.309543272541137,2,9,reproduction,BP,RBP4;TH
1339,GO:0022414,0.897908679854164,0.309543272541137,2,9,reproductive process,BP,RBP4;TH
2488,GO:0048584,0.898344710627277,0.265111063679291,3,14,positive regulation of response to stimulus,BP,FADD;PSMB10;FGF18
1790,GO:0034655,0.899621482245765,0.401073735220865,1,5,nucleobase-containing compound catabolic process,BP,NUDT7
2604,GO:0050896,0.901589685974181,0.182013281846509,15,56,response to stimulus,BP,MSRA;ACAT1;PXK;RBP4;ACADVL;ACAA2;TH;ABCG1;ETFDH;DEPTOR;FADD;PSMB10;LINGO1;FGF18;IFI30
349,GO:0005506,0.902235644440553,0.383444719246318,1,6,iron ion binding,MF,TH
554,GO:0006732,0.902382016075909,0.257423265306392,3,14,coenzyme metabolic process,BP,ACAT1;NUDT7;PTS
2496,GO:0048608,0.903804257657401,0.391156547075323,1,5,reproductive structure development,BP,RBP4
2866,GO:0061458,0.903804257657401,0.391156547075323,1,5,reproductive system development,BP,RBP4
3178,GO:0098772,0.90427226750105,0.296333334930766,2,9,molecular function regulator,MF,TBC1D14;FGF18
2354,GO:0046434,0.904960000681918,0.388374626358441,1,5,organophosphate catabolic process,BP,NUDT7
330,GO:0005215,0.905598827267345,0.288832152274917,2,10,transporter activity,MF,RBP4;ABCG1
203,GO:0002790,0.90652001137684,0.384590139125249,1,5,peptide secretion,BP,RBP4
833,GO:0009306,0.90652001137684,0.384590139125249,1,5,protein secretion,BP,RBP4
2165,GO:0044272,0.906931371782036,0.364347095367862,1,7,sulfur compound biosynthetic process,BP,ACAT1
3265,GO:1901652,0.907819942148903,0.362178063897934,1,7,response to peptide,BP,TH
2163,GO:0044270,0.908571832091134,0.368119627517915,1,6,cellular nitrogen compound catabolic process,BP,NUDT7
2399,GO:0046700,0.908571832091134,0.368119627517915,1,6,heterocycle catabolic process,BP,NUDT7
1399,GO:0030162,0.90921233022219,0.285824465855138,2,9,regulation of proteolysis,BP,FADD;PSMB10
391,GO:0005775,0.910252257341918,0.375394605552808,1,5,vacuolar lumen,CC,IFI30
2191,GO:0044437,0.910252257341918,0.375394605552808,1,5,vacuolar part,CC,IFI30
3276,GO:1901698,0.910898467989916,0.273904950463782,2,11,response to nitrogen compound,BP,TH;FADD
3278,GO:1901700,0.911905526202778,0.236749352159608,3,15,response to oxygen-containing compound,BP,RBP4;TH;FADD
1695,GO:0033036,0.913703972926437,0.216100112694772,4,17,macromolecule localization,BP,RBP4;CNIH4;ABCG1;TBC1D14
1171,GO:0016705,0.914113910433926,0.354254385842491,1,6,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,TH
2217,GO:0044711,0.915173760573429,0.170260787257233,10,38,single-organism biosynthetic process,BP,ACAT1;RBP4;ACADVL;ACAA2;TH;ABCG1;ACAT2;PLA2G16;FGF18;DPM3
786,GO:0009058,0.915299706729447,0.159452676248711,17,59,biosynthetic process,BP,ACAT1;MRPL14;RBP4;ACADVL;ACAA2;TH;TSFM;ALG5;ABCG1;ACAT2;FADD;PSMB10;HNF1A;PTS;PLA2G16;FGF18;DPM3
1930,GO:0042221,0.916200989383416,0.168574828781762,10,38,response to chemical,BP,ACAT1;RBP4;ACADVL;ACAA2;TH;ABCG1;FADD;PSMB10;FGF18;IFI30
999,GO:0010941,0.916735499421351,0.231599731517173,3,13,regulation of cell death,BP,ACAA2;DEPTOR;FADD
2019,GO:0042981,0.916735499421351,0.231599731517173,3,13,regulation of apoptotic process,BP,ACAA2;DEPTOR;FADD
2038,GO:0043067,0.916735499421351,0.231599731517173,3,13,regulation of programmed cell death,BP,ACAA2;DEPTOR;FADD
569,GO:0006793,0.918608652294217,0.172162656075726,8,31,phosphorus metabolic process,BP,ACAT1;NUDT7;DEPTOR;PSMB10;PLA2G16;FGF18;ZFYVE21;DPM3
2030,GO:0043025,0.920145925039957,0.338634009523251,1,6,neuronal cell body,CC,TH
2129,GO:0043648,0.921236332180342,0.328055258134772,1,7,dicarboxylic acid metabolic process,BP,TH
2085,GO:0043281,0.921843881053219,0.34546096646781,1,5,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,FADD
3465,GO:2000116,0.921843881053219,0.34546096646781,1,5,regulation of cysteine-type endopeptidase activity,BP,FADD
935,GO:0010605,0.922036445774018,0.257400953110038,2,9,negative regulation of macromolecule metabolic process,BP,DEPTOR;PSMB10
3078,GO:0080134,0.922309549232933,0.248767024066354,2,11,regulation of response to stress,BP,FADD;PSMB10
885,GO:0009893,0.922344570491449,0.186188194353598,5,21,positive regulation of metabolic process,BP,ABCG1;FADD;PSMB10;HNF1A;FGF18
581,GO:0006820,0.923704315083826,0.329141260264164,1,6,anion transport,BP,ABCG1
1144,GO:0016491,0.923768176256437,0.174316883199712,6,25,oxidoreductase activity,MF,MSRA;ACADVL;TH;ETFDH;DECR1;IFI30
2650,GO:0051186,0.923951111502224,0.212326154185268,3,15,cofactor metabolic process,BP,ACAT1;NUDT7;PTS
2666,GO:0051241,0.925248500998868,0.249998442132676,2,9,negative regulation of multicellular organismal process,BP,RBP4;LINGO1
1511,GO:0031328,0.925892558939014,0.240589831379012,2,11,positive regulation of cellular biosynthetic process,BP,FADD;HNF1A
1300,GO:0019725,0.92593604595743,0.323075991958657,1,6,cellular homeostasis,BP,TH
2773,GO:0055082,0.92593604595743,0.323075991958657,1,6,cellular chemical homeostasis,BP,TH
521,GO:0006638,0.926712455855659,0.332204569412314,1,5,neutral lipid metabolic process,BP,PLA2G16
522,GO:0006639,0.926712455855659,0.332204569412314,1,5,acylglycerol metabolic process,BP,PLA2G16
1509,GO:0031326,0.927418699750178,0.166959397937023,6,26,regulation of cellular biosynthetic process,BP,ACADVL;TSFM;ABCG1;FADD;PSMB10;HNF1A
2644,GO:0051171,0.930741552858569,0.169300217297582,5,22,regulation of nitrogen compound metabolic process,BP,TSFM;ABCG1;FADD;PSMB10;HNF1A
137,GO:0002252,0.933405911520332,0.222952688762556,2,11,immune effector process,BP,RBP4;FADD
1355,GO:0022857,0.935849111127418,0.287519192829194,1,7,transmembrane transporter activity,MF,ABCG1
1267,GO:0019220,0.937961870848934,0.215197854960581,2,10,regulation of phosphate metabolic process,BP,DEPTOR;FGF18
420,GO:0005996,0.938381511087795,0.28750753675139,1,6,monosaccharide metabolic process,BP,RBP4
674,GO:0007548,0.938849912303593,0.286105796212759,1,6,sex differentiation,BP,RBP4
2774,GO:0055085,0.94099607977649,0.201799529952679,2,12,transmembrane transport,BP,ABCG1;PSMB10
2190,GO:0044433,0.941044285094626,0.201679755556394,2,12,cytoplasmic vesicle part,CC,TH;ZFYVE21
135,GO:0002237,0.941334183323672,0.271220743835218,1,7,response to molecule of bacterial origin,BP,TH
858,GO:0009617,0.941334183323672,0.271220743835218,1,7,response to bacterium,BP,TH
1613,GO:0032496,0.941334183323672,0.271220743835218,1,7,response to lipopolysaccharide,BP,TH
2155,GO:0044249,0.941561028933148,0.118753529425103,14,52,cellular biosynthetic process,BP,ACAT1;MRPL14;ACADVL;TH;TSFM;ALG5;ABCG1;FADD;PSMB10;HNF1A;PTS;PLA2G16;FGF18;DPM3
645,GO:0007249,0.942191746161552,0.275958302518938,1,6,I-kappaB kinase/NF-kappaB signaling,BP,FADD
2049,GO:0043122,0.942191746161552,0.275958302518938,1,6,regulation of I-kappaB kinase/NF-kappaB signaling,BP,FADD
881,GO:0009889,0.942835027062579,0.137347331086946,6,27,regulation of biosynthetic process,BP,ACADVL;TSFM;ABCG1;FADD;PSMB10;HNF1A
517,GO:0006633,0.946271043077437,0.250764239708235,1,8,fatty acid biosynthetic process,BP,ACADVL
2750,GO:0052547,0.946409819621047,0.262762132097815,1,6,regulation of peptidase activity,BP,FADD
2751,GO:0052548,0.946409819621047,0.262762132097815,1,6,regulation of endopeptidase activity,BP,FADD
614,GO:0006954,0.949217499931167,0.241434390383561,1,8,inflammatory response,BP,PXK
2647,GO:0051174,0.950038828887154,0.18115342783572,2,11,regulation of phosphorus metabolic process,BP,DEPTOR;FGF18
606,GO:0006915,0.953641356775857,0.146081017645034,3,15,apoptotic process,BP,ACAA2;DEPTOR;FADD
1679,GO:0032880,0.954357271028974,0.236580887818621,1,6,regulation of protein localization,BP,RBP4
2660,GO:0051223,0.954357271028974,0.236580887818621,1,6,regulation of protein transport,BP,RBP4
2887,GO:0070201,0.954357271028974,0.236580887818621,1,6,regulation of establishment of protein localization,BP,RBP4
3086,GO:0090087,0.954357271028974,0.236580887818621,1,6,regulation of peptide transport,BP,RBP4
1419,GO:0030234,0.955987603153315,0.224057997517275,1,7,enzyme regulator activity,MF,TBC1D14
1000,GO:0010942,0.956707484154106,0.228468758538784,1,6,positive regulation of cell death,BP,FADD
2036,GO:0043065,0.956707484154106,0.228468758538784,1,6,positive regulation of apoptotic process,BP,FADD
2039,GO:0043068,0.956707484154106,0.228468758538784,1,6,positive regulation of programmed cell death,BP,FADD
3143,GO:0097367,0.957476230602202,0.210334004624401,1,9,carbohydrate derivative binding,MF,ABCG1
151,GO:0002443,0.957724516409336,0.21805662978748,1,7,leukocyte mediated immunity,BP,FADD
2120,GO:0043603,0.958969996671735,0.154505642323509,2,12,cellular amide metabolic process,BP,MRPL14;TSFM
1797,GO:0034754,0.959397660860415,0.21218009979694,1,7,cellular hormone metabolic process,BP,RBP4
3253,GO:1901565,0.960189324100171,0.151076906194778,2,12,organonitrogen compound catabolic process,BP,ACAT1;NUDT7
3234,GO:1901136,0.960297195630796,0.208980380516918,1,7,carbohydrate derivative catabolic process,BP,NUDT7
2579,GO:0050801,0.960766278595358,0.202503855258049,1,8,ion homeostasis,BP,ABCG1
2211,GO:0044702,0.960886117661157,0.206869798736691,1,7,single organism reproductive process,BP,RBP4
212,GO:0003006,0.961145282571527,0.205936988313587,1,7,developmental process involved in reproduction,BP,RBP4
928,GO:0010562,0.962254873138557,0.201914964945063,1,7,positive regulation of phosphorus metabolic process,BP,FGF18
2320,GO:0045937,0.962254873138557,0.201914964945063,1,7,positive regulation of phosphate metabolic process,BP,FGF18
1970,GO:0042493,0.963590380087134,0.192319929101494,1,8,response to drug,BP,TH
1014,GO:0012505,0.964214051929998,0.0846494058412831,9,37,endomembrane system,CC,CNIH4;TH;ALG5;ABCG1;TBC1D14;PLA2G16;CPT1C;ZFYVE21;DPM3
2872,GO:0065007,0.965035805587359,0.0755436818673327,18,68,biological regulation,BP,PXK;RBP4;ACADVL;ACAA2;TH;TSFM;ABCG1;DEPTOR;FADD;PSMB10;TBC1D14;HNF1A;PTS;PLA2G16;LINGO1;FGF18;DPM3;IFI30
27,GO:0000323,0.966097278602199,0.187612945061026,1,7,lytic vacuole,CC,IFI30
385,GO:0005764,0.966097278602199,0.187612945061026,1,7,lysosome,CC,IFI30
3248,GO:1901361,0.966880368470986,0.180067098371212,1,8,organic cyclic compound catabolic process,BP,NUDT7
1287,GO:0019439,0.9677913697163,0.1765944685385,1,8,aromatic compound catabolic process,BP,NUDT7
1508,GO:0031325,0.968371552619008,0.0965194453528442,4,20,positive regulation of cellular metabolic process,BP,FADD;PSMB10;HNF1A;FGF18
3195,GO:0099503,0.970811247633136,0.164813768204784,1,8,secretory vesicle,CC,TH
3047,GO:0072330,0.971070309222836,0.158008516068187,1,10,monocarboxylic acid biosynthetic process,BP,ACADVL
2224,GO:0044765,0.971533963760648,0.0880797771485659,4,21,single-organism transport,BP,RBP4;TH;ABCG1;HNF1A
3321,GO:1902578,0.971533963760648,0.0880797771485659,4,21,single-organism localization,BP,RBP4;TH;ABCG1;HNF1A
882,GO:0009890,0.971552643488207,0.166185240933139,1,7,negative regulation of biosynthetic process,BP,ACADVL
1510,GO:0031327,0.971552643488207,0.166185240933139,1,7,negative regulation of cellular biosynthetic process,BP,ACADVL
969,GO:0010817,0.971936549395783,0.160311217474388,1,8,regulation of hormone levels,BP,RBP4
1962,GO:0042445,0.971936549395783,0.160311217474388,1,8,hormone metabolic process,BP,RBP4
705,GO:0008092,0.974614754105326,0.14932576549897,1,8,cytoskeletal protein binding,MF,PXK
615,GO:0006955,0.976260369002999,0.0849564706890095,3,17,immune response,BP,FADD;PSMB10;IFI30
85,GO:0001775,0.976690943535262,0.137521030282818,1,9,cell activation,BP,FADD
2256,GO:0045321,0.976690943535262,0.137521030282818,1,9,leukocyte activation,BP,FADD
418,GO:0005975,0.977078970048881,0.0981405833004852,2,13,carbohydrate metabolic process,BP,RBP4;DPM3
3279,GO:1901701,0.978450710153981,0.12589745921813,1,11,cellular response to oxygen-containing compound,BP,TH
147,GO:0002376,0.986172489940147,0.0485199789984327,4,22,immune system process,BP,RBP4;FADD;PSMB10;IFI30
1101,GO:0016053,0.988495230371616,0.0777088376563055,1,12,organic acid biosynthetic process,BP,ACADVL
2349,GO:0046394,0.988495230371616,0.0777088376563055,1,12,carboxylic acid biosynthetic process,BP,ACADVL
1681,GO:0032940,0.988688537237498,0.0791335610746518,1,10,secretion by cell,BP,RBP4
2417,GO:0046903,0.988688537237498,0.0791335610746518,1,10,secretion,BP,RBP4
2475,GO:0048518,0.989435215220115,0.0332637068975663,6,31,positive regulation of biological process,BP,RBP4;ABCG1;FADD;PSMB10;HNF1A;FGF18
2219,GO:0044723,0.989978387393107,0.0722140705629862,1,10,single-organism carbohydrate metabolic process,BP,RBP4
576,GO:0006811,0.990838034087987,0.0662568719633769,1,11,ion transport,BP,ABCG1
2477,GO:0048522,0.991843557816545,0.0283342742626677,5,28,positive regulation of cellular process,BP,RBP4;FADD;PSMB10;HNF1A;FGF18
3,GO:0000038,1,0.762488370432474,0,1,very long-chain fatty acid metabolic process,BP,
4,GO:0000041,1,0.64381053571965,0,1,transition metal ion transport,BP,
8,GO:0000097,1,0.747143336113352,0,1,sulfur amino acid biosynthetic process,BP,
9,GO:0000122,1,0.567926568876566,0,1,negative regulation of transcription from RNA polymerase II promoter,BP,
13,GO:0000187,1,0.859384162384488,0,1,activation of MAPK activity,BP,
15,GO:0000245,1,0.616295371802482,0,1,spliceosomal complex assembly,BP,
16,GO:0000247,1,0.600923415171073,0,1,C-8 sterol isomerase activity,MF,
17,GO:0000248,1,0.864847534366939,0,1,C-5 sterol desaturase activity,MF,
18,GO:0000255,1,0.859384162384488,0,1,allantoin metabolic process,BP,
22,GO:0000302,1,0.464582333323742,0,2,response to reactive oxygen species,BP,
23,GO:0000303,1,0.655086466259755,0,1,response to superoxide,BP,
24,GO:0000305,1,0.655086466259755,0,1,response to oxygen radical,BP,
28,GO:0000375,1,0.616295371802482,0,1,RNA splicing, via transesterification reactions,BP,
29,GO:0000377,1,0.616295371802482,0,1,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,
30,GO:0000398,1,0.616295371802482,0,1,mRNA splicing, via spliceosome,BP,
34,GO:0000922,1,0.821441120987107,0,1,spindle pole,CC,
35,GO:0000932,1,0.859384162384488,0,1,P-body,CC,
43,GO:0000988,1,0.366288549121611,0,2,transcription factor activity, protein binding,MF,
44,GO:0000989,1,0.366288549121611,0,2,transcription factor activity, transcription factor binding,MF,
49,GO:0001085,1,0.567926568876566,0,1,RNA polymerase II transcription factor binding,MF,
51,GO:0001102,1,0.567926568876566,0,1,RNA polymerase II activating transcription factor binding,MF,
55,GO:0001504,1,0.79420415032525,0,1,neurotransmitter uptake,BP,
57,GO:0001510,1,0.587339765995185,0,1,RNA methylation,BP,
62,GO:0001541,1,0.589082786340178,0,1,ovarian follicle development,BP,
63,GO:0001556,1,0.589082786340178,0,1,oocyte maturation,BP,
66,GO:0001573,1,0.653661854217472,0,1,ganglioside metabolic process,BP,
67,GO:0001608,1,0.704636963882892,0,1,G-protein coupled nucleotide receptor activity,MF,
68,GO:0001614,1,0.704636963882892,0,1,purinergic nucleotide receptor activity,MF,
69,GO:0001650,1,0.747143336113352,0,1,fibrillar center,CC,
77,GO:0001669,1,0.653661854217472,0,1,acrosomal vesicle,CC,
78,GO:0001676,1,0.65854791730691,0,2,long-chain fatty acid metabolic process,BP,
80,GO:0001726,1,0.599447363464003,0,1,ruffle,CC,
84,GO:0001773,1,0.583640461943381,0,1,myeloid dendritic cell activation,BP,
89,GO:0001818,1,0.36173012831955,0,2,negative regulation of cytokine production,BP,
92,GO:0001836,1,0.357630949940387,0,2,release of cytochrome c from mitochondria,BP,
93,GO:0001848,1,0.709208929974408,0,1,complement binding,MF,
94,GO:0001882,1,0.477338019508531,0,2,nucleoside binding,MF,
95,GO:0001883,1,0.692483461339883,0,1,purine nucleoside binding,MF,
97,GO:0001890,1,0.589082786340178,0,1,placenta development,BP,
109,GO:0001935,1,0.589082786340178,0,1,endothelial cell proliferation,BP,
110,GO:0001936,1,0.589082786340178,0,1,regulation of endothelial cell proliferation,BP,
111,GO:0001938,1,0.589082786340178,0,1,positive regulation of endothelial cell proliferation,BP,
112,GO:0001942,1,0.623289805927393,0,1,hair follicle development,BP,
117,GO:0001960,1,0.616295371802482,0,1,negative regulation of cytokine-mediated signaling pathway,BP,
120,GO:0001974,1,0.616295371802482,0,1,blood vessel remodeling,BP,
124,GO:0002028,1,0.560477493310972,0,1,regulation of sodium ion transport,BP,
125,GO:0002054,1,0.691634315525481,0,1,nucleobase binding,MF,
126,GO:0002060,1,0.691634315525481,0,1,purine nucleobase binding,MF,
140,GO:0002263,1,0.0467074893110455,0,7,cell activation involved in immune response,BP,
141,GO:0002274,1,0.0371669493980328,0,8,myeloid leukocyte activation,BP,
142,GO:0002275,1,0.0467074893110455,0,7,myeloid cell activation involved in immune response,BP,
143,GO:0002277,1,0.583640461943381,0,1,myeloid dendritic cell activation involved in immune response,BP,
144,GO:0002281,1,0.713969292256814,0,1,macrophage activation involved in immune response,BP,
145,GO:0002283,1,0.0669370568571096,0,6,neutrophil activation involved in immune response,BP,
146,GO:0002366,1,0.0467074893110455,0,7,leukocyte activation involved in immune response,BP,
152,GO:0002444,1,0.0669370568571096,0,6,myeloid leukocyte mediated immunity,BP,
153,GO:0002446,1,0.0669370568571096,0,6,neutrophil mediated immunity,BP,
164,GO:0002526,1,0.709208929974408,0,1,acute inflammatory response,BP,
166,GO:0002577,1,0.583640461943381,0,1,regulation of antigen processing and presentation,BP,
167,GO:0002579,1,0.583640461943381,0,1,positive regulation of antigen processing and presentation,BP,
168,GO:0002580,1,0.583640461943381,0,1,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
169,GO:0002582,1,0.583640461943381,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
170,GO:0002583,1,0.583640461943381,0,1,regulation of antigen processing and presentation of peptide antigen,BP,
171,GO:0002585,1,0.583640461943381,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
172,GO:0002586,1,0.583640461943381,0,1,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
173,GO:0002588,1,0.583640461943381,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
176,GO:0002673,1,0.709208929974408,0,1,regulation of acute inflammatory response,BP,
210,GO:0002920,1,0.709208929974408,0,1,regulation of humoral immune response,BP,
211,GO:0002931,1,0.616295371802482,0,1,response to ischemia,BP,
215,GO:0003012,1,0.207852721596308,0,3,muscle system process,BP,
221,GO:0003333,1,0.79420415032525,0,1,amino acid transmembrane transport,BP,
227,GO:0003712,1,0.366288549121611,0,2,transcription cofactor activity,MF,
228,GO:0003713,1,0.590930005023909,0,1,transcription coactivator activity,MF,
230,GO:0003729,1,0.719242044270235,0,1,mRNA binding,MF,
231,GO:0003730,1,0.719242044270235,0,1,mRNA 3'-UTR binding,MF,
236,GO:0003854,1,0.641908063478118,0,1,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
237,GO:0003857,1,0.587339765995185,0,1,3-hydroxyacyl-CoA dehydrogenase activity,MF,
238,GO:0003858,1,0.732102610026488,0,1,3-hydroxybutyrate dehydrogenase activity,MF,
240,GO:0003940,1,0.674865017619115,0,1,L-iduronidase activity,MF,
244,GO:0003993,1,0.630292050615999,0,1,acid phosphatase activity,MF,
246,GO:0003996,1,0.468621401168997,0,2,acyl-CoA ligase activity,MF,
247,GO:0004031,1,0.918333225139973,0,1,aldehyde oxidase activity,MF,
248,GO:0004033,1,0.578797687193198,0,1,aldo-keto reductase (NADP) activity,MF,
249,GO:0004064,1,0.634317961549412,0,1,arylesterase activity,MF,
251,GO:0004129,1,0.578797687193198,0,1,cytochrome-c oxidase activity,MF,
252,GO:0004139,1,0.640583205088349,0,1,deoxyribose-phosphate aldolase activity,MF,
259,GO:0004197,1,0.355678835293696,0,2,cysteine-type endopeptidase activity,MF,
260,GO:0004252,1,0.709208929974408,0,1,serine-type endopeptidase activity,MF,
263,GO:0004303,1,0.651257914139894,0,1,estradiol 17-beta-dehydrogenase activity,MF,
264,GO:0004312,1,0.762488370432474,0,1,fatty acid synthase activity,MF,
265,GO:0004321,1,0.692483461339883,0,1,fatty-acyl-CoA synthase activity,MF,
266,GO:0004341,1,0.655086466259755,0,1,gluconolactonase activity,MF,
267,GO:0004364,1,0.577407483649635,0,1,glutathione transferase activity,MF,
268,GO:0004448,1,0.685412997987241,0,1,isocitrate dehydrogenase activity,MF,
269,GO:0004450,1,0.685412997987241,0,1,isocitrate dehydrogenase (NADP+) activity,MF,
270,GO:0004457,1,0.663180137854112,0,1,lactate dehydrogenase activity,MF,
271,GO:0004458,1,0.663180137854112,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
272,GO:0004464,1,0.577407483649635,0,1,leukotriene-C4 synthase activity,MF,
274,GO:0004470,1,0.608833693873605,0,1,malic enzyme activity,MF,
276,GO:0004505,1,0.590930005023909,0,1,phenylalanine 4-monooxygenase activity,MF,
277,GO:0004508,1,0.650967119323947,0,1,steroid 17-alpha-monooxygenase activity,MF,
279,GO:0004518,1,0.492970366688253,0,2,nuclease activity,MF,
280,GO:0004519,1,0.492970366688253,0,2,endonuclease activity,MF,
281,GO:0004521,1,0.839081013955894,0,1,endoribonuclease activity,MF,
282,GO:0004540,1,0.492970366688253,0,2,ribonuclease activity,MF,
283,GO:0004553,1,0.269483595517061,0,3,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,
284,GO:0004557,1,0.618986977187954,0,1,alpha-galactosidase activity,MF,
285,GO:0004563,1,0.653661854217472,0,1,beta-N-acetylhexosaminidase activity,MF,
289,GO:0004601,1,0.577407483649635,0,1,peroxidase activity,MF,
290,GO:0004602,1,0.577407483649635,0,1,glutathione peroxidase activity,MF,
296,GO:0004721,1,0.569963413166498,0,1,phosphoprotein phosphatase activity,MF,
297,GO:0004725,1,0.569963413166498,0,1,protein tyrosine phosphatase activity,MF,
299,GO:0004731,1,0.691634315525481,0,1,purine-nucleoside phosphorylase activity,MF,
300,GO:0004740,1,0.798192256085599,0,1,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
301,GO:0004769,1,0.383773361883214,0,2,steroid delta-isomerase activity,MF,
302,GO:0004854,1,0.918333225139973,0,1,xanthine dehydrogenase activity,MF,
303,GO:0004857,1,0.236537745092976,0,3,enzyme inhibitor activity,MF,
304,GO:0004859,1,0.555979667472001,0,1,phospholipase inhibitor activity,MF,
305,GO:0004866,1,0.430204914310017,0,2,endopeptidase inhibitor activity,MF,
306,GO:0004867,1,0.700914309098006,0,1,serine-type endopeptidase inhibitor activity,MF,
307,GO:0004869,1,0.616295371802482,0,1,cysteine-type endopeptidase inhibitor activity,MF,
308,GO:0004871,1,0.0936804449601742,0,7,signal transducer activity,MF,
309,GO:0004872,1,0.338744046042821,0,4,receptor activity,MF,
310,GO:0004888,1,0.338744046042821,0,4,transmembrane signaling receptor activity,MF,
311,GO:0004896,1,0.859384162384488,0,1,cytokine receptor activity,MF,
312,GO:0004930,1,0.704636963882892,0,1,G-protein coupled receptor activity,MF,
313,GO:0004970,1,0.941673510689999,0,1,ionotropic glutamate receptor activity,MF,
314,GO:0004971,1,0.941673510689999,0,1,AMPA glutamate receptor activity,MF,
315,GO:0005057,1,0.65227670309888,0,1,signal transducer activity, downstream of receptor,MF,
325,GO:0005138,1,0.583640461943381,0,1,interleukin-6 receptor binding,MF,
327,GO:0005158,1,0.65227670309888,0,1,insulin receptor binding,MF,
331,GO:0005216,1,0.526897073579373,0,2,ion channel activity,MF,
332,GO:0005230,1,0.941673510689999,0,1,extracellular ligand-gated ion channel activity,MF,
333,GO:0005231,1,0.941673510689999,0,1,excitatory extracellular ligand-gated ion channel activity,MF,
334,GO:0005234,1,0.941673510689999,0,1,extracellular-glutamate-gated ion channel activity,MF,
335,GO:0005253,1,0.560477493310972,0,1,anion channel activity,MF,
336,GO:0005254,1,0.560477493310972,0,1,chloride channel activity,MF,
337,GO:0005261,1,0.941673510689999,0,1,cation channel activity,MF,
338,GO:0005310,1,0.79420415032525,0,1,dicarboxylic acid transmembrane transporter activity,MF,
339,GO:0005313,1,0.79420415032525,0,1,L-glutamate transmembrane transporter activity,MF,
340,GO:0005314,1,0.79420415032525,0,1,high-affinity glutamate transmembrane transporter activity,MF,
342,GO:0005324,1,0.596972964066786,0,1,long-chain fatty acid transporter activity,MF,
343,GO:0005342,1,0.79420415032525,0,1,organic acid transmembrane transporter activity,MF,
344,GO:0005375,1,0.64381053571965,0,1,copper ion transmembrane transporter activity,MF,
348,GO:0005504,1,0.329743218610697,0,2,fatty acid binding,MF,
350,GO:0005507,1,0.589082786340178,0,1,copper ion binding,MF,
351,GO:0005509,1,0.16605019238323,0,4,calcium ion binding,MF,
353,GO:0005521,1,0.567926568876566,0,1,lamin binding,MF,
354,GO:0005523,1,0.355418010872913,0,2,tropomyosin binding,MF,
356,GO:0005525,1,0.692483461339883,0,1,GTP binding,MF,
357,GO:0005539,1,0.589082786340178,0,1,glycosaminoglycan binding,MF,
359,GO:0005544,1,0.705187209057733,0,1,calcium-dependent phospholipid binding,MF,
360,GO:0005546,1,0.752322012235064,0,1,phosphatidylinositol-4,5-bisphosphate binding,MF,
365,GO:0005604,1,0.589082786340178,0,1,basement membrane,CC,
366,GO:0005605,1,0.589082786340178,0,1,basal lamina,CC,
371,GO:0005635,1,0.135520132356712,0,4,nuclear envelope,CC,
372,GO:0005637,1,0.567926568876566,0,1,nuclear inner membrane,CC,
373,GO:0005640,1,0.710514904531027,0,1,nuclear outer membrane,CC,
381,GO:0005758,1,0.455172482657657,0,2,mitochondrial intermembrane space,CC,
386,GO:0005766,1,0.232470457655634,0,3,primary lysosome,CC,
388,GO:0005769,1,0.752322012235064,0,1,early endosome,CC,
389,GO:0005770,1,0.64381053571965,0,1,late endosome,CC,
401,GO:0005811,1,0.380906983751945,0,2,lipid particle,CC,
403,GO:0005819,1,0.821441120987107,0,1,spindle,CC,
408,GO:0005865,1,0.612519110445417,0,1,striated muscle thin filament,CC,
409,GO:0005874,1,0.821441120987107,0,1,microtubule,CC,
413,GO:0005890,1,0.560477493310972,0,1,sodium:potassium-exchanging ATPase complex,CC,
417,GO:0005938,1,0.821441120987107,0,1,cell cortex,CC,
419,GO:0005984,1,0.674865017619115,0,1,disaccharide metabolic process,BP,
422,GO:0006011,1,0.613341072417478,0,1,UDP-glucose metabolic process,BP,
423,GO:0006012,1,0.613341072417478,0,1,galactose metabolic process,BP,
424,GO:0006022,1,0.361689608665274,0,3,aminoglycan metabolic process,BP,
425,GO:0006023,1,0.826942722683401,0,1,aminoglycan biosynthetic process,BP,
426,GO:0006024,1,0.826942722683401,0,1,glycosaminoglycan biosynthetic process,BP,
427,GO:0006026,1,0.439379228515079,0,2,aminoglycan catabolic process,BP,
428,GO:0006027,1,0.439379228515079,0,2,glycosaminoglycan catabolic process,BP,
429,GO:0006029,1,0.361689608665274,0,3,proteoglycan metabolic process,BP,
431,GO:0006081,1,0.352805065061302,0,3,cellular aldehyde metabolic process,BP,
435,GO:0006086,1,0.798192256085599,0,1,acetyl-CoA biosynthetic process from pyruvate,BP,
436,GO:0006090,1,0.798192256085599,0,1,pyruvate metabolic process,BP,
439,GO:0006097,1,0.685412997987241,0,1,glyoxylate cycle,BP,
440,GO:0006098,1,0.517995302719917,0,2,pentose-phosphate shunt,BP,
441,GO:0006099,1,0.415475209216131,0,2,tricarboxylic acid cycle,BP,
442,GO:0006101,1,0.355565779713859,0,3,citrate metabolic process,BP,
443,GO:0006102,1,0.685412997987241,0,1,isocitrate metabolic process,BP,
444,GO:0006103,1,0.37171574891781,0,3,2-oxoglutarate metabolic process,BP,
445,GO:0006105,1,0.859384162384488,0,1,succinate metabolic process,BP,
446,GO:0006107,1,0.522018332943839,0,2,oxaloacetate metabolic process,BP,
447,GO:0006108,1,0.608833693873605,0,1,malate metabolic process,BP,
448,GO:0006109,1,0.521525279218897,0,2,regulation of carbohydrate metabolic process,BP,
450,GO:0006140,1,0.578183005063771,0,1,regulation of nucleotide metabolic process,BP,
451,GO:0006144,1,0.918333225139973,0,1,purine nucleobase metabolic process,BP,
452,GO:0006145,1,0.918333225139973,0,1,purine nucleobase catabolic process,BP,
453,GO:0006148,1,0.691634315525481,0,1,inosine catabolic process,BP,
454,GO:0006152,1,0.691634315525481,0,1,purine nucleoside catabolic process,BP,
457,GO:0006171,1,0.578183005063771,0,1,cAMP biosynthetic process,BP,
459,GO:0006258,1,0.613341072417478,0,1,UDP-glucose catabolic process,BP,
460,GO:0006259,1,0.391418498521638,0,2,DNA metabolic process,BP,
461,GO:0006260,1,0.600453374364825,0,1,DNA replication,BP,
462,GO:0006308,1,0.655086466259755,0,1,DNA catabolic process,BP,
468,GO:0006364,1,0.839081013955894,0,1,rRNA processing,BP,
471,GO:0006376,1,0.616295371802482,0,1,mRNA splice site selection,BP,
484,GO:0006470,1,0.371385064509245,0,2,protein dephosphorylation,BP,
497,GO:0006536,1,0.79420415032525,0,1,glutamate metabolic process,BP,
498,GO:0006537,1,0.79420415032525,0,1,glutamate biosynthetic process,BP,
502,GO:0006558,1,0.590930005023909,0,1,L-phenylalanine metabolic process,BP,
503,GO:0006559,1,0.590930005023909,0,1,L-phenylalanine catabolic process,BP,
505,GO:0006573,1,0.859384162384488,0,1,valine metabolic process,BP,
507,GO:0006576,1,0.764401591462327,0,1,cellular biogenic amine metabolic process,BP,
511,GO:0006600,1,0.859384162384488,0,1,creatine metabolic process,BP,
512,GO:0006605,1,0.616295371802482,0,1,protein targeting,BP,
513,GO:0006606,1,0.616295371802482,0,1,protein import into nucleus,BP,
514,GO:0006611,1,0.567926568876566,0,1,protein export from nucleus,BP,
519,GO:0006636,1,0.864847534366939,0,1,unsaturated fatty acid biosynthetic process,BP,
527,GO:0006651,1,0.589082786340178,0,1,diacylglycerol biosynthetic process,BP,
528,GO:0006656,1,0.596972964066786,0,1,phosphatidylcholine biosynthetic process,BP,
534,GO:0006672,1,0.275170728913175,0,3,ceramide metabolic process,BP,
535,GO:0006677,1,0.618986977187954,0,1,glycosylceramide metabolic process,BP,
536,GO:0006687,1,0.402714433748352,0,2,glycosphingolipid metabolic process,BP,
537,GO:0006689,1,0.653661854217472,0,1,ganglioside catabolic process,BP,
538,GO:0006690,1,0.313557450150904,0,3,icosanoid metabolic process,BP,
539,GO:0006691,1,0.577407483649635,0,1,leukotriene metabolic process,BP,
542,GO:0006699,1,0.711704209234577,0,1,bile acid biosynthetic process,BP,
543,GO:0006700,1,0.466885825493178,0,2,C21-steroid hormone biosynthetic process,BP,
544,GO:0006702,1,0.247039560676311,0,3,androgen biosynthetic process,BP,
545,GO:0006703,1,0.461848476223235,0,2,estrogen biosynthetic process,BP,
546,GO:0006704,1,0.416014474614587,0,2,glucocorticoid biosynthetic process,BP,
547,GO:0006705,1,0.641908063478118,0,1,mineralocorticoid biosynthetic process,BP,
548,GO:0006706,1,0.651257914139894,0,1,steroid catabolic process,BP,
549,GO:0006710,1,0.651257914139894,0,1,androgen catabolic process,BP,
555,GO:0006733,1,0.0891618066743344,0,6,oxidoreduction coenzyme metabolic process,BP,
556,GO:0006734,1,0.608833693873605,0,1,NADH metabolic process,BP,
557,GO:0006738,1,0.691634315525481,0,1,nicotinamide riboside catabolic process,BP,
558,GO:0006739,1,0.352805065061302,0,3,NADP metabolic process,BP,
559,GO:0006740,1,0.685412997987241,0,1,NADPH regeneration,BP,
560,GO:0006749,1,0.393873559338259,0,2,glutathione metabolic process,BP,
561,GO:0006750,1,0.577407483649635,0,1,glutathione biosynthetic process,BP,
563,GO:0006766,1,0.139340156691568,0,5,vitamin metabolic process,BP,
564,GO:0006767,1,0.215013445381918,0,4,water-soluble vitamin metabolic process,BP,
565,GO:0006771,1,0.630292050615999,0,1,riboflavin metabolic process,BP,
566,GO:0006775,1,0.658312207785409,0,1,fat-soluble vitamin metabolic process,BP,
567,GO:0006778,1,0.732102610026488,0,1,porphyrin-containing compound metabolic process,BP,
571,GO:0006801,1,0.655086466259755,0,1,superoxide metabolic process,BP,
572,GO:0006805,1,0.337787899847262,0,3,xenobiotic metabolic process,BP,
574,GO:0006809,1,0.286008402283601,0,3,nitric oxide biosynthetic process,BP,
577,GO:0006812,1,0.0797592550821367,0,5,cation transport,BP,
578,GO:0006814,1,0.560477493310972,0,1,sodium ion transport,BP,
579,GO:0006816,1,0.401830738437191,0,2,calcium ion transport,BP,
580,GO:0006818,1,0.578797687193198,0,1,hydrogen transport,BP,
582,GO:0006821,1,0.560477493310972,0,1,chloride transport,BP,
583,GO:0006825,1,0.64381053571965,0,1,copper ion transport,BP,
584,GO:0006835,1,0.79420415032525,0,1,dicarboxylic acid transport,BP,
587,GO:0006853,1,0.74593727007522,0,1,carnitine shuttle,BP,
588,GO:0006855,1,0.600923415171073,0,1,drug transmembrane transport,BP,
589,GO:0006865,1,0.79420415032525,0,1,amino acid transport,BP,
591,GO:0006873,1,0.165272908964229,0,4,cellular ion homeostasis,BP,
592,GO:0006874,1,0.260295466360574,0,3,cellular calcium ion homeostasis,BP,
593,GO:0006875,1,0.165272908964229,0,4,cellular metal ion homeostasis,BP,
594,GO:0006878,1,0.64381053571965,0,1,cellular copper ion homeostasis,BP,
595,GO:0006885,1,0.798192256085599,0,1,regulation of pH,BP,
597,GO:0006887,1,0.0461030329033915,0,7,exocytosis,BP,
599,GO:0006897,1,0.275539143225617,0,3,endocytosis,BP,
600,GO:0006898,1,0.555979667472001,0,1,receptor-mediated endocytosis,BP,
602,GO:0006907,1,0.583640461943381,0,1,pinocytosis,BP,
603,GO:0006909,1,0.583640461943381,0,1,phagocytosis,BP,
604,GO:0006913,1,0.347915894904772,0,2,nucleocytoplasmic transport,BP,
611,GO:0006936,1,0.341185751606592,0,2,muscle contraction,BP,
616,GO:0006956,1,0.709208929974408,0,1,complement activation,BP,
617,GO:0006957,1,0.709208929974408,0,1,complement activation, alternative pathway,BP,
620,GO:0006974,1,0.583640461943381,0,1,cellular response to DNA damage stimulus,BP,
626,GO:0007010,1,0.206860194262745,0,3,cytoskeleton organization,BP,
627,GO:0007015,1,0.206860194262745,0,3,actin filament organization,BP,
630,GO:0007040,1,0.653661854217472,0,1,lysosome organization,BP,
640,GO:0007173,1,0.65227670309888,0,1,epidermal growth factor receptor signaling pathway,BP,
641,GO:0007186,1,0.495364190148486,0,2,G-protein coupled receptor signaling pathway,BP,
642,GO:0007202,1,0.589082786340178,0,1,activation of phospholipase C activity,BP,
643,GO:0007204,1,0.616295371802482,0,1,positive regulation of cytosolic calcium ion concentration,BP,
644,GO:0007215,1,0.941673510689999,0,1,glutamate receptor signaling pathway,BP,
646,GO:0007254,1,0.583640461943381,0,1,JNK cascade,BP,
647,GO:0007259,1,0.53446429230772,0,2,JAK-STAT cascade,BP,
648,GO:0007260,1,0.859384162384488,0,1,tyrosine phosphorylation of STAT protein,BP,
649,GO:0007264,1,0.65227670309888,0,1,small GTPase mediated signal transduction,BP,
650,GO:0007265,1,0.65227670309888,0,1,Ras protein signal transduction,BP,
654,GO:0007272,1,0.653661854217472,0,1,ensheathment of neurons,BP,
656,GO:0007276,1,0.248617073429876,0,3,gamete generation,BP,
657,GO:0007281,1,0.383103383990114,0,2,germ cell development,BP,
658,GO:0007283,1,0.655086466259755,0,1,spermatogenesis,BP,
659,GO:0007292,1,0.383103383990114,0,2,female gamete generation,BP,
660,GO:0007338,1,0.653661854217472,0,1,single fertilization,BP,
661,GO:0007341,1,0.653661854217472,0,1,penetration of zona pellucida,BP,
667,GO:0007411,1,0.65227670309888,0,1,axon guidance,BP,
673,GO:0007519,1,0.599447363464003,0,1,skeletal muscle tissue development,BP,
676,GO:0007584,1,0.711704209234577,0,1,response to nutrient,BP,
678,GO:0007596,1,0.691167248140885,0,2,blood coagulation,BP,
679,GO:0007598,1,0.700914309098006,0,1,blood coagulation, extrinsic pathway,BP,
680,GO:0007599,1,0.691167248140885,0,2,hemostasis,BP,
690,GO:0007619,1,0.653661854217472,0,1,courtship behavior,BP,
695,GO:0007638,1,0.79420415032525,0,1,mechanosensory behavior,BP,
701,GO:0008049,1,0.653661854217472,0,1,male courtship behavior,BP,
702,GO:0008064,1,0.355418010872913,0,2,regulation of actin polymerization or depolymerization,BP,
703,GO:0008066,1,0.941673510689999,0,1,glutamate receptor activity,MF,
707,GO:0008108,1,0.613341072417478,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
708,GO:0008112,1,0.629869738173705,0,1,nicotinamide N-methyltransferase activity,MF,
710,GO:0008124,1,0.590930005023909,0,1,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
711,GO:0008134,1,0.567926568876566,0,1,transcription factor binding,MF,
713,GO:0008144,1,0.691634315525481,0,1,drug binding,MF,
716,GO:0008154,1,0.206860194262745,0,3,actin polymerization or depolymerization,BP,
717,GO:0008168,1,0.629869738173705,0,1,methyltransferase activity,MF,
718,GO:0008170,1,0.629869738173705,0,1,N-methyltransferase activity,MF,
722,GO:0008201,1,0.589082786340178,0,1,heparin binding,MF,
725,GO:0008206,1,0.711704209234577,0,1,bile acid metabolic process,BP,
726,GO:0008207,1,0.301543530651029,0,3,C21-steroid hormone metabolic process,BP,
727,GO:0008209,1,0.158648247717332,0,4,androgen metabolic process,BP,
728,GO:0008210,1,0.461848476223235,0,2,estrogen metabolic process,BP,
729,GO:0008211,1,0.293916379842535,0,3,glucocorticoid metabolic process,BP,
730,GO:0008212,1,0.641908063478118,0,1,mineralocorticoid metabolic process,BP,
734,GO:0008234,1,0.355678835293696,0,2,cysteine-type peptidase activity,MF,
736,GO:0008236,1,0.709208929974408,0,1,serine-type peptidase activity,MF,
739,GO:0008270,1,0.237185204014397,0,3,zinc ion binding,MF,
740,GO:0008277,1,0.705187209057733,0,1,regulation of G-protein coupled receptor protein signaling pathway,BP,
744,GO:0008286,1,0.798192256085599,0,1,insulin receptor signaling pathway,BP,
746,GO:0008324,1,0.274468955839678,0,4,cation transmembrane transporter activity,MF,
748,GO:0008347,1,0.653661854217472,0,1,glial cell migration,BP,
749,GO:0008360,1,0.389899543980631,0,2,regulation of cell shape,BP,
751,GO:0008366,1,0.653661854217472,0,1,axon ensheathment,BP,
753,GO:0008375,1,0.539284728702601,0,2,acetylglucosaminyltransferase activity,MF,
755,GO:0008385,1,0.583640461943381,0,1,IkappaB kinase complex,CC,
756,GO:0008386,1,0.658312207785409,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
757,GO:0008395,1,0.426734545974164,0,2,steroid hydroxylase activity,MF,
758,GO:0008406,1,0.2838747425761,0,3,gonad development,BP,
760,GO:0008480,1,0.764401591462327,0,1,sarcosine dehydrogenase activity,MF,
761,GO:0008509,1,0.443593830761724,0,2,anion transmembrane transporter activity,MF,
762,GO:0008514,1,0.79420415032525,0,1,organic anion transmembrane transporter activity,MF,
766,GO:0008584,1,0.711704209234577,0,1,male gonad development,BP,
767,GO:0008585,1,0.401897905291834,0,2,female gonad development,BP,
770,GO:0008630,1,0.583640461943381,0,1,intrinsic apoptotic signaling pathway in response to DNA damage,BP,
771,GO:0008631,1,0.616295371802482,0,1,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
775,GO:0008652,1,0.592226348561825,0,2,cellular amino acid biosynthetic process,BP,
777,GO:0008656,1,0.583640461943381,0,1,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
779,GO:0008709,1,0.587339765995185,0,1,cholate 7-alpha-dehydrogenase activity,MF,
780,GO:0008757,1,0.629869738173705,0,1,S-adenosylmethionine-dependent methyltransferase activity,MF,
782,GO:0009052,1,0.810726287680263,0,1,pentose-phosphate shunt, non-oxidative branch,BP,
788,GO:0009060,1,0.415475209216131,0,2,aerobic respiration,BP,
791,GO:0009064,1,0.79420415032525,0,1,glutamine family amino acid metabolic process,BP,
793,GO:0009067,1,0.747143336113352,0,1,aspartate family amino acid biosynthetic process,BP,
795,GO:0009074,1,0.590930005023909,0,1,aromatic amino acid family catabolic process,BP,
798,GO:0009084,1,0.79420415032525,0,1,glutamine family amino acid biosynthetic process,BP,
799,GO:0009086,1,0.747143336113352,0,1,methionine biosynthetic process,BP,
804,GO:0009110,1,0.655086466259755,0,1,vitamin biosynthetic process,BP,
805,GO:0009112,1,0.918333225139973,0,1,nucleobase metabolic process,BP,
806,GO:0009115,1,0.918333225139973,0,1,xanthine catabolic process,BP,
807,GO:0009116,1,0.441310542861161,0,2,nucleoside metabolic process,BP,
809,GO:0009119,1,0.691634315525481,0,1,ribonucleoside metabolic process,BP,
810,GO:0009120,1,0.640583205088349,0,1,deoxyribonucleoside metabolic process,BP,
815,GO:0009164,1,0.441310542861161,0,2,nucleoside catabolic process,BP,
818,GO:0009187,1,0.578183005063771,0,1,cyclic nucleotide metabolic process,BP,
819,GO:0009190,1,0.578183005063771,0,1,cyclic nucleotide biosynthetic process,BP,
820,GO:0009225,1,0.613341072417478,0,1,nucleotide-sugar metabolic process,BP,
821,GO:0009227,1,0.613341072417478,0,1,nucleotide-sugar catabolic process,BP,
822,GO:0009237,1,0.732102610026488,0,1,siderophore metabolic process,BP,
827,GO:0009262,1,0.640583205088349,0,1,deoxyribonucleotide metabolic process,BP,
828,GO:0009264,1,0.640583205088349,0,1,deoxyribonucleotide catabolic process,BP,
830,GO:0009267,1,0.689510455942169,0,2,cellular response to starvation,BP,
832,GO:0009303,1,0.589082786340178,0,1,rRNA transcription,BP,
835,GO:0009310,1,0.764401591462327,0,1,amine catabolic process,BP,
836,GO:0009311,1,0.269483595517061,0,3,oligosaccharide metabolic process,BP,
837,GO:0009313,1,0.653661854217472,0,1,oligosaccharide catabolic process,BP,
839,GO:0009395,1,0.379149515625133,0,2,phospholipid catabolic process,BP,
842,GO:0009410,1,0.337787899847262,0,3,response to xenobiotic stimulus,BP,
846,GO:0009435,1,0.433876173620188,0,2,NAD biosynthetic process,BP,
848,GO:0009448,1,0.79420415032525,0,1,gamma-aminobutyric acid metabolic process,BP,
849,GO:0009449,1,0.79420415032525,0,1,gamma-aminobutyric acid biosynthetic process,BP,
851,GO:0009566,1,0.653661854217472,0,1,fertilization,BP,
855,GO:0009611,1,0.334604398719145,0,4,response to wounding,BP,
874,GO:0009791,1,0.710514904531027,0,1,post-embryonic development,BP,
893,GO:0009918,1,0.710514904531027,0,1,sterol delta7 reductase activity,MF,
894,GO:0009922,1,0.762488370432474,0,1,fatty acid elongase activity,MF,
902,GO:0009994,1,0.589082786340178,0,1,oocyte differentiation,BP,
903,GO:0010001,1,0.599447363464003,0,1,glial cell differentiation,BP,
910,GO:0010212,1,0.711704209234577,0,1,response to ionizing radiation,BP,
913,GO:0010288,1,0.711704209234577,0,1,response to lead ion,BP,
915,GO:0010466,1,0.430204914310017,0,2,negative regulation of peptidase activity,BP,
921,GO:0010508,1,0.713969292256814,0,1,positive regulation of autophagy,BP,
922,GO:0010510,1,0.798192256085599,0,1,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
923,GO:0010517,1,0.589082786340178,0,1,regulation of phospholipase activity,BP,
924,GO:0010518,1,0.589082786340178,0,1,positive regulation of phospholipase activity,BP,
927,GO:0010558,1,0.132107262006897,0,4,negative regulation of macromolecule biosynthetic process,BP,
938,GO:0010629,1,0.202451254678745,0,3,negative regulation of gene expression,BP,
942,GO:0010638,1,0.583640461943381,0,1,positive regulation of organelle organization,BP,
947,GO:0010656,1,0.616295371802482,0,1,negative regulation of muscle cell apoptotic process,BP,
948,GO:0010657,1,0.616295371802482,0,1,muscle cell apoptotic process,BP,
949,GO:0010658,1,0.616295371802482,0,1,striated muscle cell apoptotic process,BP,
950,GO:0010659,1,0.616295371802482,0,1,cardiac muscle cell apoptotic process,BP,
951,GO:0010660,1,0.616295371802482,0,1,regulation of muscle cell apoptotic process,BP,
952,GO:0010662,1,0.616295371802482,0,1,regulation of striated muscle cell apoptotic process,BP,
953,GO:0010664,1,0.616295371802482,0,1,negative regulation of striated muscle cell apoptotic process,BP,
954,GO:0010665,1,0.616295371802482,0,1,regulation of cardiac muscle cell apoptotic process,BP,
955,GO:0010667,1,0.616295371802482,0,1,negative regulation of cardiac muscle cell apoptotic process,BP,
957,GO:0010675,1,0.521525279218897,0,2,regulation of cellular carbohydrate metabolic process,BP,
958,GO:0010676,1,0.655086466259755,0,1,positive regulation of cellular carbohydrate metabolic process,BP,
959,GO:0010720,1,0.711704209234577,0,1,positive regulation of cell development,BP,
964,GO:0010765,1,0.560477493310972,0,1,positive regulation of sodium ion transport,BP,
967,GO:0010803,1,0.220486614047561,0,3,regulation of tumor necrosis factor-mediated signaling pathway,BP,
968,GO:0010804,1,0.616295371802482,0,1,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
971,GO:0010822,1,0.583640461943381,0,1,positive regulation of mitochondrion organization,BP,
973,GO:0010827,1,0.839081013955894,0,1,regulation of glucose transport,BP,
974,GO:0010828,1,0.839081013955894,0,1,positive regulation of glucose transport,BP,
975,GO:0010863,1,0.589082786340178,0,1,positive regulation of phospholipase C activity,BP,
976,GO:0010866,1,0.655086466259755,0,1,regulation of triglyceride biosynthetic process,BP,
977,GO:0010867,1,0.655086466259755,0,1,positive regulation of triglyceride biosynthetic process,BP,
979,GO:0010873,1,0.555979667472001,0,1,positive regulation of cholesterol esterification,BP,
989,GO:0010899,1,0.555979667472001,0,1,regulation of phosphatidylcholine catabolic process,BP,
990,GO:0010900,1,0.555979667472001,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
991,GO:0010906,1,0.521525279218897,0,2,regulation of glucose metabolic process,BP,
992,GO:0010907,1,0.655086466259755,0,1,positive regulation of glucose metabolic process,BP,
993,GO:0010915,1,0.555979667472001,0,1,regulation of very-low-density lipoprotein particle clearance,BP,
994,GO:0010916,1,0.555979667472001,0,1,negative regulation of very-low-density lipoprotein particle clearance,BP,
995,GO:0010921,1,0.655086466259755,0,1,regulation of phosphatase activity,BP,
996,GO:0010922,1,0.655086466259755,0,1,positive regulation of phosphatase activity,BP,
997,GO:0010923,1,0.655086466259755,0,1,negative regulation of phosphatase activity,BP,
1003,GO:0010951,1,0.430204914310017,0,2,negative regulation of endopeptidase activity,BP,
1005,GO:0010955,1,0.616295371802482,0,1,negative regulation of protein processing,BP,
1006,GO:0010959,1,0.232721929639651,0,3,regulation of metal ion transport,BP,
1010,GO:0010984,1,0.555979667472001,0,1,regulation of lipoprotein particle clearance,BP,
1011,GO:0010985,1,0.555979667472001,0,1,negative regulation of lipoprotein particle clearance,BP,
1012,GO:0010996,1,0.79420415032525,0,1,response to auditory stimulus,BP,
1016,GO:0014047,1,0.79420415032525,0,1,glutamate secretion,BP,
1021,GO:0014074,1,0.711704209234577,0,1,response to purine-containing compound,BP,
1024,GO:0014735,1,0.616295371802482,0,1,regulation of muscle atrophy,BP,
1025,GO:0014736,1,0.616295371802482,0,1,negative regulation of muscle atrophy,BP,
1026,GO:0014745,1,0.616295371802482,0,1,negative regulation of muscle adaptation,BP,
1027,GO:0014808,1,0.616295371802482,0,1,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
1030,GO:0014874,1,0.616295371802482,0,1,response to stimulus involved in regulation of muscle adaptation,BP,
1031,GO:0014876,1,0.616295371802482,0,1,response to injury involved in regulation of muscle adaptation,BP,
1032,GO:0014889,1,0.616295371802482,0,1,muscle atrophy,BP,
1033,GO:0015002,1,0.578797687193198,0,1,heme-copper terminal oxidase activity,MF,
1034,GO:0015012,1,0.826942722683401,0,1,heparan sulfate proteoglycan biosynthetic process,BP,
1036,GO:0015065,1,0.704636963882892,0,1,uridine nucleotide receptor activity,MF,
1037,GO:0015075,1,0.151085588763213,0,5,ion transmembrane transporter activity,MF,
1038,GO:0015077,1,0.458171043257866,0,2,monovalent inorganic cation transmembrane transporter activity,MF,
1039,GO:0015078,1,0.578797687193198,0,1,hydrogen ion transmembrane transporter activity,MF,
1040,GO:0015081,1,0.79420415032525,0,1,sodium ion transmembrane transporter activity,MF,
1041,GO:0015103,1,0.560477493310972,0,1,inorganic anion transmembrane transporter activity,MF,
1042,GO:0015108,1,0.560477493310972,0,1,chloride transmembrane transporter activity,MF,
1043,GO:0015171,1,0.79420415032525,0,1,amino acid transmembrane transporter activity,MF,
1044,GO:0015172,1,0.79420415032525,0,1,acidic amino acid transmembrane transporter activity,MF,
1045,GO:0015179,1,0.79420415032525,0,1,L-amino acid transmembrane transporter activity,MF,
1047,GO:0015238,1,0.600923415171073,0,1,drug transmembrane transporter activity,MF,
1048,GO:0015245,1,0.596972964066786,0,1,fatty acid transporter activity,MF,
1050,GO:0015267,1,0.526897073579373,0,2,channel activity,MF,
1051,GO:0015276,1,0.941673510689999,0,1,ligand-gated ion channel activity,MF,
1052,GO:0015291,1,0.79420415032525,0,1,secondary active transmembrane transporter activity,MF,
1053,GO:0015293,1,0.79420415032525,0,1,symporter activity,MF,
1054,GO:0015294,1,0.79420415032525,0,1,solute:cation symporter activity,MF,
1055,GO:0015370,1,0.79420415032525,0,1,solute:sodium symporter activity,MF,
1061,GO:0015631,1,0.821441120987107,0,1,tubulin binding,MF,
1062,GO:0015645,1,0.692483461339883,0,1,fatty acid ligase activity,MF,
1063,GO:0015672,1,0.322210434340186,0,2,monovalent inorganic cation transport,BP,
1064,GO:0015698,1,0.560477493310972,0,1,inorganic anion transport,BP,
1066,GO:0015718,1,0.443646730468227,0,2,monocarboxylic acid transport,BP,
1067,GO:0015740,1,0.79420415032525,0,1,C4-dicarboxylate transport,BP,
1071,GO:0015800,1,0.79420415032525,0,1,acidic amino acid transport,BP,
1072,GO:0015807,1,0.79420415032525,0,1,L-amino acid transport,BP,
1073,GO:0015810,1,0.79420415032525,0,1,aspartate transport,BP,
1074,GO:0015813,1,0.79420415032525,0,1,L-glutamate transport,BP,
1078,GO:0015849,1,0.350536300205429,0,3,organic acid transport,BP,
1080,GO:0015893,1,0.600923415171073,0,1,drug transport,BP,
1081,GO:0015908,1,0.443646730468227,0,2,fatty acid transport,BP,
1082,GO:0015909,1,0.443646730468227,0,2,long-chain fatty acid transport,BP,
1085,GO:0015925,1,0.618986977187954,0,1,galactosidase activity,MF,
1086,GO:0015929,1,0.653661854217472,0,1,hexosaminidase activity,MF,
1092,GO:0015992,1,0.578797687193198,0,1,proton transport,BP,
1100,GO:0016052,1,0.253193481269184,0,3,carbohydrate catabolic process,BP,
1106,GO:0016072,1,0.492970366688253,0,2,rRNA metabolic process,BP,
1110,GO:0016128,1,0.710514904531027,0,1,phytosteroid metabolic process,BP,
1111,GO:0016129,1,0.710514904531027,0,1,phytosteroid biosynthetic process,BP,
1112,GO:0016131,1,0.710514904531027,0,1,brassinosteroid metabolic process,BP,
1113,GO:0016132,1,0.710514904531027,0,1,brassinosteroid biosynthetic process,BP,
1115,GO:0016139,1,0.618986977187954,0,1,glycoside catabolic process,BP,
1119,GO:0016209,1,0.577407483649635,0,1,antioxidant activity,MF,
1120,GO:0016229,1,0.142749943824279,0,4,steroid dehydrogenase activity,MF,
1123,GO:0016247,1,0.560477493310972,0,1,channel regulator activity,MF,
1130,GO:0016311,1,0.231665156726814,0,3,dephosphorylation,BP,
1132,GO:0016363,1,0.839081013955894,0,1,nuclear matrix,CC,
1133,GO:0016405,1,0.468621401168997,0,2,CoA-ligase activity,MF,
1145,GO:0016502,1,0.704636963882892,0,1,nucleotide receptor activity,MF,
1146,GO:0016504,1,0.583640461943381,0,1,peptidase activator activity,MF,
1147,GO:0016505,1,0.583640461943381,0,1,peptidase activator activity involved in apoptotic process,MF,
1148,GO:0016528,1,0.365875553360617,0,2,sarcoplasm,CC,
1149,GO:0016529,1,0.616295371802482,0,1,sarcoplasmic reticulum,CC,
1153,GO:0016595,1,0.79420415032525,0,1,glutamate binding,MF,
1157,GO:0016614,1,0.0130892345970151,0,10,oxidoreductase activity, acting on CH-OH group of donors,MF,
1158,GO:0016615,1,0.608833693873605,0,1,malate dehydrogenase activity,MF,
1159,GO:0016616,1,0.0226712600318893,0,8,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
1160,GO:0016623,1,0.918333225139973,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
1168,GO:0016675,1,0.578797687193198,0,1,oxidoreductase activity, acting on a heme group of donors,MF,
1169,GO:0016676,1,0.578797687193198,0,1,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
1170,GO:0016684,1,0.577407483649635,0,1,oxidoreductase activity, acting on peroxide as acceptor,MF,
1172,GO:0016706,1,0.636162746596575,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
1173,GO:0016713,1,0.658312207785409,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
1175,GO:0016717,1,0.864847534366939,0,1,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
1177,GO:0016725,1,0.918333225139973,0,1,oxidoreductase activity, acting on CH or CH2 groups,MF,
1178,GO:0016726,1,0.918333225139973,0,1,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
1180,GO:0016741,1,0.629869738173705,0,1,transferase activity, transferring one-carbon groups,MF,
1185,GO:0016763,1,0.691634315525481,0,1,transferase activity, transferring pentosyl groups,MF,
1186,GO:0016765,1,0.577407483649635,0,1,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
1189,GO:0016779,1,0.613341072417478,0,1,nucleotidyltransferase activity,MF,
1193,GO:0016791,1,0.357187322218882,0,2,phosphatase activity,MF,
1194,GO:0016798,1,0.269483595517061,0,3,hydrolase activity, acting on glycosyl bonds,MF,
1196,GO:0016810,1,0.688862453062182,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
1197,GO:0016811,1,0.688862453062182,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
1203,GO:0016832,1,0.41514877889167,0,2,aldehyde-lyase activity,MF,
1207,GO:0016846,1,0.577407483649635,0,1,carbon-sulfur lyase activity,MF,
1210,GO:0016861,1,0.747143336113352,0,1,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
1214,GO:0016877,1,0.468621401168997,0,2,ligase activity, forming carbon-sulfur bonds,MF,
1215,GO:0016878,1,0.468621401168997,0,2,acid-thiol ligase activity,MF,
1218,GO:0016898,1,0.663180137854112,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
1219,GO:0016903,1,0.918333225139973,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
1221,GO:0016936,1,0.618986977187954,0,1,galactoside binding,MF,
1223,GO:0017022,1,0.583640461943381,0,1,myosin binding,MF,
1224,GO:0017024,1,0.583640461943381,0,1,myosin I binding,MF,
1225,GO:0017038,1,0.616295371802482,0,1,protein import,BP,
1226,GO:0017040,1,0.688862453062182,0,1,ceramidase activity,MF,
1227,GO:0017046,1,0.859384162384488,0,1,peptide hormone binding,MF,
1229,GO:0017080,1,0.560477493310972,0,1,sodium channel regulator activity,MF,
1235,GO:0017143,1,0.711704209234577,0,1,insecticide metabolic process,BP,
1236,GO:0017148,1,0.589082786340178,0,1,negative regulation of translation,BP,
1237,GO:0017156,1,0.705187209057733,0,1,calcium ion regulated exocytosis,BP,
1238,GO:0017157,1,0.705187209057733,0,1,regulation of exocytosis,BP,
1239,GO:0017158,1,0.705187209057733,0,1,regulation of calcium ion-dependent exocytosis,BP,
1240,GO:0017171,1,0.709208929974408,0,1,serine hydrolase activity,MF,
1252,GO:0018879,1,0.711704209234577,0,1,biphenyl metabolic process,BP,
1253,GO:0018894,1,0.711704209234577,0,1,dibenzo-p-dioxin metabolic process,BP,
1257,GO:0019001,1,0.692483461339883,0,1,guanyl nucleotide binding,MF,
1258,GO:0019058,1,0.839081013955894,0,1,viral life cycle,BP,
1259,GO:0019079,1,0.839081013955894,0,1,viral genome replication,BP,
1261,GO:0019166,1,0.651403359485368,0,1,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
1262,GO:0019184,1,0.420981913950351,0,2,nonribosomal peptide biosynthetic process,BP,
1270,GO:0019290,1,0.732102610026488,0,1,siderophore biosynthetic process,BP,
1273,GO:0019320,1,0.613341072417478,0,1,hexose catabolic process,BP,
1274,GO:0019359,1,0.433876173620188,0,2,nicotinamide nucleotide biosynthetic process,BP,
1275,GO:0019362,1,0.0891618066743344,0,6,pyridine nucleotide metabolic process,BP,
1276,GO:0019363,1,0.433876173620188,0,2,pyridine nucleotide biosynthetic process,BP,
1277,GO:0019367,1,0.762488370432474,0,1,fatty acid elongation, saturated fatty acid,BP,
1278,GO:0019370,1,0.577407483649635,0,1,leukotriene biosynthetic process,BP,
1279,GO:0019372,1,0.634317961549412,0,1,lipoxygenase pathway,BP,
1280,GO:0019377,1,0.402714433748352,0,2,glycolipid catabolic process,BP,
1281,GO:0019388,1,0.613341072417478,0,1,galactose catabolic process,BP,
1283,GO:0019430,1,0.655086466259755,0,1,removal of superoxide radicals,BP,
1284,GO:0019432,1,0.655086466259755,0,1,triglyceride biosynthetic process,BP,
1285,GO:0019433,1,0.596972964066786,0,1,triglyceride catabolic process,BP,
1288,GO:0019509,1,0.747143336113352,0,1,L-methionine salvage from methylthioadenosine,BP,
1289,GO:0019530,1,0.859384162384488,0,1,taurine metabolic process,BP,
1293,GO:0019674,1,0.261643387329191,0,3,NAD metabolic process,BP,
1294,GO:0019682,1,0.517995302719917,0,2,glyceraldehyde-3-phosphate metabolic process,BP,
1295,GO:0019692,1,0.640583205088349,0,1,deoxyribose phosphate metabolic process,BP,
1297,GO:0019694,1,0.859384162384488,0,1,alkanesulfonate metabolic process,BP,
1298,GO:0019695,1,0.764401591462327,0,1,choline metabolic process,BP,
1299,GO:0019722,1,0.655086466259755,0,1,calcium-mediated signaling,BP,
1307,GO:0019843,1,0.294578145780974,0,3,rRNA binding,MF,
1308,GO:0019852,1,0.377188759674881,0,2,L-ascorbic acid metabolic process,BP,
1309,GO:0019853,1,0.655086466259755,0,1,L-ascorbic acid biosynthetic process,BP,
1320,GO:0019932,1,0.655086466259755,0,1,second-messenger-mediated signaling,BP,
1323,GO:0020037,1,0.244399852068762,0,3,heme binding,MF,
1326,GO:0021545,1,0.79420415032525,0,1,cranial nerve development,BP,
1327,GO:0021675,1,0.79420415032525,0,1,nerve development,BP,
1328,GO:0021700,1,0.589082786340178,0,1,developmental maturation,BP,
1332,GO:0022404,1,0.623289805927393,0,1,molting cycle process,BP,
1333,GO:0022405,1,0.623289805927393,0,1,hair cycle process,BP,
1336,GO:0022410,1,0.711704209234577,0,1,circadian sleep/wake cycle process,BP,
1338,GO:0022412,1,0.383103383990114,0,2,cellular process involved in reproduction in multicellular organism,BP,
1341,GO:0022602,1,0.589082786340178,0,1,ovulation cycle process,BP,
1346,GO:0022613,1,0.515846452772191,0,2,ribonucleoprotein complex biogenesis,BP,
1347,GO:0022618,1,0.616295371802482,0,1,ribonucleoprotein complex assembly,BP,
1348,GO:0022803,1,0.526897073579373,0,2,passive transmembrane transporter activity,MF,
1350,GO:0022824,1,0.941673510689999,0,1,transmitter-gated ion channel activity,MF,
1351,GO:0022834,1,0.941673510689999,0,1,ligand-gated channel activity,MF,
1352,GO:0022835,1,0.941673510689999,0,1,transmitter-gated channel activity,MF,
1353,GO:0022836,1,0.941673510689999,0,1,gated channel activity,MF,
1354,GO:0022838,1,0.526897073579373,0,2,substrate-specific channel activity,MF,
1356,GO:0022890,1,0.274468955839678,0,4,inorganic cation transmembrane transporter activity,MF,
1357,GO:0022891,1,0.151085588763213,0,5,substrate-specific transmembrane transporter activity,MF,
1359,GO:0022898,1,0.365154074377246,0,2,regulation of transmembrane transporter activity,BP,
1368,GO:0030001,1,0.141144650896957,0,4,metal ion transport,BP,
1369,GO:0030003,1,0.165272908964229,0,4,cellular cation homeostasis,BP,
1370,GO:0030016,1,0.612519110445417,0,1,myofibril,CC,
1371,GO:0030017,1,0.612519110445417,0,1,sarcomere,CC,
1372,GO:0030029,1,0.206860194262745,0,3,actin filament-based process,BP,
1374,GO:0030031,1,0.821441120987107,0,1,cell projection assembly,BP,
1375,GO:0030036,1,0.206860194262745,0,3,actin cytoskeleton organization,BP,
1376,GO:0030041,1,0.206860194262745,0,3,actin filament polymerization,BP,
1377,GO:0030042,1,0.612519110445417,0,1,actin filament depolymerization,BP,
1380,GO:0030060,1,0.608833693873605,0,1,L-malate dehydrogenase activity,MF,
1381,GO:0030061,1,0.711704209234577,0,1,mitochondrial crista,CC,
1388,GO:0030100,1,0.322301488517455,0,2,regulation of endocytosis,BP,
1389,GO:0030101,1,0.713969292256814,0,1,natural killer cell activation,BP,
1392,GO:0030135,1,0.674865017619115,0,1,coated vesicle,CC,
1393,GO:0030139,1,0.941673510689999,0,1,endocytic vesicle,CC,
1394,GO:0030141,1,0.0461030329033915,0,7,secretory granule,CC,
1396,GO:0030149,1,0.402714433748352,0,2,sphingolipid catabolic process,BP,
1401,GO:0030166,1,0.826942722683401,0,1,proteoglycan biosynthetic process,BP,
1402,GO:0030170,1,0.662995103019366,0,1,pyridoxal phosphate binding,MF,
1407,GO:0030193,1,0.986830983483857,0,1,regulation of blood coagulation,BP,
1408,GO:0030201,1,0.826942722683401,0,1,heparan sulfate proteoglycan metabolic process,BP,
1409,GO:0030203,1,0.361689608665274,0,3,glycosaminoglycan metabolic process,BP,
1410,GO:0030204,1,0.439379228515079,0,2,chondroitin sulfate metabolic process,BP,
1411,GO:0030205,1,0.674865017619115,0,1,dermatan sulfate metabolic process,BP,
1412,GO:0030207,1,0.439379228515079,0,2,chondroitin sulfate catabolic process,BP,
1413,GO:0030209,1,0.674865017619115,0,1,dermatan sulfate catabolic process,BP,
1414,GO:0030212,1,0.653661854217472,0,1,hyaluronan metabolic process,BP,
1415,GO:0030214,1,0.653661854217472,0,1,hyaluronan catabolic process,BP,
1420,GO:0030246,1,0.636162746596575,0,1,carbohydrate binding,MF,
1422,GO:0030274,1,0.705187209057733,0,1,LIM domain binding,MF,
1425,GO:0030283,1,0.587339765995185,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
1427,GO:0030317,1,0.655086466259755,0,1,flagellated sperm motility,BP,
1432,GO:0030414,1,0.430204914310017,0,2,peptidase inhibitor activity,MF,
1435,GO:0030426,1,0.589082786340178,0,1,growth cone,CC,
1436,GO:0030427,1,0.589082786340178,0,1,site of polarized growth,CC,
1437,GO:0030431,1,0.711704209234577,0,1,sleep,BP,
1438,GO:0030449,1,0.709208929974408,0,1,regulation of complement activation,BP,
1439,GO:0030488,1,0.587339765995185,0,1,tRNA methylation,BP,
1440,GO:0030497,1,0.762488370432474,0,1,fatty acid elongation,BP,
1444,GO:0030539,1,0.599916628402907,0,1,male genitalia development,BP,
1448,GO:0030594,1,0.941673510689999,0,1,neurotransmitter receptor activity,MF,
1449,GO:0030658,1,0.705187209057733,0,1,transport vesicle membrane,CC,
1451,GO:0030666,1,0.941673510689999,0,1,endocytic vesicle membrane,CC,
1452,GO:0030667,1,0.705187209057733,0,1,secretory granule membrane,CC,
1453,GO:0030677,1,0.587339765995185,0,1,ribonuclease P complex,CC,
1454,GO:0030678,1,0.587339765995185,0,1,mitochondrial ribonuclease P complex,CC,
1456,GO:0030760,1,0.629869738173705,0,1,pyridine N-methyltransferase activity,MF,
1457,GO:0030799,1,0.578183005063771,0,1,regulation of cyclic nucleotide metabolic process,BP,
1458,GO:0030801,1,0.578183005063771,0,1,positive regulation of cyclic nucleotide metabolic process,BP,
1459,GO:0030802,1,0.578183005063771,0,1,regulation of cyclic nucleotide biosynthetic process,BP,
1460,GO:0030804,1,0.578183005063771,0,1,positive regulation of cyclic nucleotide biosynthetic process,BP,
1461,GO:0030808,1,0.578183005063771,0,1,regulation of nucleotide biosynthetic process,BP,
1462,GO:0030810,1,0.578183005063771,0,1,positive regulation of nucleotide biosynthetic process,BP,
1463,GO:0030814,1,0.578183005063771,0,1,regulation of cAMP metabolic process,BP,
1464,GO:0030816,1,0.578183005063771,0,1,positive regulation of cAMP metabolic process,BP,
1465,GO:0030817,1,0.578183005063771,0,1,regulation of cAMP biosynthetic process,BP,
1466,GO:0030819,1,0.578183005063771,0,1,positive regulation of cAMP biosynthetic process,BP,
1467,GO:0030832,1,0.355418010872913,0,2,regulation of actin filament length,BP,
1468,GO:0030833,1,0.355418010872913,0,2,regulation of actin filament polymerization,BP,
1469,GO:0030834,1,0.612519110445417,0,1,regulation of actin filament depolymerization,BP,
1470,GO:0030835,1,0.612519110445417,0,1,negative regulation of actin filament depolymerization,BP,
1471,GO:0030837,1,0.612519110445417,0,1,negative regulation of actin filament polymerization,BP,
1472,GO:0030838,1,0.583640461943381,0,1,positive regulation of actin filament polymerization,BP,
1474,GO:0030868,1,0.641908063478118,0,1,smooth endoplasmic reticulum membrane,CC,
1475,GO:0030888,1,0.713969292256814,0,1,regulation of B cell proliferation,BP,
1476,GO:0030890,1,0.713969292256814,0,1,positive regulation of B cell proliferation,BP,
1485,GO:0031098,1,0.583640461943381,0,1,stress-activated protein kinase signaling cascade,BP,
1486,GO:0031099,1,0.410754276936526,0,2,regeneration,BP,
1487,GO:0031100,1,0.410754276936526,0,2,animal organ regeneration,BP,
1492,GO:0031210,1,0.555979667472001,0,1,phosphatidylcholine binding,MF,
1493,GO:0031223,1,0.79420415032525,0,1,auditory behavior,BP,
1495,GO:0031225,1,0.700914309098006,0,1,anchored component of membrane,CC,
1498,GO:0031252,1,0.599447363464003,0,1,cell leading edge,CC,
1515,GO:0031333,1,0.612519110445417,0,1,negative regulation of protein complex assembly,BP,
1523,GO:0031348,1,0.623289805927393,0,1,negative regulation of defense response,BP,
1533,GO:0031418,1,0.636162746596575,0,1,L-ascorbic acid binding,MF,
1536,GO:0031503,1,0.616295371802482,0,1,protein complex localization,BP,
1539,GO:0031663,1,0.713969292256814,0,1,lipopolysaccharide-mediated signaling pathway,BP,
1541,GO:0031668,1,0.689510455942169,0,2,cellular response to extracellular stimulus,BP,
1542,GO:0031669,1,0.689510455942169,0,2,cellular response to nutrient levels,BP,
1544,GO:0031779,1,0.578183005063771,0,1,melanocortin receptor binding,MF,
1545,GO:0031780,1,0.578183005063771,0,1,corticotropin hormone receptor binding,MF,
1546,GO:0031781,1,0.578183005063771,0,1,type 3 melanocortin receptor binding,MF,
1547,GO:0031782,1,0.578183005063771,0,1,type 4 melanocortin receptor binding,MF,
1548,GO:0031783,1,0.578183005063771,0,1,type 5 melanocortin receptor binding,MF,
1549,GO:0031901,1,0.752322012235064,0,1,early endosome membrane,CC,
1554,GO:0031965,1,0.401693009555656,0,2,nuclear membrane,CC,
1558,GO:0031970,1,0.455172482657657,0,2,organelle envelope lumen,CC,
1563,GO:0031983,1,0.0669370568571096,0,6,vesicle lumen,CC,
1567,GO:0032088,1,0.583640461943381,0,1,negative regulation of NF-kappaB transcription factor activity,BP,
1568,GO:0032090,1,0.583640461943381,0,1,Pyrin domain binding,MF,
1569,GO:0032092,1,0.713969292256814,0,1,positive regulation of protein binding,BP,
1572,GO:0032147,1,0.505015780163201,0,2,activation of protein kinase activity,BP,
1573,GO:0032148,1,0.589082786340178,0,1,activation of protein kinase B activity,BP,
1575,GO:0032266,1,0.752322012235064,0,1,phosphatidylinositol-3-phosphate binding,MF,
1579,GO:0032271,1,0.355418010872913,0,2,regulation of protein polymerization,BP,
1580,GO:0032272,1,0.612519110445417,0,1,negative regulation of protein polymerization,BP,
1581,GO:0032273,1,0.583640461943381,0,1,positive regulation of protein polymerization,BP,
1583,GO:0032311,1,0.589082786340178,0,1,angiogenin-PRI complex,CC,
1586,GO:0032354,1,0.711704209234577,0,1,response to follicle-stimulating hormone,BP,
1592,GO:0032369,1,0.555979667472001,0,1,negative regulation of lipid transport,BP,
1595,GO:0032372,1,0.555979667472001,0,1,negative regulation of sterol transport,BP,
1598,GO:0032375,1,0.555979667472001,0,1,negative regulation of cholesterol transport,BP,
1600,GO:0032386,1,0.347915894904772,0,2,regulation of intracellular transport,BP,
1602,GO:0032409,1,0.365154074377246,0,2,regulation of transporter activity,BP,
1603,GO:0032411,1,0.655086466259755,0,1,positive regulation of transporter activity,BP,
1604,GO:0032412,1,0.365154074377246,0,2,regulation of ion transmembrane transporter activity,BP,
1605,GO:0032414,1,0.655086466259755,0,1,positive regulation of ion transmembrane transporter activity,BP,
1606,GO:0032429,1,0.589082786340178,0,1,regulation of phospholipase A2 activity,BP,
1607,GO:0032430,1,0.589082786340178,0,1,positive regulation of phospholipase A2 activity,BP,
1608,GO:0032431,1,0.589082786340178,0,1,activation of phospholipase A2 activity,BP,
1610,GO:0032479,1,0.256143453910256,0,3,regulation of type I interferon production,BP,
1611,GO:0032480,1,0.36173012831955,0,2,negative regulation of type I interferon production,BP,
1612,GO:0032481,1,0.713969292256814,0,1,positive regulation of type I interferon production,BP,
1617,GO:0032515,1,0.655086466259755,0,1,negative regulation of phosphoprotein phosphatase activity,BP,
1621,GO:0032549,1,0.692483461339883,0,1,ribonucleoside binding,MF,
1622,GO:0032550,1,0.692483461339883,0,1,purine ribonucleoside binding,MF,
1626,GO:0032561,1,0.692483461339883,0,1,guanyl ribonucleotide binding,MF,
1628,GO:0032602,1,0.414912777820062,0,2,chemokine production,BP,
1629,GO:0032606,1,0.256143453910256,0,3,type I interferon production,BP,
1630,GO:0032607,1,0.623289805927393,0,1,interferon-alpha production,BP,
1631,GO:0032608,1,0.256143453910256,0,3,interferon-beta production,BP,
1633,GO:0032611,1,0.583640461943381,0,1,interleukin-1 beta production,BP,
1634,GO:0032612,1,0.583640461943381,0,1,interleukin-1 production,BP,
1635,GO:0032613,1,0.583640461943381,0,1,interleukin-10 production,BP,
1636,GO:0032623,1,0.691634315525481,0,1,interleukin-2 production,BP,
1637,GO:0032635,1,0.414912777820062,0,2,interleukin-6 production,BP,
1640,GO:0032642,1,0.414912777820062,0,2,regulation of chemokine production,BP,
1641,GO:0032647,1,0.623289805927393,0,1,regulation of interferon-alpha production,BP,
1642,GO:0032648,1,0.256143453910256,0,3,regulation of interferon-beta production,BP,
1644,GO:0032651,1,0.583640461943381,0,1,regulation of interleukin-1 beta production,BP,
1645,GO:0032652,1,0.583640461943381,0,1,regulation of interleukin-1 production,BP,
1646,GO:0032653,1,0.583640461943381,0,1,regulation of interleukin-10 production,BP,
1647,GO:0032675,1,0.414912777820062,0,2,regulation of interleukin-6 production,BP,
1650,GO:0032687,1,0.623289805927393,0,1,negative regulation of interferon-alpha production,BP,
1651,GO:0032688,1,0.36173012831955,0,2,negative regulation of interferon-beta production,BP,
1652,GO:0032722,1,0.414912777820062,0,2,positive regulation of chemokine production,BP,
1653,GO:0032728,1,0.713969292256814,0,1,positive regulation of interferon-beta production,BP,
1655,GO:0032731,1,0.583640461943381,0,1,positive regulation of interleukin-1 beta production,BP,
1656,GO:0032732,1,0.583640461943381,0,1,positive regulation of interleukin-1 production,BP,
1657,GO:0032733,1,0.583640461943381,0,1,positive regulation of interleukin-10 production,BP,
1658,GO:0032755,1,0.414912777820062,0,2,positive regulation of interleukin-6 production,BP,
1662,GO:0032769,1,0.618986977187954,0,1,negative regulation of monooxygenase activity,BP,
1664,GO:0032780,1,0.655086466259755,0,1,negative regulation of ATPase activity,BP,
1665,GO:0032781,1,0.655086466259755,0,1,positive regulation of ATPase activity,BP,
1669,GO:0032814,1,0.713969292256814,0,1,regulation of natural killer cell activation,BP,
1670,GO:0032816,1,0.713969292256814,0,1,positive regulation of natural killer cell activation,BP,
1673,GO:0032868,1,0.280209400229028,0,4,response to insulin,BP,
1674,GO:0032869,1,0.474114330150476,0,3,cellular response to insulin stimulus,BP,
1675,GO:0032870,1,0.405842830831887,0,4,cellular response to hormone stimulus,BP,
1676,GO:0032872,1,0.583640461943381,0,1,regulation of stress-activated MAPK cascade,BP,
1677,GO:0032874,1,0.583640461943381,0,1,positive regulation of stress-activated MAPK cascade,BP,
1685,GO:0032956,1,0.355418010872913,0,2,regulation of actin cytoskeleton organization,BP,
1687,GO:0032970,1,0.355418010872913,0,2,regulation of actin filament-based process,BP,
1692,GO:0032994,1,0.555979667472001,0,1,protein-lipid complex,CC,
1694,GO:0033013,1,0.732102610026488,0,1,tetrapyrrole metabolic process,BP,
1699,GO:0033157,1,0.347915894904772,0,2,regulation of intracellular protein transport,BP,
1703,GO:0033218,1,0.505015780163201,0,2,amide binding,MF,
1706,GO:0033293,1,0.329743218610697,0,2,monocarboxylic acid binding,MF,
1707,GO:0033306,1,0.651403359485368,0,1,phytol metabolic process,BP,
1709,GO:0033365,1,0.616295371802482,0,1,protein localization to organelle,BP,
1710,GO:0033489,1,0.425198076251097,0,2,cholesterol biosynthetic process via desmosterol,BP,
1711,GO:0033490,1,0.425198076251097,0,2,cholesterol biosynthetic process via lathosterol,BP,
1715,GO:0033559,1,0.864847534366939,0,1,unsaturated fatty acid metabolic process,BP,
1717,GO:0033613,1,0.567926568876566,0,1,activating transcription factor binding,MF,
1721,GO:0033764,1,0.142749943824279,0,4,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
1735,GO:0034103,1,0.798192256085599,0,1,regulation of tissue remodeling,BP,
1736,GO:0034121,1,0.713969292256814,0,1,regulation of toll-like receptor signaling pathway,BP,
1737,GO:0034122,1,0.713969292256814,0,1,negative regulation of toll-like receptor signaling pathway,BP,
1738,GO:0034127,1,0.713969292256814,0,1,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
1739,GO:0034128,1,0.713969292256814,0,1,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
1740,GO:0034220,1,0.0424643300218628,0,8,ion transmembrane transport,BP,
1742,GO:0034249,1,0.589082786340178,0,1,negative regulation of cellular amide metabolic process,BP,
1743,GO:0034250,1,0.719242044270235,0,1,positive regulation of cellular amide metabolic process,BP,
1744,GO:0034260,1,0.655086466259755,0,1,negative regulation of GTPase activity,BP,
1747,GO:0034330,1,0.589082786340178,0,1,cell junction organization,BP,
1748,GO:0034332,1,0.589082786340178,0,1,adherens junction organization,BP,
1751,GO:0034356,1,0.433876173620188,0,2,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
1752,GO:0034358,1,0.555979667472001,0,1,plasma lipoprotein particle,CC,
1753,GO:0034361,1,0.555979667472001,0,1,very-low-density lipoprotein particle,CC,
1754,GO:0034364,1,0.555979667472001,0,1,high-density lipoprotein particle,CC,
1760,GO:0034377,1,0.555979667472001,0,1,plasma lipoprotein particle assembly,BP,
1761,GO:0034379,1,0.555979667472001,0,1,very-low-density lipoprotein particle assembly,BP,
1762,GO:0034381,1,0.555979667472001,0,1,plasma lipoprotein particle clearance,BP,
1763,GO:0034382,1,0.555979667472001,0,1,chylomicron remnant clearance,BP,
1764,GO:0034385,1,0.555979667472001,0,1,triglyceride-rich plasma lipoprotein particle,CC,
1765,GO:0034394,1,0.578183005063771,0,1,protein localization to cell surface,BP,
1766,GO:0034399,1,0.839081013955894,0,1,nuclear periphery,CC,
1767,GO:0034418,1,0.691634315525481,0,1,urate biosynthetic process,BP,
1774,GO:0034447,1,0.555979667472001,0,1,very-low-density lipoprotein particle clearance,BP,
1776,GO:0034504,1,0.616295371802482,0,1,protein localization to nucleus,BP,
1777,GO:0034599,1,0.401830738437191,0,2,cellular response to oxidative stress,BP,
1780,GO:0034614,1,0.655086466259755,0,1,cellular response to reactive oxygen species,BP,
1783,GO:0034622,1,0.125323060183981,0,4,cellular macromolecular complex assembly,BP,
1786,GO:0034638,1,0.555979667472001,0,1,phosphatidylcholine catabolic process,BP,
1792,GO:0034698,1,0.711704209234577,0,1,response to gonadotropin,BP,
1793,GO:0034699,1,0.711704209234577,0,1,response to luteinizing hormone,BP,
1796,GO:0034707,1,0.560477493310972,0,1,chloride channel complex,CC,
1798,GO:0034762,1,0.232721929639651,0,3,regulation of transmembrane transport,BP,
1799,GO:0034764,1,0.365154074377246,0,2,positive regulation of transmembrane transport,BP,
1800,GO:0034765,1,0.232721929639651,0,3,regulation of ion transmembrane transport,BP,
1801,GO:0034767,1,0.365154074377246,0,2,positive regulation of ion transmembrane transport,BP,
1802,GO:0034774,1,0.0669370568571096,0,6,secretory granule lumen,CC,
1809,GO:0035235,1,0.941673510689999,0,1,ionotropic glutamate receptor signaling pathway,BP,
1812,GO:0035264,1,0.609584579935148,0,2,multicellular organism growth,BP,
1817,GO:0035303,1,0.655086466259755,0,1,regulation of dephosphorylation,BP,
1818,GO:0035304,1,0.655086466259755,0,1,regulation of protein dephosphorylation,BP,
1819,GO:0035305,1,0.655086466259755,0,1,negative regulation of dephosphorylation,BP,
1820,GO:0035306,1,0.655086466259755,0,1,positive regulation of dephosphorylation,BP,
1821,GO:0035308,1,0.655086466259755,0,1,negative regulation of protein dephosphorylation,BP,
1822,GO:0035335,1,0.569963413166498,0,1,peptidyl-tyrosine dephosphorylation,BP,
1823,GO:0035336,1,0.516372868737228,0,2,long-chain fatty-acyl-CoA metabolic process,BP,
1824,GO:0035337,1,0.516372868737228,0,2,fatty-acyl-CoA metabolic process,BP,
1825,GO:0035338,1,0.516372868737228,0,2,long-chain fatty-acyl-CoA biosynthetic process,BP,
1828,GO:0035434,1,0.64381053571965,0,1,copper ion transmembrane transport,BP,
1829,GO:0035455,1,0.711704209234577,0,1,response to interferon-alpha,BP,
1830,GO:0035457,1,0.711704209234577,0,1,cellular response to interferon-alpha,BP,
1833,GO:0035578,1,0.232470457655634,0,3,azurophil granule lumen,CC,
1834,GO:0035586,1,0.704636963882892,0,1,purinergic receptor activity,MF,
1835,GO:0035587,1,0.704636963882892,0,1,purinergic receptor signaling pathway,BP,
1836,GO:0035588,1,0.704636963882892,0,1,G-protein coupled purinergic receptor signaling pathway,BP,
1837,GO:0035589,1,0.704636963882892,0,1,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
1838,GO:0035590,1,0.704636963882892,0,1,purinergic nucleotide receptor signaling pathway,BP,
1841,GO:0035637,1,0.560477493310972,0,1,multicellular organismal signaling,BP,
1847,GO:0035725,1,0.560477493310972,0,1,sodium ion transmembrane transport,BP,
1851,GO:0035770,1,0.859384162384488,0,1,ribonucleoprotein granule,CC,
1857,GO:0035914,1,0.599447363464003,0,1,skeletal muscle cell differentiation,BP,
1858,GO:0035962,1,0.810726287680263,0,1,response to interleukin-13,BP,
1859,GO:0035963,1,0.810726287680263,0,1,cellular response to interleukin-13,BP,
1862,GO:0036041,1,0.596972964066786,0,1,long-chain fatty acid binding,MF,
1867,GO:0036109,1,0.864847534366939,0,1,alpha-linolenic acid metabolic process,BP,
1873,GO:0036230,1,0.0669370568571096,0,6,granulocyte activation,BP,
1876,GO:0036376,1,0.560477493310972,0,1,sodium ion export from cell,BP,
1877,GO:0036379,1,0.612519110445417,0,1,myofilament,CC,
1879,GO:0036464,1,0.859384162384488,0,1,cytoplasmic ribonucleoprotein granule,CC,
1880,GO:0036473,1,0.616295371802482,0,1,cell death in response to oxidative stress,BP,
1883,GO:0038023,1,0.338744046042821,0,4,signaling receptor activity,MF,
1888,GO:0038127,1,0.65227670309888,0,1,ERBB signaling pathway,BP,
1893,GO:0040013,1,0.655086466259755,0,1,negative regulation of locomotion,BP,
1894,GO:0040014,1,0.859384162384488,0,1,regulation of multicellular organism growth,BP,
1896,GO:0040018,1,0.859384162384488,0,1,positive regulation of multicellular organism growth,BP,
1897,GO:0042033,1,0.713969292256814,0,1,chemokine biosynthetic process,BP,
1898,GO:0042035,1,0.443299473628315,0,2,regulation of cytokine biosynthetic process,BP,
1899,GO:0042036,1,0.623289805927393,0,1,negative regulation of cytokine biosynthetic process,BP,
1900,GO:0042058,1,0.65227670309888,0,1,regulation of epidermal growth factor receptor signaling pathway,BP,
1901,GO:0042060,1,0.691167248140885,0,2,wound healing,BP,
1902,GO:0042063,1,0.389899543980631,0,2,gliogenesis,BP,
1903,GO:0042089,1,0.443299473628315,0,2,cytokine biosynthetic process,BP,
1905,GO:0042100,1,0.713969292256814,0,1,B cell proliferation,BP,
1908,GO:0042107,1,0.443299473628315,0,2,cytokine metabolic process,BP,
1909,GO:0042108,1,0.713969292256814,0,1,positive regulation of cytokine biosynthetic process,BP,
1911,GO:0042113,1,0.713969292256814,0,1,B cell activation,BP,
1912,GO:0042116,1,0.577647540220655,0,2,macrophage activation,BP,
1913,GO:0042119,1,0.0669370568571096,0,6,neutrophil activation,BP,
1922,GO:0042168,1,0.732102610026488,0,1,heme metabolic process,BP,
1926,GO:0042181,1,0.42519801020939,0,2,ketone biosynthetic process,BP,
1928,GO:0042219,1,0.764401591462327,0,1,cellular modified amino acid catabolic process,BP,
1931,GO:0042254,1,0.839081013955894,0,1,ribosome biogenesis,BP,
1932,GO:0042277,1,0.505015780163201,0,2,peptide binding,MF,
1933,GO:0042278,1,0.691634315525481,0,1,purine nucleoside metabolic process,BP,
1934,GO:0042301,1,0.691634315525481,0,1,phosphate ion binding,MF,
1935,GO:0042303,1,0.623289805927393,0,1,molting cycle,BP,
1937,GO:0042306,1,0.616295371802482,0,1,regulation of protein import into nucleus,BP,
1942,GO:0042339,1,0.653661854217472,0,1,keratan sulfate metabolic process,BP,
1943,GO:0042340,1,0.653661854217472,0,1,keratan sulfate catabolic process,BP,
1944,GO:0042345,1,0.616295371802482,0,1,regulation of NF-kappaB import into nucleus,BP,
1945,GO:0042348,1,0.616295371802482,0,1,NF-kappaB import into nucleus,BP,
1946,GO:0042359,1,0.658312207785409,0,1,vitamin D metabolic process,BP,
1947,GO:0042364,1,0.655086466259755,0,1,water-soluble vitamin biosynthetic process,BP,
1949,GO:0042383,1,0.560477493310972,0,1,sarcolemma,CC,
1950,GO:0042391,1,0.526897073579373,0,2,regulation of membrane potential,BP,
1951,GO:0042398,1,0.577407483649635,0,1,cellular modified amino acid biosynthetic process,BP,
1952,GO:0042402,1,0.764401591462327,0,1,cellular biogenic amine catabolic process,BP,
1960,GO:0042426,1,0.764401591462327,0,1,choline catabolic process,BP,
1961,GO:0042440,1,0.732102610026488,0,1,pigment metabolic process,BP,
1963,GO:0042446,1,0.0497266005593815,0,7,hormone biosynthetic process,BP,
1964,GO:0042447,1,0.651257914139894,0,1,hormone catabolic process,BP,
1965,GO:0042448,1,0.650967119323947,0,1,progesterone metabolic process,BP,
1966,GO:0042454,1,0.691634315525481,0,1,ribonucleoside catabolic process,BP,
1971,GO:0042503,1,0.859384162384488,0,1,tyrosine phosphorylation of Stat3 protein,BP,
1972,GO:0042506,1,0.859384162384488,0,1,tyrosine phosphorylation of Stat5 protein,BP,
1973,GO:0042509,1,0.859384162384488,0,1,regulation of tyrosine phosphorylation of STAT protein,BP,
1974,GO:0042516,1,0.859384162384488,0,1,regulation of tyrosine phosphorylation of Stat3 protein,BP,
1975,GO:0042517,1,0.859384162384488,0,1,positive regulation of tyrosine phosphorylation of Stat3 protein,BP,
1976,GO:0042522,1,0.859384162384488,0,1,regulation of tyrosine phosphorylation of Stat5 protein,BP,
1977,GO:0042523,1,0.859384162384488,0,1,positive regulation of tyrosine phosphorylation of Stat5 protein,BP,
1978,GO:0042531,1,0.859384162384488,0,1,positive regulation of tyrosine phosphorylation of STAT protein,BP,
1980,GO:0042542,1,0.711704209234577,0,1,response to hydrogen peroxide,BP,
1981,GO:0042552,1,0.653661854217472,0,1,myelination,BP,
1984,GO:0042562,1,0.859384162384488,0,1,hormone binding,MF,
1986,GO:0042578,1,0.357187322218882,0,2,phosphoric ester hydrolase activity,MF,
1988,GO:0042582,1,0.232470457655634,0,3,azurophil granule,CC,
1995,GO:0042627,1,0.555979667472001,0,1,chylomicron,CC,
1997,GO:0042633,1,0.623289805927393,0,1,hair cycle,BP,
1998,GO:0042634,1,0.623289805927393,0,1,regulation of hair cycle,BP,
1999,GO:0042635,1,0.623289805927393,0,1,positive regulation of hair cycle,BP,
2001,GO:0042698,1,0.589082786340178,0,1,ovulation cycle,BP,
2002,GO:0042726,1,0.630292050615999,0,1,flavin-containing compound metabolic process,BP,
2003,GO:0042742,1,0.583640461943381,0,1,defense response to bacterium,BP,
2005,GO:0042747,1,0.711704209234577,0,1,circadian sleep/wake cycle, REM sleep,BP,
2007,GO:0042759,1,0.762488370432474,0,1,long-chain fatty acid biosynthetic process,BP,
2008,GO:0042761,1,0.762488370432474,0,1,very long-chain fatty acid biosynthetic process,BP,
2009,GO:0042762,1,0.798192256085599,0,1,regulation of sulfur metabolic process,BP,
2010,GO:0042771,1,0.583640461943381,0,1,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
2014,GO:0042816,1,0.918333225139973,0,1,vitamin B6 metabolic process,BP,
2016,GO:0042940,1,0.79420415032525,0,1,D-amino acid transport,BP,
2017,GO:0042976,1,0.859384162384488,0,1,activation of Janus kinase activity,BP,
2018,GO:0042977,1,0.859384162384488,0,1,activation of JAK2 kinase activity,BP,
2022,GO:0042990,1,0.616295371802482,0,1,regulation of transcription factor import into nucleus,BP,
2023,GO:0042991,1,0.616295371802482,0,1,transcription factor import into nucleus,BP,
2028,GO:0043014,1,0.821441120987107,0,1,alpha-tubulin binding,MF,
2029,GO:0043021,1,0.839081013955894,0,1,ribonucleoprotein complex binding,MF,
2031,GO:0043027,1,0.616295371802482,0,1,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
2032,GO:0043028,1,0.357630949940387,0,2,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
2034,GO:0043030,1,0.810726287680263,0,1,regulation of macrophage activation,BP,
2044,GO:0043090,1,0.79420415032525,0,1,amino acid import,BP,
2045,GO:0043092,1,0.79420415032525,0,1,L-amino acid import,BP,
2046,GO:0043094,1,0.515302215114596,0,2,cellular metabolic compound salvage,BP,
2047,GO:0043101,1,0.691634315525481,0,1,purine-containing compound salvage,BP,
2048,GO:0043102,1,0.747143336113352,0,1,amino acid salvage,BP,
2051,GO:0043124,1,0.583640461943381,0,1,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
2052,GO:0043154,1,0.616295371802482,0,1,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
2064,GO:0043209,1,0.608833693873605,0,1,myelin sheath,CC,
2076,GO:0043242,1,0.612519110445417,0,1,negative regulation of protein complex disassembly,BP,
2077,GO:0043244,1,0.612519110445417,0,1,regulation of protein complex disassembly,BP,
2079,GO:0043269,1,0.232721929639651,0,3,regulation of ion transport,BP,
2080,GO:0043270,1,0.365154074377246,0,2,positive regulation of ion transport,BP,
2081,GO:0043276,1,0.798192256085599,0,1,anoikis,BP,
2086,GO:0043292,1,0.612519110445417,0,1,contractile fiber,CC,
2087,GO:0043299,1,0.0669370568571096,0,6,leukocyte degranulation,BP,
2088,GO:0043312,1,0.0669370568571096,0,6,neutrophil degranulation,BP,
2089,GO:0043330,1,0.713969292256814,0,1,response to exogenous dsRNA,BP,
2090,GO:0043331,1,0.713969292256814,0,1,response to dsRNA,BP,
2091,GO:0043393,1,0.420130725640792,0,2,regulation of protein binding,BP,
2099,GO:0043433,1,0.583640461943381,0,1,negative regulation of sequence-specific DNA binding transcription factor activity,BP,
2102,GO:0043462,1,0.655086466259755,0,1,regulation of ATPase activity,BP,
2106,GO:0043491,1,0.821441120987107,0,1,protein kinase B signaling,BP,
2108,GO:0043496,1,0.420130725640792,0,2,regulation of protein homodimerization activity,BP,
2109,GO:0043500,1,0.616295371802482,0,1,muscle adaptation,BP,
2110,GO:0043502,1,0.616295371802482,0,1,regulation of muscle adaptation,BP,
2111,GO:0043523,1,0.711704209234577,0,1,regulation of neuron apoptotic process,BP,
2112,GO:0043524,1,0.711704209234577,0,1,negative regulation of neuron apoptotic process,BP,
2115,GO:0043546,1,0.918333225139973,0,1,molybdopterin cofactor binding,MF,
2122,GO:0043615,1,0.653661854217472,0,1,astrocyte cell migration,BP,
2125,GO:0043623,1,0.206860194262745,0,3,cellular protein complex assembly,BP,
2127,GO:0043627,1,0.711704209234577,0,1,response to estrogen,BP,
2130,GO:0043650,1,0.79420415032525,0,1,dicarboxylic acid biosynthetic process,BP,
2131,GO:0043651,1,0.864847534366939,0,1,linoleic acid metabolic process,BP,
2132,GO:0043666,1,0.655086466259755,0,1,regulation of phosphoprotein phosphatase activity,BP,
2136,GO:0043900,1,0.839081013955894,0,1,regulation of multi-organism process,BP,
2137,GO:0043901,1,0.839081013955894,0,1,negative regulation of multi-organism process,BP,
2138,GO:0043903,1,0.839081013955894,0,1,regulation of symbiosis, encompassing mutualism through parasitism,BP,
2160,GO:0044262,1,0.237292229607244,0,4,cellular carbohydrate metabolic process,BP,
2172,GO:0044321,1,0.711704209234577,0,1,response to leptin,BP,
2173,GO:0044325,1,0.560477493310972,0,1,ion channel binding,MF,
2175,GO:0044351,1,0.583640461943381,0,1,macropinocytosis,BP,
2176,GO:0044381,1,0.839081013955894,0,1,glucose import in response to insulin stimulus,BP,
2180,GO:0044420,1,0.589082786340178,0,1,extracellular matrix component,CC,
2198,GO:0044449,1,0.612519110445417,0,1,contractile fiber part,CC,
2200,GO:0044452,1,0.747143336113352,0,1,nucleolar part,CC,
2206,GO:0044539,1,0.596972964066786,0,1,long-chain fatty acid import,BP,
2207,GO:0044548,1,0.599447363464003,0,1,S100 protein binding,MF,
2208,GO:0044550,1,0.732102610026488,0,1,secondary metabolite biosynthetic process,BP,
2213,GO:0044706,1,0.653661854217472,0,1,multi-multicellular organism process,BP,
2220,GO:0044724,1,0.399011275471935,0,2,single-organism carbohydrate catabolic process,BP,
2221,GO:0044744,1,0.616295371802482,0,1,protein targeting to nucleus,BP,
2234,GO:0045019,1,0.403600025965013,0,2,negative regulation of nitric oxide biosynthetic process,BP,
2235,GO:0045028,1,0.704636963882892,0,1,G-protein coupled purinergic nucleotide receptor activity,MF,
2236,GO:0045029,1,0.704636963882892,0,1,UDP-activated nucleotide receptor activity,MF,
2237,GO:0045055,1,0.0461030329033915,0,7,regulated exocytosis,BP,
2238,GO:0045069,1,0.839081013955894,0,1,regulation of viral genome replication,BP,
2239,GO:0045071,1,0.839081013955894,0,1,negative regulation of viral genome replication,BP,
2240,GO:0045073,1,0.713969292256814,0,1,regulation of chemokine biosynthetic process,BP,
2241,GO:0045080,1,0.713969292256814,0,1,positive regulation of chemokine biosynthetic process,BP,
2248,GO:0045124,1,0.798192256085599,0,1,regulation of bone resorption,BP,
2249,GO:0045137,1,0.2838747425761,0,3,development of primary sexual characteristics,BP,
2252,GO:0045211,1,0.941673510689999,0,1,postsynaptic membrane,CC,
2253,GO:0045216,1,0.589082786340178,0,1,cell-cell junction organization,BP,
2255,GO:0045296,1,0.685412997987241,0,1,cadherin binding,MF,
2258,GO:0045349,1,0.623289805927393,0,1,interferon-alpha biosynthetic process,BP,
2259,GO:0045350,1,0.443299473628315,0,2,interferon-beta biosynthetic process,BP,
2260,GO:0045351,1,0.443299473628315,0,2,type I interferon biosynthetic process,BP,
2261,GO:0045354,1,0.623289805927393,0,1,regulation of interferon-alpha biosynthetic process,BP,
2262,GO:0045355,1,0.623289805927393,0,1,negative regulation of interferon-alpha biosynthetic process,BP,
2263,GO:0045357,1,0.443299473628315,0,2,regulation of interferon-beta biosynthetic process,BP,
2264,GO:0045358,1,0.623289805927393,0,1,negative regulation of interferon-beta biosynthetic process,BP,
2265,GO:0045359,1,0.713969292256814,0,1,positive regulation of interferon-beta biosynthetic process,BP,
2266,GO:0045428,1,0.286008402283601,0,3,regulation of nitric oxide biosynthetic process,BP,
2267,GO:0045429,1,0.713969292256814,0,1,positive regulation of nitric oxide biosynthetic process,BP,
2269,GO:0045453,1,0.798192256085599,0,1,bone resorption,BP,
2272,GO:0045485,1,0.864847534366939,0,1,omega-6 fatty acid desaturase activity,MF,
2275,GO:0045580,1,0.691634315525481,0,1,regulation of T cell differentiation,BP,
2276,GO:0045582,1,0.691634315525481,0,1,positive regulation of T cell differentiation,BP,
2280,GO:0045619,1,0.691634315525481,0,1,regulation of lymphocyte differentiation,BP,
2281,GO:0045621,1,0.691634315525481,0,1,positive regulation of lymphocyte differentiation,BP,
2288,GO:0045682,1,0.623289805927393,0,1,regulation of epidermis development,BP,
2289,GO:0045684,1,0.623289805927393,0,1,positive regulation of epidermis development,BP,
2291,GO:0045723,1,0.655086466259755,0,1,positive regulation of fatty acid biosynthetic process,BP,
2292,GO:0045727,1,0.719242044270235,0,1,positive regulation of translation,BP,
2294,GO:0045742,1,0.65227670309888,0,1,positive regulation of epidermal growth factor receptor signaling pathway,BP,
2295,GO:0045744,1,0.705187209057733,0,1,negative regulation of G-protein coupled receptor protein signaling pathway,BP,
2299,GO:0045806,1,0.555979667472001,0,1,negative regulation of endocytosis,BP,
2300,GO:0045807,1,0.583640461943381,0,1,positive regulation of endocytosis,BP,
2301,GO:0045824,1,0.623289805927393,0,1,negative regulation of innate immune response,BP,
2307,GO:0045861,1,0.430204914310017,0,2,negative regulation of proteolysis,BP,
2309,GO:0045892,1,0.567926568876566,0,1,negative regulation of transcription, DNA-templated,BP,
2311,GO:0045913,1,0.655086466259755,0,1,positive regulation of carbohydrate metabolic process,BP,
2313,GO:0045923,1,0.655086466259755,0,1,positive regulation of fatty acid metabolic process,BP,
2315,GO:0045927,1,0.859384162384488,0,1,positive regulation of growth,BP,
2317,GO:0045934,1,0.370047057446183,0,2,negative regulation of nucleobase-containing compound metabolic process,BP,
2323,GO:0045981,1,0.578183005063771,0,1,positive regulation of nucleotide metabolic process,BP,
2325,GO:0046058,1,0.578183005063771,0,1,cAMP metabolic process,BP,
2326,GO:0046102,1,0.691634315525481,0,1,inosine metabolic process,BP,
2327,GO:0046110,1,0.918333225139973,0,1,xanthine metabolic process,BP,
2328,GO:0046113,1,0.918333225139973,0,1,nucleobase catabolic process,BP,
2329,GO:0046121,1,0.640583205088349,0,1,deoxyribonucleoside catabolic process,BP,
2330,GO:0046128,1,0.691634315525481,0,1,purine ribonucleoside metabolic process,BP,
2331,GO:0046130,1,0.691634315525481,0,1,purine ribonucleoside catabolic process,BP,
2335,GO:0046209,1,0.286008402283601,0,3,nitric oxide metabolic process,BP,
2339,GO:0046324,1,0.839081013955894,0,1,regulation of glucose import,BP,
2340,GO:0046326,1,0.839081013955894,0,1,positive regulation of glucose import,BP,
2341,GO:0046328,1,0.583640461943381,0,1,regulation of JNK cascade,BP,
2342,GO:0046330,1,0.583640461943381,0,1,positive regulation of JNK cascade,BP,
2343,GO:0046339,1,0.589082786340178,0,1,diacylglycerol metabolic process,BP,
2346,GO:0046365,1,0.613341072417478,0,1,monosaccharide catabolic process,BP,
2347,GO:0046386,1,0.640583205088349,0,1,deoxyribose phosphate catabolic process,BP,
2351,GO:0046415,1,0.691634315525481,0,1,urate metabolic process,BP,
2352,GO:0046425,1,0.859384162384488,0,1,regulation of JAK-STAT cascade,BP,
2353,GO:0046427,1,0.859384162384488,0,1,positive regulation of JAK-STAT cascade,BP,
2355,GO:0046449,1,0.859384162384488,0,1,creatinine metabolic process,BP,
2356,GO:0046456,1,0.498144391540649,0,2,icosanoid biosynthetic process,BP,
2357,GO:0046460,1,0.383946473467724,0,2,neutral lipid biosynthetic process,BP,
2358,GO:0046461,1,0.596972964066786,0,1,neutral lipid catabolic process,BP,
2359,GO:0046463,1,0.383946473467724,0,2,acylglycerol biosynthetic process,BP,
2360,GO:0046464,1,0.596972964066786,0,1,acylglycerol catabolic process,BP,
2361,GO:0046466,1,0.402714433748352,0,2,membrane lipid catabolic process,BP,
2365,GO:0046475,1,0.555979667472001,0,1,glycerophospholipid catabolic process,BP,
2366,GO:0046477,1,0.618986977187954,0,1,glycosylceramide catabolic process,BP,
2367,GO:0046479,1,0.402714433748352,0,2,glycosphingolipid catabolic process,BP,
2371,GO:0046487,1,0.685412997987241,0,1,glyoxylate metabolic process,BP,
2373,GO:0046495,1,0.691634315525481,0,1,nicotinamide riboside metabolic process,BP,
2374,GO:0046496,1,0.0891618066743344,0,6,nicotinamide nucleotide metabolic process,BP,
2375,GO:0046503,1,0.329743218610697,0,2,glycerolipid catabolic process,BP,
2376,GO:0046514,1,0.402714433748352,0,2,ceramide catabolic process,BP,
2377,GO:0046523,1,0.747143336113352,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
2380,GO:0046545,1,0.401897905291834,0,2,development of primary female sexual characteristics,BP,
2381,GO:0046546,1,0.711704209234577,0,1,development of primary male sexual characteristics,BP,
2382,GO:0046573,1,0.634317961549412,0,1,lactonohydrolase activity,MF,
2385,GO:0046631,1,0.691634315525481,0,1,alpha-beta T cell activation,BP,
2386,GO:0046632,1,0.691634315525481,0,1,alpha-beta T cell differentiation,BP,
2387,GO:0046634,1,0.691634315525481,0,1,regulation of alpha-beta T cell activation,BP,
2388,GO:0046635,1,0.691634315525481,0,1,positive regulation of alpha-beta T cell activation,BP,
2389,GO:0046637,1,0.691634315525481,0,1,regulation of alpha-beta T cell differentiation,BP,
2390,GO:0046638,1,0.691634315525481,0,1,positive regulation of alpha-beta T cell differentiation,BP,
2394,GO:0046661,1,0.42519801020939,0,2,male sex differentiation,BP,
2395,GO:0046677,1,0.563991386176293,0,2,response to antibiotic,BP,
2396,GO:0046683,1,0.711704209234577,0,1,response to organophosphorus,BP,
2398,GO:0046686,1,0.410128158770303,0,2,response to cadmium ion,BP,
2400,GO:0046717,1,0.79420415032525,0,1,acid secretion,BP,
2401,GO:0046822,1,0.347915894904772,0,2,regulation of nucleocytoplasmic transport,BP,
2402,GO:0046825,1,0.567926568876566,0,1,regulation of protein export from nucleus,BP,
2404,GO:0046849,1,0.798192256085599,0,1,bone remodeling,BP,
2405,GO:0046850,1,0.798192256085599,0,1,regulation of bone remodeling,BP,
2410,GO:0046873,1,0.509920120789622,0,2,metal ion transmembrane transporter activity,MF,
2418,GO:0046906,1,0.244399852068762,0,3,tetrapyrrole binding,MF,
2421,GO:0046915,1,0.64381053571965,0,1,transition metal ion transmembrane transporter activity,MF,
2422,GO:0046916,1,0.64381053571965,0,1,cellular transition metal ion homeostasis,BP,
2424,GO:0046942,1,0.350536300205429,0,3,carboxylic acid transport,BP,
2425,GO:0046943,1,0.79420415032525,0,1,carboxylic acid transmembrane transporter activity,MF,
2426,GO:0046949,1,0.516372868737228,0,2,fatty-acyl-CoA biosynthetic process,BP,
2432,GO:0046997,1,0.764401591462327,0,1,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
2433,GO:0047015,1,0.587339765995185,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
2434,GO:0047035,1,0.599916628402907,0,1,testosterone dehydrogenase (NAD+) activity,MF,
2435,GO:0047045,1,0.599916628402907,0,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
2436,GO:0047442,1,0.650967119323947,0,1,17-alpha-hydroxyprogesterone aldolase activity,MF,
2437,GO:0047598,1,0.710514904531027,0,1,7-dehydrocholesterol reductase activity,MF,
2438,GO:0047750,1,0.600923415171073,0,1,cholestenol delta-isomerase activity,MF,
2439,GO:0047760,1,0.692483461339883,0,1,butyrate-CoA ligase activity,MF,
2440,GO:0047860,1,0.608833693873605,0,1,diiodophenylpyruvate reductase activity,MF,
2442,GO:0048009,1,0.859384162384488,0,1,insulin-like growth factor receptor signaling pathway,BP,
2447,GO:0048029,1,0.636162746596575,0,1,monosaccharide binding,MF,
2456,GO:0048156,1,0.599447363464003,0,1,tau protein binding,MF,
2457,GO:0048167,1,0.424863116860886,0,2,regulation of synaptic plasticity,BP,
2458,GO:0048168,1,0.424863116860886,0,2,regulation of neuronal synaptic plasticity,BP,
2460,GO:0048232,1,0.655086466259755,0,1,male gamete generation,BP,
2461,GO:0048244,1,0.636162746596575,0,1,phytanoyl-CoA dioxygenase activity,MF,
2462,GO:0048259,1,0.555979667472001,0,1,regulation of receptor-mediated endocytosis,BP,
2463,GO:0048261,1,0.555979667472001,0,1,negative regulation of receptor-mediated endocytosis,BP,
2466,GO:0048306,1,0.599447363464003,0,1,calcium-dependent protein binding,MF,
2468,GO:0048469,1,0.589082786340178,0,1,cell maturation,BP,
2470,GO:0048477,1,0.383103383990114,0,2,oogenesis,BP,
2479,GO:0048525,1,0.839081013955894,0,1,negative regulation of viral process,BP,
2495,GO:0048599,1,0.589082786340178,0,1,oocyte development,BP,
2501,GO:0048639,1,0.859384162384488,0,1,positive regulation of developmental growth,BP,
2503,GO:0048641,1,0.599447363464003,0,1,regulation of skeletal muscle tissue development,BP,
2504,GO:0048642,1,0.599447363464003,0,1,negative regulation of skeletal muscle tissue development,BP,
2506,GO:0048659,1,0.589082786340178,0,1,smooth muscle cell proliferation,BP,
2507,GO:0048660,1,0.589082786340178,0,1,regulation of smooth muscle cell proliferation,BP,
2508,GO:0048662,1,0.589082786340178,0,1,negative regulation of smooth muscle cell proliferation,BP,
2514,GO:0048708,1,0.599447363464003,0,1,astrocyte differentiation,BP,
2520,GO:0048771,1,0.490487801570082,0,2,tissue remodeling,BP,
2531,GO:0050277,1,0.810726287680263,0,1,sedoheptulokinase activity,MF,
2532,GO:0050508,1,0.826942722683401,0,1,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
2533,GO:0050543,1,0.596972964066786,0,1,icosatetraenoic acid binding,MF,
2534,GO:0050654,1,0.439379228515079,0,2,chondroitin sulfate proteoglycan metabolic process,BP,
2535,GO:0050655,1,0.674865017619115,0,1,dermatan sulfate proteoglycan metabolic process,BP,
2539,GO:0050663,1,0.401807098827276,0,2,cytokine secretion,BP,
2542,GO:0050673,1,0.383946473467724,0,2,epithelial cell proliferation,BP,
2543,GO:0050678,1,0.383946473467724,0,2,regulation of epithelial cell proliferation,BP,
2544,GO:0050679,1,0.589082786340178,0,1,positive regulation of epithelial cell proliferation,BP,
2545,GO:0050680,1,0.655086466259755,0,1,negative regulation of epithelial cell proliferation,BP,
2546,GO:0050699,1,0.601528286054534,0,1,WW domain binding,MF,
2547,GO:0050701,1,0.583640461943381,0,1,interleukin-1 secretion,BP,
2548,GO:0050702,1,0.583640461943381,0,1,interleukin-1 beta secretion,BP,
2549,GO:0050704,1,0.583640461943381,0,1,regulation of interleukin-1 secretion,BP,
2550,GO:0050706,1,0.583640461943381,0,1,regulation of interleukin-1 beta secretion,BP,
2551,GO:0050707,1,0.583640461943381,0,1,regulation of cytokine secretion,BP,
2554,GO:0050715,1,0.583640461943381,0,1,positive regulation of cytokine secretion,BP,
2555,GO:0050716,1,0.583640461943381,0,1,positive regulation of interleukin-1 secretion,BP,
2556,GO:0050718,1,0.583640461943381,0,1,positive regulation of interleukin-1 beta secretion,BP,
2557,GO:0050727,1,0.349290737064033,0,3,regulation of inflammatory response,BP,
2558,GO:0050730,1,0.859384162384488,0,1,regulation of peptidyl-tyrosine phosphorylation,BP,
2559,GO:0050731,1,0.859384162384488,0,1,positive regulation of peptidyl-tyrosine phosphorylation,BP,
2560,GO:0050755,1,0.713969292256814,0,1,chemokine metabolic process,BP,
2561,GO:0050764,1,0.583640461943381,0,1,regulation of phagocytosis,BP,
2562,GO:0050766,1,0.583640461943381,0,1,positive regulation of phagocytosis,BP,
2565,GO:0050769,1,0.711704209234577,0,1,positive regulation of neurogenesis,BP,
2569,GO:0050777,1,0.623289805927393,0,1,negative regulation of immune response,BP,
2571,GO:0050786,1,0.599447363464003,0,1,RAGE receptor binding,MF,
2574,GO:0050792,1,0.839081013955894,0,1,regulation of viral process,BP,
2580,GO:0050802,1,0.711704209234577,0,1,circadian sleep/wake cycle, sleep,BP,
2582,GO:0050806,1,0.474604687322434,0,2,positive regulation of synaptic transmission,BP,
2584,GO:0050812,1,0.798192256085599,0,1,regulation of acyl-CoA biosynthetic process,BP,
2585,GO:0050817,1,0.691167248140885,0,2,coagulation,BP,
2586,GO:0050818,1,0.986830983483857,0,1,regulation of coagulation,BP,
2588,GO:0050829,1,0.583640461943381,0,1,defense response to Gram-negative bacterium,BP,
2589,GO:0050839,1,0.685412997987241,0,1,cell adhesion molecule binding,MF,
2590,GO:0050848,1,0.655086466259755,0,1,regulation of calcium-mediated signaling,BP,
2594,GO:0050864,1,0.713969292256814,0,1,regulation of B cell activation,BP,
2598,GO:0050871,1,0.713969292256814,0,1,positive regulation of B cell activation,BP,
2601,GO:0050878,1,0.691167248140885,0,2,regulation of body fluid levels,BP,
2602,GO:0050885,1,0.517764045825394,0,2,neuromuscular process controlling balance,BP,
2606,GO:0050905,1,0.517764045825394,0,2,neuromuscular process,BP,
2611,GO:0050994,1,0.379149515625133,0,2,regulation of lipid catabolic process,BP,
2612,GO:0050995,1,0.555979667472001,0,1,negative regulation of lipid catabolic process,BP,
2613,GO:0050997,1,0.555979667472001,0,1,quaternary ammonium group binding,MF,
2615,GO:0051001,1,0.618986977187954,0,1,negative regulation of nitric-oxide synthase activity,BP,
2616,GO:0051004,1,0.555979667472001,0,1,regulation of lipoprotein lipase activity,BP,
2617,GO:0051005,1,0.555979667472001,0,1,negative regulation of lipoprotein lipase activity,BP,
2618,GO:0051015,1,0.612519110445417,0,1,actin filament binding,MF,
2627,GO:0051052,1,0.655086466259755,0,1,regulation of DNA metabolic process,BP,
2628,GO:0051053,1,0.655086466259755,0,1,negative regulation of DNA metabolic process,BP,
2630,GO:0051090,1,0.256143453910256,0,3,regulation of sequence-specific DNA binding transcription factor activity,BP,
2631,GO:0051091,1,0.256143453910256,0,3,positive regulation of sequence-specific DNA binding transcription factor activity,BP,
2632,GO:0051092,1,0.256143453910256,0,3,positive regulation of NF-kappaB transcription factor activity,BP,
2635,GO:0051098,1,0.420130725640792,0,2,regulation of binding,BP,
2636,GO:0051099,1,0.713969292256814,0,1,positive regulation of binding,BP,
2640,GO:0051156,1,0.517995302719917,0,2,glucose 6-phosphate metabolic process,BP,
2641,GO:0051168,1,0.567926568876566,0,1,nuclear export,BP,
2642,GO:0051169,1,0.347915894904772,0,2,nuclear transport,BP,
2643,GO:0051170,1,0.616295371802482,0,1,nuclear import,BP,
2645,GO:0051172,1,0.0710366945749023,0,5,negative regulation of nitrogen compound metabolic process,BP,
2653,GO:0051193,1,0.798192256085599,0,1,regulation of cofactor metabolic process,BP,
2654,GO:0051196,1,0.798192256085599,0,1,regulation of coenzyme metabolic process,BP,
2655,GO:0051208,1,0.616295371802482,0,1,sequestering of calcium ion,BP,
2656,GO:0051209,1,0.616295371802482,0,1,release of sequestered calcium ion into cytosol,BP,
2657,GO:0051213,1,0.636162746596575,0,1,dioxygenase activity,MF,
2663,GO:0051238,1,0.616295371802482,0,1,sequestering of metal ion,BP,
2673,GO:0051253,1,0.370047057446183,0,2,negative regulation of RNA metabolic process,BP,
2675,GO:0051258,1,0.206860194262745,0,3,protein polymerization,BP,
2678,GO:0051261,1,0.612519110445417,0,1,protein depolymerization,BP,
2681,GO:0051271,1,0.655086466259755,0,1,negative regulation of cellular component movement,BP,
2683,GO:0051282,1,0.616295371802482,0,1,regulation of sequestering of calcium ion,BP,
2684,GO:0051283,1,0.616295371802482,0,1,negative regulation of sequestering of calcium ion,BP,
2685,GO:0051287,1,0.276240527861266,0,4,NAD binding,MF,
2687,GO:0051291,1,0.366288549121611,0,2,protein heterooligomerization,BP,
2690,GO:0051340,1,0.655086466259755,0,1,regulation of ligase activity,BP,
2692,GO:0051342,1,0.655086466259755,0,1,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
2693,GO:0051344,1,0.655086466259755,0,1,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
2695,GO:0051346,1,0.15276578737209,0,4,negative regulation of hydrolase activity,BP,
2698,GO:0051352,1,0.655086466259755,0,1,negative regulation of ligase activity,BP,
2699,GO:0051353,1,0.655086466259755,0,1,positive regulation of oxidoreductase activity,BP,
2700,GO:0051354,1,0.618986977187954,0,1,negative regulation of oxidoreductase activity,BP,
2704,GO:0051403,1,0.583640461943381,0,1,stress-activated MAPK cascade,BP,
2712,GO:0051480,1,0.616295371802482,0,1,regulation of cytosolic calcium ion concentration,BP,
2713,GO:0051493,1,0.355418010872913,0,2,regulation of cytoskeleton organization,BP,
2714,GO:0051494,1,0.612519110445417,0,1,negative regulation of cytoskeleton organization,BP,
2715,GO:0051495,1,0.583640461943381,0,1,positive regulation of cytoskeleton organization,BP,
2717,GO:0051537,1,0.918333225139973,0,1,2 iron, 2 sulfur cluster binding,MF,
2720,GO:0051591,1,0.711704209234577,0,1,response to cAMP,BP,
2721,GO:0051597,1,0.599447363464003,0,1,response to methylmercury,BP,
2730,GO:0051693,1,0.612519110445417,0,1,actin filament capping,BP,
2731,GO:0051694,1,0.612519110445417,0,1,pointed-end actin filament capping,BP,
2738,GO:0051797,1,0.623289805927393,0,1,regulation of hair follicle development,BP,
2739,GO:0051798,1,0.623289805927393,0,1,positive regulation of hair follicle development,BP,
2740,GO:0051896,1,0.821441120987107,0,1,regulation of protein kinase B signaling,BP,
2741,GO:0051897,1,0.821441120987107,0,1,positive regulation of protein kinase B signaling,BP,
2742,GO:0051924,1,0.655086466259755,0,1,regulation of calcium ion transport,BP,
2743,GO:0051928,1,0.655086466259755,0,1,positive regulation of calcium ion transport,BP,
2744,GO:0051938,1,0.79420415032525,0,1,L-glutamate import,BP,
2747,GO:0051962,1,0.711704209234577,0,1,positive regulation of nervous system development,BP,
2748,GO:0051990,1,0.685412997987241,0,1,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
2752,GO:0052652,1,0.578183005063771,0,1,cyclic purine nucleotide metabolic process,BP,
2754,GO:0052692,1,0.618986977187954,0,1,raffinose alpha-galactosidase activity,MF,
2765,GO:0055065,1,0.119290470096636,0,5,metal ion homeostasis,BP,
2766,GO:0055067,1,0.798192256085599,0,1,monovalent inorganic cation homeostasis,BP,
2767,GO:0055070,1,0.64381053571965,0,1,copper ion homeostasis,BP,
2768,GO:0055072,1,0.732102610026488,0,1,iron ion homeostasis,BP,
2769,GO:0055074,1,0.260295466360574,0,3,calcium ion homeostasis,BP,
2770,GO:0055076,1,0.469726984985489,0,2,transition metal ion homeostasis,BP,
2771,GO:0055080,1,0.093944078970059,0,6,cation homeostasis,BP,
2781,GO:0055102,1,0.555979667472001,0,1,lipase inhibitor activity,MF,
2794,GO:0060078,1,0.941673510689999,0,1,regulation of postsynaptic membrane potential,BP,
2795,GO:0060079,1,0.941673510689999,0,1,excitatory postsynaptic potential,BP,
2796,GO:0060089,1,0.338744046042821,0,4,molecular transducer activity,MF,
2797,GO:0060090,1,0.623289805927393,0,1,binding, bridging,MF,
2799,GO:0060179,1,0.653661854217472,0,1,male mating behavior,BP,
2800,GO:0060191,1,0.325338988961646,0,2,regulation of lipase activity,BP,
2801,GO:0060192,1,0.555979667472001,0,1,negative regulation of lipase activity,BP,
2802,GO:0060193,1,0.589082786340178,0,1,positive regulation of lipase activity,BP,
2803,GO:0060205,1,0.0669370568571096,0,6,cytoplasmic vesicle lumen,CC,
2804,GO:0060228,1,0.555979667472001,0,1,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
2810,GO:0060291,1,0.599447363464003,0,1,long-term synaptic potentiation,BP,
2817,GO:0060341,1,0.347915894904772,0,2,regulation of cellular localization,BP,
2824,GO:0060396,1,0.859384162384488,0,1,growth hormone receptor signaling pathway,BP,
2825,GO:0060397,1,0.859384162384488,0,1,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
2826,GO:0060401,1,0.616295371802482,0,1,cytosolic calcium ion transport,BP,
2827,GO:0060402,1,0.616295371802482,0,1,calcium ion transport into cytosol,BP,
2828,GO:0060416,1,0.610609107297596,0,2,response to growth hormone,BP,
2832,GO:0060491,1,0.821441120987107,0,1,regulation of cell projection assembly,BP,
2834,GO:0060538,1,0.599447363464003,0,1,skeletal muscle organ development,BP,
2843,GO:0060696,1,0.379149515625133,0,2,regulation of phospholipid catabolic process,BP,
2846,GO:0060761,1,0.616295371802482,0,1,negative regulation of response to cytokine stimulus,BP,
2848,GO:0060992,1,0.711704209234577,0,1,response to fungicide,BP,
2854,GO:0061041,1,0.986830983483857,0,1,regulation of wound healing,BP,
2857,GO:0061134,1,0.248503063235893,0,3,peptidase regulator activity,MF,
2858,GO:0061135,1,0.430204914310017,0,2,endopeptidase regulator activity,MF,
2860,GO:0061337,1,0.560477493310972,0,1,cardiac conduction,BP,
2861,GO:0061370,1,0.42519801020939,0,2,testosterone biosynthetic process,BP,
2868,GO:0061695,1,0.583640461943381,0,1,transferase complex, transferring phosphorus-containing groups,CC,
2869,GO:0061702,1,0.355678835293696,0,2,inflammasome complex,CC,
2871,GO:0065005,1,0.555979667472001,0,1,protein-lipid complex assembly,BP,
2878,GO:0070059,1,0.612964205012402,0,1,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
2880,GO:0070064,1,0.859384162384488,0,1,proline-rich region binding,MF,
2886,GO:0070195,1,0.859384162384488,0,1,growth hormone receptor complex,CC,
2900,GO:0070279,1,0.662995103019366,0,1,vitamin B6 binding,MF,
2902,GO:0070296,1,0.616295371802482,0,1,sarcoplasmic reticulum calcium ion transport,BP,
2903,GO:0070302,1,0.583640461943381,0,1,regulation of stress-activated protein kinase signaling cascade,BP,
2904,GO:0070304,1,0.583640461943381,0,1,positive regulation of stress-activated protein kinase signaling cascade,BP,
2912,GO:0070509,1,0.616295371802482,0,1,calcium ion import,BP,
2913,GO:0070513,1,0.623289805927393,0,1,death domain binding,MF,
2915,GO:0070538,1,0.596972964066786,0,1,oleic acid binding,MF,
2916,GO:0070542,1,0.475031293533901,0,2,response to fatty acid,BP,
2917,GO:0070555,1,0.407251906460113,0,2,response to interleukin-1,BP,
2918,GO:0070569,1,0.613341072417478,0,1,uridylyltransferase activity,MF,
2919,GO:0070588,1,0.401830738437191,0,2,calcium ion transmembrane transport,BP,
2920,GO:0070613,1,0.435342303308956,0,2,regulation of protein processing,BP,
2921,GO:0070637,1,0.691634315525481,0,1,pyridine nucleoside metabolic process,BP,
2922,GO:0070638,1,0.691634315525481,0,1,pyridine nucleoside catabolic process,BP,
2928,GO:0070670,1,0.810726287680263,0,1,response to interleukin-4,BP,
2929,GO:0070696,1,0.583640461943381,0,1,transmembrane receptor protein serine/threonine kinase binding,MF,
2930,GO:0070700,1,0.583640461943381,0,1,BMP receptor binding,MF,
2931,GO:0070704,1,0.864847534366939,0,1,sterol desaturase activity,MF,
2933,GO:0070742,1,0.951869607711085,0,1,C2H2 zinc finger domain binding,MF,
2934,GO:0070777,1,0.79420415032525,0,1,D-aspartate transport,BP,
2935,GO:0070779,1,0.79420415032525,0,1,D-aspartate import,BP,
2936,GO:0070820,1,0.685412997987241,0,1,tertiary granule,CC,
2937,GO:0070838,1,0.401830738437191,0,2,divalent metal ion transport,BP,
2940,GO:0070857,1,0.711704209234577,0,1,regulation of bile acid biosynthetic process,BP,
2941,GO:0070859,1,0.711704209234577,0,1,positive regulation of bile acid biosynthetic process,BP,
2944,GO:0070901,1,0.587339765995185,0,1,mitochondrial tRNA methylation,BP,
2947,GO:0070936,1,0.623289805927393,0,1,protein K48-linked ubiquitination,BP,
2948,GO:0070970,1,0.691634315525481,0,1,interleukin-2 secretion,BP,
2949,GO:0070996,1,0.578183005063771,0,1,type 1 melanocortin receptor binding,MF,
2951,GO:0071071,1,0.407321429086963,0,2,regulation of phospholipid biosynthetic process,BP,
2952,GO:0071073,1,0.596972964066786,0,1,positive regulation of phospholipid biosynthetic process,BP,
2954,GO:0071216,1,0.163202101469173,0,5,cellular response to biotic stimulus,BP,
2955,GO:0071219,1,0.163202101469173,0,5,cellular response to molecule of bacterial origin,BP,
2956,GO:0071222,1,0.163202101469173,0,5,cellular response to lipopolysaccharide,BP,
2957,GO:0071229,1,0.798192256085599,0,1,cellular response to acid chemical,BP,
2958,GO:0071236,1,0.711704209234577,0,1,cellular response to antibiotic,BP,
2962,GO:0071265,1,0.747143336113352,0,1,L-methionine biosynthetic process,BP,
2963,GO:0071267,1,0.747143336113352,0,1,L-methionine salvage,BP,
2964,GO:0071276,1,0.711704209234577,0,1,cellular response to cadmium ion,BP,
2969,GO:0071320,1,0.711704209234577,0,1,cellular response to cAMP,BP,
2976,GO:0071347,1,0.407251906460113,0,2,cellular response to interleukin-1,BP,
2977,GO:0071353,1,0.810726287680263,0,1,cellular response to interleukin-4,BP,
2981,GO:0071371,1,0.711704209234577,0,1,cellular response to gonadotropin stimulus,BP,
2982,GO:0071372,1,0.711704209234577,0,1,cellular response to follicle-stimulating hormone stimulus,BP,
2983,GO:0071373,1,0.711704209234577,0,1,cellular response to luteinizing hormone stimulus,BP,
2984,GO:0071375,1,0.405842830831887,0,4,cellular response to peptide hormone stimulus,BP,
2985,GO:0071378,1,0.610609107297596,0,2,cellular response to growth hormone stimulus,BP,
2986,GO:0071383,1,0.711704209234577,0,1,cellular response to steroid hormone stimulus,BP,
2987,GO:0071384,1,0.711704209234577,0,1,cellular response to corticosteroid stimulus,BP,
2988,GO:0071385,1,0.711704209234577,0,1,cellular response to glucocorticoid stimulus,BP,
2989,GO:0071396,1,0.128741098581258,0,6,cellular response to lipid,BP,
2990,GO:0071398,1,0.798192256085599,0,1,cellular response to fatty acid,BP,
2993,GO:0071436,1,0.560477493310972,0,1,sodium ion export,BP,
2994,GO:0071450,1,0.655086466259755,0,1,cellular response to oxygen radical,BP,
2995,GO:0071451,1,0.655086466259755,0,1,cellular response to superoxide,BP,
2998,GO:0071466,1,0.337787899847262,0,3,cellular response to xenobiotic stimulus,BP,
3001,GO:0071548,1,0.711704209234577,0,1,response to dexamethasone,BP,
3002,GO:0071549,1,0.711704209234577,0,1,cellular response to dexamethasone stimulus,BP,
3004,GO:0071553,1,0.704636963882892,0,1,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,
3005,GO:0071559,1,0.711704209234577,0,1,response to transforming growth factor beta,BP,
3006,GO:0071560,1,0.711704209234577,0,1,cellular response to transforming growth factor beta stimulus,BP,
3015,GO:0071826,1,0.616295371802482,0,1,ribonucleoprotein complex subunit organization,BP,
3017,GO:0071830,1,0.555979667472001,0,1,triglyceride-rich lipoprotein particle clearance,BP,
3019,GO:0071855,1,0.578183005063771,0,1,neuropeptide receptor binding,MF,
3020,GO:0071867,1,0.711704209234577,0,1,response to monoamine,BP,
3021,GO:0071868,1,0.711704209234577,0,1,cellular response to monoamine stimulus,BP,
3022,GO:0071869,1,0.711704209234577,0,1,response to catecholamine,BP,
3023,GO:0071870,1,0.711704209234577,0,1,cellular response to catecholamine stimulus,BP,
3024,GO:0071871,1,0.711704209234577,0,1,response to epinephrine,BP,
3025,GO:0071872,1,0.711704209234577,0,1,cellular response to epinephrine stimulus,BP,
3027,GO:0071897,1,0.655086466259755,0,1,DNA biosynthetic process,BP,
3029,GO:0071901,1,0.583640461943381,0,1,negative regulation of protein serine/threonine kinase activity,BP,
3048,GO:0072331,1,0.583640461943381,0,1,signal transduction by p53 class mediator,BP,
3049,GO:0072332,1,0.583640461943381,0,1,intrinsic apoptotic signaling pathway by p53 class mediator,BP,
3050,GO:0072338,1,0.859384162384488,0,1,cellular lactam metabolic process,BP,
3051,GO:0072350,1,0.355565779713859,0,3,tricarboxylic acid metabolic process,BP,
3054,GO:0072376,1,0.495558916702705,0,2,protein activation cascade,BP,
3055,GO:0072378,1,0.700914309098006,0,1,blood coagulation, fibrin clot formation,BP,
3056,GO:0072503,1,0.260295466360574,0,3,cellular divalent inorganic cation homeostasis,BP,
3057,GO:0072507,1,0.260295466360574,0,3,divalent inorganic cation homeostasis,BP,
3058,GO:0072511,1,0.401830738437191,0,2,divalent inorganic cation transport,BP,
3063,GO:0072525,1,0.433876173620188,0,2,pyridine-containing compound biosynthetic process,BP,
3064,GO:0072526,1,0.691634315525481,0,1,pyridine-containing compound catabolic process,BP,
3065,GO:0072557,1,0.612964205012402,0,1,IPAF inflammasome complex,CC,
3066,GO:0072558,1,0.583640461943381,0,1,NLRP1 inflammasome complex,CC,
3067,GO:0072559,1,0.355678835293696,0,2,NLRP3 inflammasome complex,CC,
3068,GO:0072562,1,0.709208929974408,0,1,blood microparticle,CC,
3069,GO:0072593,1,0.206895236106891,0,5,reactive oxygen species metabolic process,BP,
3070,GO:0072594,1,0.616295371802482,0,1,establishment of protein localization to organelle,BP,
3071,GO:0072604,1,0.583640461943381,0,1,interleukin-6 secretion,BP,
3072,GO:0072606,1,0.583640461943381,0,1,interleukin-8 secretion,BP,
3073,GO:0072608,1,0.583640461943381,0,1,interleukin-10 secretion,BP,
3079,GO:0080135,1,0.231955255542508,0,3,regulation of cellular response to stress,BP,
3080,GO:0080171,1,0.653661854217472,0,1,lytic vacuole organization,BP,
3081,GO:0086036,1,0.560477493310972,0,1,regulation of cardiac muscle cell membrane potential,BP,
3082,GO:0089711,1,0.79420415032525,0,1,L-glutamate transmembrane transport,BP,
3093,GO:0090195,1,0.583640461943381,0,1,chemokine secretion,BP,
3094,GO:0090196,1,0.583640461943381,0,1,regulation of chemokine secretion,BP,
3095,GO:0090197,1,0.583640461943381,0,1,positive regulation of chemokine secretion,BP,
3096,GO:0090199,1,0.357630949940387,0,2,regulation of release of cytochrome c from mitochondria,BP,
3097,GO:0090200,1,0.583640461943381,0,1,positive regulation of release of cytochrome c from mitochondria,BP,
3098,GO:0090201,1,0.616295371802482,0,1,negative regulation of release of cytochrome c from mitochondria,BP,
3100,GO:0090207,1,0.655086466259755,0,1,regulation of triglyceride metabolic process,BP,
3101,GO:0090208,1,0.655086466259755,0,1,positive regulation of triglyceride metabolic process,BP,
3102,GO:0090257,1,0.616295371802482,0,1,regulation of muscle system process,BP,
3108,GO:0090305,1,0.492970366688253,0,2,nucleic acid phosphodiester bond hydrolysis,BP,
3109,GO:0090322,1,0.655086466259755,0,1,regulation of superoxide metabolic process,BP,
3111,GO:0090484,1,0.600923415171073,0,1,drug transporter activity,MF,
3112,GO:0090501,1,0.492970366688253,0,2,RNA phosphodiester bond hydrolysis,BP,
3113,GO:0090502,1,0.839081013955894,0,1,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
3114,GO:0090533,1,0.560477493310972,0,1,cation-transporting ATPase complex,CC,
3120,GO:0097028,1,0.593247054739141,0,1,dendritic cell differentiation,BP,
3122,GO:0097060,1,0.941673510689999,0,1,synaptic membrane,CC,
3123,GO:0097089,1,0.636162746596575,0,1,methyl-branched fatty acid metabolic process,BP,
3124,GO:0097153,1,0.355678835293696,0,2,cysteine-type endopeptidase activity involved in apoptotic process,MF,
3127,GO:0097169,1,0.355678835293696,0,2,AIM2 inflammasome complex,CC,
3131,GO:0097193,1,0.216764644748221,0,3,intrinsic apoptotic signaling pathway,BP,
3132,GO:0097194,1,0.612964205012402,0,1,execution phase of apoptosis,BP,
3133,GO:0097200,1,0.612964205012402,0,1,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
3135,GO:0097223,1,0.653661854217472,0,1,sperm part,CC,
3139,GO:0097340,1,0.616295371802482,0,1,inhibition of cysteine-type endopeptidase activity,BP,
3140,GO:0097341,1,0.616295371802482,0,1,zymogen inhibition,BP,
3144,GO:0097421,1,0.655086466259755,0,1,liver regeneration,BP,
3145,GO:0097425,1,0.641908063478118,0,1,smooth endoplasmic reticulum part,CC,
3146,GO:0097435,1,0.206860194262745,0,3,supramolecular fiber organization,BP,
3148,GO:0097485,1,0.65227670309888,0,1,neuron projection guidance,BP,
3151,GO:0097553,1,0.616295371802482,0,1,calcium ion transmembrane import into cytosol,BP,
3153,GO:0097696,1,0.53446429230772,0,2,STAT cascade,BP,
3155,GO:0097722,1,0.655086466259755,0,1,sperm motility,BP,
3156,GO:0098533,1,0.560477493310972,0,1,ATPase dependent transmembrane transport complex,CC,
3163,GO:0098590,1,0.941673510689999,0,1,plasma membrane region,CC,
3167,GO:0098655,1,0.0797592550821367,0,5,cation transmembrane transport,BP,
3168,GO:0098656,1,0.328867107415658,0,3,anion transmembrane transport,BP,
3169,GO:0098657,1,0.79420415032525,0,1,import into cell,BP,
3170,GO:0098660,1,0.0797592550821367,0,5,inorganic ion transmembrane transport,BP,
3171,GO:0098661,1,0.560477493310972,0,1,inorganic anion transmembrane transport,BP,
3172,GO:0098662,1,0.0797592550821367,0,5,inorganic cation transmembrane transport,BP,
3176,GO:0098754,1,0.376275415020107,0,2,detoxification,BP,
3177,GO:0098771,1,0.093944078970059,0,6,inorganic ion homeostasis,BP,
3180,GO:0098781,1,0.589082786340178,0,1,ncRNA transcription,BP,
3182,GO:0098794,1,0.941673510689999,0,1,postsynapse,CC,
3189,GO:0098869,1,0.376275415020107,0,2,cellular oxidant detoxification,BP,
3194,GO:0099094,1,0.941673510689999,0,1,ligand-gated cation channel activity,MF,
3201,GO:0099565,1,0.941673510689999,0,1,chemical synaptic transmission, postsynaptic,BP,
3202,GO:0099568,1,0.821441120987107,0,1,cytoplasmic region,CC,
3203,GO:0099600,1,0.338744046042821,0,4,transmembrane receptor activity,MF,
3204,GO:0101002,1,0.300213739318899,0,3,ficolin-1-rich granule,CC,
3205,GO:0102007,1,0.634317961549412,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
3207,GO:0102336,1,0.762488370432474,0,1,3-oxo-arachidoyl-CoA synthase activity,MF,
3208,GO:0102337,1,0.762488370432474,0,1,3-oxo-cerotoyl-CoA synthase activity,MF,
3209,GO:0102338,1,0.762488370432474,0,1,3-oxo-lignoceronyl-CoA synthase activity,MF,
3212,GO:1900046,1,0.986830983483857,0,1,regulation of hemostasis,BP,
3213,GO:1900076,1,0.839081013955894,0,1,regulation of cellular response to insulin stimulus,BP,
3214,GO:1900078,1,0.839081013955894,0,1,positive regulation of cellular response to insulin stimulus,BP,
3215,GO:1900180,1,0.616295371802482,0,1,regulation of protein localization to nucleus,BP,
3216,GO:1900274,1,0.589082786340178,0,1,regulation of phospholipase C activity,BP,
3217,GO:1900371,1,0.578183005063771,0,1,regulation of purine nucleotide biosynthetic process,BP,
3218,GO:1900373,1,0.578183005063771,0,1,positive regulation of purine nucleotide biosynthetic process,BP,
3219,GO:1900407,1,0.401830738437191,0,2,regulation of cellular response to oxidative stress,BP,
3220,GO:1900408,1,0.616295371802482,0,1,negative regulation of cellular response to oxidative stress,BP,
3221,GO:1900409,1,0.655086466259755,0,1,positive regulation of cellular response to oxidative stress,BP,
3222,GO:1900542,1,0.578183005063771,0,1,regulation of purine nucleotide metabolic process,BP,
3223,GO:1900544,1,0.578183005063771,0,1,positive regulation of purine nucleotide metabolic process,BP,
3225,GO:1901019,1,0.655086466259755,0,1,regulation of calcium ion transmembrane transporter activity,BP,
3226,GO:1901021,1,0.655086466259755,0,1,positive regulation of calcium ion transmembrane transporter activity,BP,
3229,GO:1901031,1,0.655086466259755,0,1,regulation of response to reactive oxygen species,BP,
3230,GO:1901033,1,0.655086466259755,0,1,positive regulation of response to reactive oxygen species,BP,
3231,GO:1901052,1,0.764401591462327,0,1,sarcosine metabolic process,BP,
3232,GO:1901053,1,0.764401591462327,0,1,sarcosine catabolic process,BP,
3236,GO:1901184,1,0.65227670309888,0,1,regulation of ERBB signaling pathway,BP,
3237,GO:1901186,1,0.65227670309888,0,1,positive regulation of ERBB signaling pathway,BP,
3238,GO:1901214,1,0.711704209234577,0,1,regulation of neuron death,BP,
3239,GO:1901215,1,0.711704209234577,0,1,negative regulation of neuron death,BP,
3244,GO:1901317,1,0.655086466259755,0,1,regulation of flagellated sperm motility,BP,
3245,GO:1901318,1,0.655086466259755,0,1,negative regulation of flagellated sperm motility,BP,
3255,GO:1901568,1,0.313557450150904,0,3,fatty acid derivative metabolic process,BP,
3256,GO:1901570,1,0.498144391540649,0,2,fatty acid derivative biosynthetic process,BP,
3261,GO:1901607,1,0.592226348561825,0,2,alpha-amino acid biosynthetic process,BP,
3266,GO:1901653,1,0.24580280436158,0,5,cellular response to peptide,BP,
3268,GO:1901655,1,0.711704209234577,0,1,cellular response to ketone,BP,
3270,GO:1901658,1,0.270678885256802,0,3,glycosyl compound catabolic process,BP,
3271,GO:1901668,1,0.655086466259755,0,1,regulation of superoxide dismutase activity,BP,
3272,GO:1901671,1,0.655086466259755,0,1,positive regulation of superoxide dismutase activity,BP,
3274,GO:1901685,1,0.577407483649635,0,1,glutathione derivative metabolic process,BP,
3275,GO:1901687,1,0.577407483649635,0,1,glutathione derivative biosynthetic process,BP,
3282,GO:1901879,1,0.612519110445417,0,1,regulation of protein depolymerization,BP,
3283,GO:1901880,1,0.612519110445417,0,1,negative regulation of protein depolymerization,BP,
3284,GO:1901894,1,0.655086466259755,0,1,regulation of calcium-transporting ATPase activity,BP,
3285,GO:1901896,1,0.655086466259755,0,1,positive regulation of calcium-transporting ATPase activity,BP,
3286,GO:1901981,1,0.752322012235064,0,1,phosphatidylinositol phosphate binding,MF,
3292,GO:1902001,1,0.74593727007522,0,1,fatty acid transmembrane transport,BP,
3297,GO:1902106,1,0.593247054739141,0,1,negative regulation of leukocyte differentiation,BP,
3303,GO:1902175,1,0.616295371802482,0,1,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
3304,GO:1902176,1,0.616295371802482,0,1,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
3305,GO:1902221,1,0.590930005023909,0,1,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
3306,GO:1902222,1,0.590930005023909,0,1,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
3308,GO:1902305,1,0.560477493310972,0,1,regulation of sodium ion transmembrane transport,BP,
3309,GO:1902307,1,0.560477493310972,0,1,positive regulation of sodium ion transmembrane transport,BP,
3310,GO:1902311,1,0.64381053571965,0,1,regulation of copper ion transmembrane transport,BP,
3311,GO:1902475,1,0.79420415032525,0,1,L-alpha-amino acid transmembrane transport,BP,
3312,GO:1902476,1,0.560477493310972,0,1,chloride transmembrane transport,BP,
3315,GO:1902524,1,0.623289805927393,0,1,positive regulation of protein K48-linked ubiquitination,BP,
3319,GO:1902554,1,0.583640461943381,0,1,serine/threonine protein kinase complex,CC,
3320,GO:1902555,1,0.587339765995185,0,1,endoribonuclease complex,CC,
3325,GO:1902593,1,0.616295371802482,0,1,single-organism nuclear import,BP,
3326,GO:1902600,1,0.578797687193198,0,1,hydrogen ion transmembrane transport,BP,
3329,GO:1902656,1,0.616295371802482,0,1,calcium ion import into cytosol,BP,
3330,GO:1902679,1,0.370047057446183,0,2,negative regulation of RNA biosynthetic process,BP,
3337,GO:1902882,1,0.401830738437191,0,2,regulation of response to oxidative stress,BP,
3338,GO:1902883,1,0.616295371802482,0,1,negative regulation of response to oxidative stress,BP,
3339,GO:1902884,1,0.655086466259755,0,1,positive regulation of response to oxidative stress,BP,
3340,GO:1902903,1,0.355418010872913,0,2,regulation of supramolecular fiber organization,BP,
3341,GO:1902904,1,0.612519110445417,0,1,negative regulation of supramolecular fiber organization,BP,
3342,GO:1902905,1,0.583640461943381,0,1,positive regulation of supramolecular fiber organization,BP,
3343,GO:1902911,1,0.583640461943381,0,1,protein kinase complex,CC,
3344,GO:1902914,1,0.623289805927393,0,1,regulation of protein polyubiquitination,BP,
3345,GO:1902916,1,0.623289805927393,0,1,positive regulation of protein polyubiquitination,BP,
3348,GO:1902936,1,0.752322012235064,0,1,phosphatidylinositol bisphosphate binding,MF,
3349,GO:1903010,1,0.655086466259755,0,1,regulation of bone development,BP,
3350,GO:1903011,1,0.655086466259755,0,1,negative regulation of bone development,BP,
3351,GO:1903034,1,0.986830983483857,0,1,regulation of response to wounding,BP,
3357,GO:1903169,1,0.655086466259755,0,1,regulation of calcium ion transmembrane transport,BP,
3358,GO:1903173,1,0.651403359485368,0,1,fatty alcohol metabolic process,BP,
3359,GO:1903201,1,0.616295371802482,0,1,regulation of oxidative stress-induced cell death,BP,
3360,GO:1903202,1,0.616295371802482,0,1,negative regulation of oxidative stress-induced cell death,BP,
3361,GO:1903273,1,0.560477493310972,0,1,regulation of sodium ion export,BP,
3362,GO:1903275,1,0.560477493310972,0,1,positive regulation of sodium ion export,BP,
3363,GO:1903276,1,0.560477493310972,0,1,regulation of sodium ion export from cell,BP,
3364,GO:1903278,1,0.560477493310972,0,1,positive regulation of sodium ion export from cell,BP,
3365,GO:1903305,1,0.705187209057733,0,1,regulation of regulated secretory pathway,BP,
3366,GO:1903317,1,0.435342303308956,0,2,regulation of protein maturation,BP,
3367,GO:1903318,1,0.616295371802482,0,1,negative regulation of protein maturation,BP,
3373,GO:1903409,1,0.286008402283601,0,3,reactive oxygen species biosynthetic process,BP,
3374,GO:1903426,1,0.286008402283601,0,3,regulation of reactive oxygen species biosynthetic process,BP,
3375,GO:1903427,1,0.403600025965013,0,2,negative regulation of reactive oxygen species biosynthetic process,BP,
3376,GO:1903428,1,0.713969292256814,0,1,positive regulation of reactive oxygen species biosynthetic process,BP,
3378,GO:1903507,1,0.567926568876566,0,1,negative regulation of nucleic acid-templated transcription,BP,
3381,GO:1903510,1,0.439379228515079,0,2,mucopolysaccharide metabolic process,BP,
3382,GO:1903514,1,0.616295371802482,0,1,calcium ion transport from endoplasmic reticulum to cytosol,BP,
3386,GO:1903533,1,0.616295371802482,0,1,regulation of protein targeting,BP,
3390,GO:1903610,1,0.655086466259755,0,1,regulation of calcium-dependent ATPase activity,BP,
3391,GO:1903611,1,0.655086466259755,0,1,negative regulation of calcium-dependent ATPase activity,BP,
3392,GO:1903624,1,0.655086466259755,0,1,regulation of DNA catabolic process,BP,
3393,GO:1903625,1,0.655086466259755,0,1,negative regulation of DNA catabolic process,BP,
3394,GO:1903627,1,0.655086466259755,0,1,regulation of dUTP diphosphatase activity,BP,
3395,GO:1903629,1,0.655086466259755,0,1,positive regulation of dUTP diphosphatase activity,BP,
3396,GO:1903630,1,0.655086466259755,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
3397,GO:1903631,1,0.655086466259755,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
3398,GO:1903633,1,0.655086466259755,0,1,regulation of leucine-tRNA ligase activity,BP,
3399,GO:1903634,1,0.655086466259755,0,1,negative regulation of leucine-tRNA ligase activity,BP,
3401,GO:1903707,1,0.593247054739141,0,1,negative regulation of hemopoiesis,BP,
3403,GO:1903725,1,0.223824828125612,0,3,regulation of phospholipid metabolic process,BP,
3404,GO:1903726,1,0.555979667472001,0,1,negative regulation of phospholipid metabolic process,BP,
3405,GO:1903727,1,0.596972964066786,0,1,positive regulation of phospholipid metabolic process,BP,
3406,GO:1903779,1,0.560477493310972,0,1,regulation of cardiac conduction,BP,
3407,GO:1903825,1,0.591265338401167,0,2,organic acid transmembrane transport,BP,
3408,GO:1903827,1,0.347915894904772,0,2,regulation of cellular protein localization,BP,
3409,GO:1903900,1,0.839081013955894,0,1,regulation of viral life cycle,BP,
3410,GO:1903901,1,0.839081013955894,0,1,negative regulation of viral life cycle,BP,
3411,GO:1904062,1,0.232721929639651,0,3,regulation of cation transmembrane transport,BP,
3412,GO:1904064,1,0.365154074377246,0,2,positive regulation of cation transmembrane transport,BP,
3414,GO:1904251,1,0.711704209234577,0,1,regulation of bile acid metabolic process,BP,
3415,GO:1904253,1,0.711704209234577,0,1,positive regulation of bile acid metabolic process,BP,
3416,GO:1904406,1,0.403600025965013,0,2,negative regulation of nitric oxide metabolic process,BP,
3417,GO:1904407,1,0.713969292256814,0,1,positive regulation of nitric oxide metabolic process,BP,
3418,GO:1904427,1,0.655086466259755,0,1,positive regulation of calcium ion transmembrane transport,BP,
3419,GO:1904589,1,0.616295371802482,0,1,regulation of protein import,BP,
3420,GO:1904645,1,0.612964205012402,0,1,response to beta-amyloid,BP,
3421,GO:1904646,1,0.612964205012402,0,1,cellular response to beta-amyloid,BP,
3425,GO:1904724,1,0.685412997987241,0,1,tertiary granule lumen,CC,
3426,GO:1904813,1,0.300213739318899,0,3,ficolin-1-rich granule lumen,CC,
3427,GO:1904833,1,0.655086466259755,0,1,positive regulation of removal of superoxide radicals,BP,
3430,GO:1904892,1,0.859384162384488,0,1,regulation of STAT cascade,BP,
3431,GO:1904894,1,0.859384162384488,0,1,positive regulation of STAT cascade,BP,
3432,GO:1904949,1,0.560477493310972,0,1,ATPase complex,CC,
3435,GO:1905039,1,0.591265338401167,0,2,carboxylic acid transmembrane transport,BP,
3438,GO:1905348,1,0.587339765995185,0,1,endonuclease complex,CC,
3446,GO:1990001,1,0.616295371802482,0,1,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
3451,GO:1990542,1,0.74593727007522,0,1,mitochondrial transmembrane transport,BP,
3452,GO:1990748,1,0.376275415020107,0,2,cellular detoxification,BP,
3453,GO:1990777,1,0.555979667472001,0,1,lipoprotein particle,CC,
3456,GO:2000021,1,0.616295371802482,0,1,regulation of ion homeostasis,BP,
3464,GO:2000113,1,0.215460154862235,0,3,negative regulation of cellular macromolecule biosynthetic process,BP,
3466,GO:2000117,1,0.616295371802482,0,1,negative regulation of cysteine-type endopeptidase activity,BP,
3467,GO:2000121,1,0.655086466259755,0,1,regulation of removal of superoxide radicals,BP,
3471,GO:2000146,1,0.655086466259755,0,1,negative regulation of cell motility,BP,
3473,GO:2000209,1,0.798192256085599,0,1,regulation of anoikis,BP,
3474,GO:2000257,1,0.709208929974408,0,1,regulation of protein activation cascade,BP,
3475,GO:2000278,1,0.655086466259755,0,1,regulation of DNA biosynthetic process,BP,
3476,GO:2000279,1,0.655086466259755,0,1,negative regulation of DNA biosynthetic process,BP,
3477,GO:2000377,1,0.286008402283601,0,3,regulation of reactive oxygen species metabolic process,BP,
3478,GO:2000378,1,0.403600025965013,0,2,negative regulation of reactive oxygen species metabolic process,BP,
3479,GO:2000379,1,0.466072964877703,0,2,positive regulation of reactive oxygen species metabolic process,BP,
3490,GO:2000482,1,0.583640461943381,0,1,regulation of interleukin-8 secretion,BP,
3491,GO:2000484,1,0.583640461943381,0,1,positive regulation of interleukin-8 secretion,BP,
3494,GO:2000649,1,0.560477493310972,0,1,regulation of sodium ion transmembrane transporter activity,BP,
3495,GO:2000778,1,0.583640461943381,0,1,positive regulation of interleukin-6 secretion,BP,
3497,GO:2000811,1,0.798192256085599,0,1,negative regulation of anoikis,BP,
3498,GO:2001014,1,0.599447363464003,0,1,regulation of skeletal muscle cell differentiation,BP,
3499,GO:2001015,1,0.599447363464003,0,1,negative regulation of skeletal muscle cell differentiation,BP,
3503,GO:2001057,1,0.286008402283601,0,3,reactive nitrogen species metabolic process,BP,
3505,GO:2001179,1,0.583640461943381,0,1,regulation of interleukin-10 secretion,BP,
3506,GO:2001181,1,0.583640461943381,0,1,positive regulation of interleukin-10 secretion,BP,
3507,GO:2001198,1,0.593247054739141,0,1,regulation of dendritic cell differentiation,BP,
3508,GO:2001199,1,0.593247054739141,0,1,negative regulation of dendritic cell differentiation,BP,
3515,GO:2001242,1,0.357630949940387,0,2,regulation of intrinsic apoptotic signaling pathway,BP,
3516,GO:2001243,1,0.616295371802482,0,1,negative regulation of intrinsic apoptotic signaling pathway,BP,
3517,GO:2001245,1,0.596972964066786,0,1,regulation of phosphatidylcholine biosynthetic process,BP,
3520,GO:2001273,1,0.839081013955894,0,1,regulation of glucose import in response to insulin stimulus,BP,
3521,GO:2001275,1,0.839081013955894,0,1,positive regulation of glucose import in response to insulin stimulus,BP,
3062,GO:0072524,1,0.0811599805757491,0,7,pyridine-containing compound metabolic process,BP,
